The present invention relates generally to systems and methods for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor.
Diabetes mellitus is a disorder in which the pancreas cannot create sufficient insulin (Type I or insulin dependent) and/or in which insulin is not effective (Type 2 or non-insulin dependent). In the diabetic state, the victim suffers from high blood sugar, which causes an array of physiological derangements (kidney failure, skin ulcers, or bleeding into the vitreous of the eye) associated with the deterioration of small blood vessels. A hypoglycemic reaction (low blood sugar) may be induced by an inadvertent overdose of insulin, or after a normal dose of insulin or glucose-lowering agent accompanied by extraordinary exercise or insufficient food intake.
Conventionally, a diabetic person carries a self-monitoring blood glucose (SMBG) monitor, which typically requires uncomfortable finger pricking methods. Due to the lack of comfort and convenience, a diabetic will normally only measure his or her glucose level two to four times per day. Unfortunately, these time intervals are spread so far apart that the diabetic will likely find out too late, sometimes incurring dangerous side effects, of a hyperglycemic or hypoglycemic condition. In fact, it is not only unlikely that a diabetic will take a timely SMBG value, but additionally the diabetic will not know if his blood glucose value is going up (higher) or down (lower) based on conventional methods.
Consequently, a variety of non-invasive, transdermal (e.g., transcutaneous) and/or implantable electrochemical sensors are being developed for continuously detecting and/or quantifying blood glucose values. These devices generally transmit raw or minimally processed data for subsequent analysis at a remote device, which can include a display.
In one embodiment, a system for continuous measurement of an analyte in a host comprises a continuous analyte sensor configured to measure a concentration of an analyte in a host, a sensor electronics module physically connected to the continuous analyte sensor during operation of the continuous analyte sensor, wherein the sensor electronics module is configured to process a data stream associated with an analyte concentration measured by the continuous analyte sensor and to generate displayable sensor information based on at least some sensor data of the data stream. In one embodiment, the sensor electronics module comprises a storage device configured to store at least some of the displayable sensor information and a telemetry module configured to wirelessly transmit a first portion of the displayable sensor information to a first display device, wherein the first portion of displayable sensor information is formatted for display on the first display device, and to wirelessly transmit a second portion of the displayable sensor information to a second display device, wherein the second portion of displayable sensor information is formatted for display on the second display device.
In one embodiment, a computerized method for customizing displayable sensor information that is transmitted to display devices comprises determining analyte concentration data associated with a host based at least on sensor data from a continuous analyte sensor associated with the host, generating displayable sensor information based on at least some of the analyte concentration data, storing at least some of the displayable sensor information on a storage device, wirelessly transmitting a first portion of the displayable sensor information to a first display device and wirelessly transmitting a second portion of the displayable sensor information to a second display device. In one embodiment the first portion of displayable sensor information is formatted for display on the first display device and the second portion of displayable sensor information is formatted for display on the second display device.
In one embodiment, a computer readable medium stores software code thereon, the software code configured for execution by one or more processors of a sensor electronics module configured for coupling to an analyte sensor that is attached to a host, wherein the software code, if executed by the one or more processors, causes the sensor electronics module to perform a method comprising determining analyte concentration data associated with a host based at least on sensor data from a continuous analyte sensor associated with the host, generating displayable sensor information based on at least some of the analyte concentration data, storing at least some of the displayable sensor information on a storage device, wirelessly transmitting a first portion of the displayable sensor information to a first display device, and wirelessly transmitting a second portion of the displayable sensor information to a second display device. In one embodiment, the first portion of displayable sensor information is formatted for display on the first display device and the second portion of displayable sensor information is formatted for display on the second display device.
The following description and examples illustrate some exemplary embodiments of the disclosed invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a certain exemplary embodiment should not be deemed to limit the scope of the present invention.
Definitions
In order to facilitate an understanding of the systems and methods discussed herein, a number of terms are defined below. The terms defined below, as well as other terms used herein, should be construed to include the provided definitions, the ordinary and customary meaning of the terms, and any other implied meaning for the respective terms. Thus, the definitions below do not limit the meaning of these terms, but only provide exemplary definitions.
The term “analyte” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a substance or chemical constituent in a biological fluid (for example, blood, interstitial fluid, cerebral spinal fluid, lymph fluid or urine) that can be analyzed. Analytes can include naturally occurring substances, artificial substances, metabolites, and/or reaction products. In some embodiments, the analyte for measurement by the sensor heads, devices, and methods is analyte. However, other analytes are contemplated as well, including but not limited to acarboxyprothrombin; acylcarnitine; adenine phosphoribosyl transferase; adenosine deaminase; albumin; alpha-fetoprotein; amino acid profiles (arginine (Krebs cycle), histidine/urocanic acid, homocysteine, phenylalanine/tyrosine, tryptophan); andrenostenedione; antipyrine; arabinitol enantiomers; arginase; benzoylecgonine (cocaine); biotinidase; biopterin; c-reactive protein; camitine; camosinase; CD4; ceruloplasmin; chenodeoxycholic acid; chloroquine; cholesterol; cholinesterase; conjugated 1-β hydroxy-cholic acid; cortisol; creatine kinase; creatine kinase MM isoenzyme; cyclosporin A; d-penicillamine; de-ethylchloroquine; dehydroepiandrosterone sulfate; DNA (acetylator polymorphism, alcohol dehydrogenase, alpha 1-antitrypsin, cystic fibrosis, Duchenne/Becker muscular dystrophy, analyte-6-phosphate dehydrogenase, hemoglobin A, hemoglobin S, hemoglobin C, hemoglobin D, hemoglobin E, hemoglobin F, D-Punjab, beta-thalassemia, hepatitis B virus, HCMV, HIV-1, HTLV-1, Leber hereditary optic neuropathy, MCAD, RNA, PKU, Plasmodium vivax, sexual differentiation, 21-deoxycortisol); desbutylhalofantrine; dihydropteridine reductase; diptheria/tetanus antitoxin; erythrocyte arginase; erythrocyte protoporphyrin; esterase D; fatty acids/acylglycines; free β-human chorionic gonadotropin; free erythrocyte porphyrin; free thyroxine (FT4); free tri-iodothyronine (FT3); fumarylacetoacetase; galactose/gal-1-phosphate; galactose-1-phosphate uridyltransferase; gentamicin; analyte-6-phosphate dehydrogenase; glutathione; glutathione perioxidase; glycocholic acid; glycosylated hemoglobin; halofantrine; hemoglobin variants; hexosaminidase A; human erythrocyte carbonic anhydrase I; 17-alpha-hydroxyprogesterone; hypoxanthine phosphoribosyl transferase; immunoreactive trypsin; lactate; lead; lipoproteins ((a), B/A-1, β); lysozyme; mefloquine; netilmicin; phenobarbitone; phenytoin; phytanic/pristanic acid; progesterone; prolactin; prolidase; purine nucleoside phosphorylase; quinine; reverse tri-iodothyronine (rT3); selenium; serum pancreatic lipase; sissomicin; somatomedin C; specific antibodies (adenovirus, anti-nuclear antibody, anti-zeta antibody, arbovirus, Aujeszky's disease virus, dengue virus, Dracunculus medinensis, Echinococcus granulosus, Entamoeba histolytica, enterovirus, Giardia duodenalisa, Helicobacter pylori, hepatitis B virus, herpes virus, HIV-1, IgE (atopic disease), influenza virus, Leishmania donovani, leptospira, measles/mumps/rubella, Mycobacterium leprae, Mycoplasma pneumoniae, Myoglobin, Onchocerca volvulus, parainfluenza virus, Plasmodium falciparum, poliovirus, Pseudomonas aeruginosa, respiratory syncytial virus, rickettsia (scrub typhus), Schistosoma mansoni, Toxoplasma gondii, Trepenoma pallidium, Trypanosoma cruzi/rangeli, vesicular stomatis virus, Wuchereria bancrofti, yellow fever virus); specific antigens (hepatitis B virus, HIV-1); succinylacetone; sulfadoxine; theophylline; thyrotropin (TSH); thyroxine (T4); thyroxine-binding globulin; trace elements; transferring; UDP-galactose-4-epimerase; urea; uroporphyrinogen I synthase; vitamin A; white blood cells; and zinc protoporphyrin. Salts, sugar, protein, fat, vitamins, and hormones naturally occurring in blood or interstitial fluids can also constitute analytes in certain embodiments. The analyte can be naturally present in the biological fluid, for example, a metabolic product, a hormone, an antigen, an antibody, and the like. Alternatively, the analyte can be introduced into the body, for example, a contrast agent for imaging, a radioisotope, a chemical agent, a fluorocarbon-based synthetic blood, or a drug or pharmaceutical composition, including but not limited to insulin; ethanol; cannabis (marijuana, tetrahydrocannabinol, hashish); inhalants (nitrous oxide, amyl nitrite, butyl nitrite, chlorohydrocarbons, hydrocarbons); cocaine (crack cocaine); stimulants (amphetamines, methamphetamines, Ritalin, Cylert, Preludin, Didrex, PreState, Voranil, Sandrex, Plegine); depressants (barbituates, methaqualone, tranquilizers such as Valium, Librium, Miltown, Serax, Equanil, Tranxene); hallucinogens (phencyclidine, lysergic acid, mescaline, peyote, psilocybin); narcotics (heroin, codeine, morphine, opium, meperidine, Percocet, Percodan, Tussionex, Fentanyl, Darvon, Talwin, Lomotil); designer drugs (analogs of fentanyl, meperidine, amphetamines, methamphetamines, and phencyclidine, for example, Ecstasy); anabolic steroids; and nicotine. The metabolic products of drugs and pharmaceutical compositions are also contemplated analytes. Analytes such as neurochemicals and other chemicals generated within the body can also be analyzed, such as, for example, ascorbic acid, uric acid, dopamine, noradrenaline, 3-methoxytyramine (3MT), 3,4-Dihydroxyphenylacetic acid (DOPAC), Homovanillic acid (HVA), 5-Hydroxytryptamine (5HT), and 5-Hydroxyindoleacetic acid (FHIAA).
The term “A/D Converter” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to hardware and/or software that converts analog electrical signals into corresponding digital signals.
The terms “processor module,” “microprocessor” and “processor” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to a computer system, state machine, and the like that performs arithmetic and logic operations using logic circuitry that responds to and processes the basic instructions that drive a computer.
The terms “sensor data”, as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refers without limitation to any data associated with a sensor, such as a continuous analyte sensor. Sensor data includes a raw data stream, or simply data stream, of analog or digital signal directly related to a measured analyte from an analyte sensor (or other signal received from another sensor), as well as calibrated and/or filtered raw data. In one example, the sensor data comprises digital data in “counts” converted by an A/D converter from an analog signal (e.g., voltage or amps) and includes one or more data points representative of a glucose concentration. Thus, the terms “sensor data point” and “data point” refer generally to a digital representation of sensor data at a particular time. The term broadly encompasses a plurality of time spaced data points from a sensor, such as a from a substantially continuous glucose sensor, which comprises individual measurements taken at time intervals ranging from fractions of a second up to, e.g., 1, 2, or 5 minutes or longer. In another example, the sensor data includes an integrated digital value representative of one or more data points averaged over a time period. Sensor data may include calibrated data, smoothed data, filtered data, transformed data, and/or any other data associated with a sensor.
The term “calibration” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a process of determining a relationship between a raw data stream and corresponding reference data, which can be used to convert raw data into calibrated data (defined below). In some embodiments, such as continuous analyte sensors, for example, calibration can be updated or recalibrated over time as changes in the relationship between the raw data and reference data occur, for example, due to changes in sensitivity, baseline, transport, metabolism, and the like.
The terms “calibrated data” and “calibrated data stream” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to data that has been transformed from its raw state to another state using a function, for example a conversion function, to provide a meaningful value to a user.
The terms “smoothed data” and “filtered data” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to data that has been modified to make it smoother and more continuous and/or to remove or diminish outlying points, for example, by performing a moving average of the raw data stream. Examples of data filters include FIR (finite impulse response), IIR (infinite impulse response), moving average filters, and the like.
The terms “smoothing” and “filtering” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to a mathematical computation that attenuates or normalizes components of a signal, such as reducing noise errors in a raw data stream. In some embodiments, smoothing refers to modification of a data stream to make it smoother and more continuous or to remove or diminish outlying data points, for example, by performing a moving average of the raw data stream.
The term “noise signal” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a signal associated with noise on the data stream (e.g., non-analyte related signal). The noise signal can be determined by filtering and/or averaging, for example. In some embodiments, the noise signal is a signal residual, delta residual (difference of residual), absolute delta residual, and/or the like, which are described in more detail elsewhere herein.
The term “algorithm” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a computational process (associated with computer programming or other written instructions) involved in transforming information from one state to another.
The term “matched data pairs” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to reference data (for example, one or more reference analyte data points) matched with substantially time corresponding sensor data (for example, one or more sensor data points).
The term “counts” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a unit of measurement of a digital signal. In one example, a raw data stream measured in counts is directly related to a voltage (e.g., converted by an A/D converter), which is directly related to current from the working electrode. In another example, counter electrode voltage measured in counts is directly related to a voltage.
The term “sensor” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to any device (or portion of a device) that measures a physical quantity and converts it into a signal that can be processed by analog and/or digital circuitry. Thus, the output of a sensor may be an analog and/or digital signal. Examples of sensors include analyte sensors, glucose sensors, temperature sensors, altitude sensors, accelerometers, and heart rate sensors.
The terms “glucose sensor” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to any sensor by which glucose can be quantified (e.g., enzymatic or non-enzymatic). For example, some embodiments of a glucose sensor may utilize a membrane that contains glucose oxidase that catalyzes the conversion of oxygen and glucose to hydrogen peroxide and gluconate, as illustrated by the following chemical reaction:
Glucose+O2→Gluconate+H2O2
Because for each glucose molecule metabolized, there is a proportional change in the co-reactant O2 and the product H2O2, one can use an electrode to monitor the current change in either the co-reactant or the product to determine glucose concentration.
The terms “coupled”, “operably connected” and “operably linked” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to one or more components being linked to another component(s), either directly or indirectly, in a manner that allows transmission of signals between the components. For example, modules of a computing device that communicate via a common data bus are coupled to one another. As another example, one or more electrodes of a glucose sensor can be used to detect the amount of glucose in a sample and convert that information into a signal, e.g., an electrical or electromagnetic signal; the signal can then be transmitted to an electronic circuit. In this case, the electrode is “operably linked” to the electronic circuitry, even though the analog signal from the electrode is transmitted and/or transformed by analog and/or digital circuitry before reaching the electronic circuit. These terms are broad enough to include wireless connectivity.
The term “physically connected” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refers without limitation to one or more components that are connected to another component(s) through direct contact and/or a wired connection, including connecting via one or more intermediate physically connecting component(s). For example, a glucose sensor may be physically connected to a sensor electronics module, and thus the processor module located therein, either directly or via one or more electrical connections.
The term “substantially” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to being largely but not necessarily wholly that which is specified.
The term “host” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to mammal, such as a human implanted with a device.
The term “continuous analyte sensor” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a device, or portion of a device, that continuously or continually measures a concentration of an analyte, for example, at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes, or longer. In one exemplary embodiment, a glucose sensor comprises a continuous analyte sensor, such as is described in U.S. Pat. No. 7,310,544, which is incorporated herein by reference in its entirety.
The term “continuous analyte sensing” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to the period in which monitoring of an analyte is continuously or continually performed, for example, at time intervals ranging from fractions of a second up to, for example, 1, 2, or 5 minutes, or longer. In one embodiment, a glucose sensor performs continuous analyte sensing in order to monitor a glucose level in a corresponding host.
The terms “reference analyte monitor,” “reference analyte meter,” and “reference analyte sensor” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to a device that measures a concentration of an analyte and can be used as a reference for a continuous analyte sensor, for example a self-monitoring blood glucose meter (SMBG) can be used as a reference for a continuous glucose sensor for comparison, calibration, and the like.
The term “clinical acceptability”, as used herein, is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and refers without limitation to determination of the risk of inaccuracies to a patient. Clinical acceptability may consider a deviation between time corresponding glucose measurements (e.g., data from a glucose sensor and data from a reference glucose monitor) and the risk (e.g., to the decision making of a diabetic patient) associated with that deviation based on the glucose value indicated by the sensor and/or reference data. One example of clinical acceptability may be 85% of a given set of measured analyte values within the “A” and “B” region of a standard Clarke Error Grid when the sensor measurements are compared to a standard reference measurement.
The term “quality of calibration” as used herein, is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and refers without limitation to the statistical association of matched data pairs in the calibration set used to create the conversion function. For example, an R-value may be calculated for a calibration set to determine its statistical data association, wherein an R-value greater than 0.79 determines a statistically acceptable calibration quality, while an R-value less than 0.79 determines statistically unacceptable calibration quality.
The term “sensor session” as used herein, is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and refers without limitation to a period of time a sensor is in use, such as but not limited to a period of time starting at the time the sensor is implanted (e.g., by the host) to removal of the sensor (e.g., removal of the sensor from the host's body and/or removal of the sensor electronics module from the sensor housing).
The terms “noise,” “noise event(s),” “noise episode(s),” “signal artifact(s),” “signal artifact event(s),” and “signal artifact episode(s)” as used herein are broad terms and are to be given their ordinary and customary meaning to a person of ordinary skill in the art (and are not to be limited to a special or customized meaning), and furthermore refer without limitation to signal noise that is substantially non-glucose related, such as interfering species, macro- or micro-motion, ischemia, pH changes, temperature changes, pressure, stress, or even unknown sources of mechanical, electrical and/or biochemical noise for example.
The term “measured analyte values” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to an analyte value or set of analyte values for a time period for which analyte data has been measured by an analyte sensor. The term is broad enough to include sensor data from the analyte sensor before or after data processing in the sensor and/or receiver (for example, data smoothing, calibration, and the like).
The term “estimated analyte values” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to an analyte value or set of analyte values, which have been algorithmically extrapolated from measured analyte values. In some embodiments, estimated analyte values are estimated for a time period during which no data exists. However, estimated analyte values can also be estimated during a time period for which measured data exists, but is to be replaced by algorithmically extrapolated (e.g. processed or filtered) data due to noise or a time lag in the measured data, for example.
The term “calibration information” as used herein is a broad term and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to any information useful in calibration of a sensor. Calibration information may include reference data received from a reference analyte monitor, including one or more reference data points, one or more matched data pairs formed by matching reference data (e.g., one or more reference glucose data points) with substantially time corresponding sensor data (e.g., one or more continuous sensor data points), a calibration set formed from a set of one or more matched data pairs, a calibration line drawn from the calibration set, in vitro parameters (e.g., sensor sensitivity), and/or a manufacturing code, for example.
The term “alarm” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to an alert or signal, such as an audible, visual, or tactile signal, triggered in response to one or more alarm conditions. In one embodiment, hyperglycemic and hypoglycemic alarms are triggered when present or predicted clinical danger is assessed based on continuous analyte data.
The term “transformed sensor data” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to any data that is derived, either fully or in part, from raw sensor data from one or more sensors. For example, raw sensor data over a time period (e.g., 5 minutes) may be processed in order to generated transformed sensor data including one or more trend indicators (e.g., a 5 minute trend). Other examples of transformed data include filtered sensor data (e.g., one or more filtered analyte concentration values), calibrated sensor data (e.g., one or more calibrated analyte concentration values), rate of change information, trend information, rate of acceleration information, sensor diagnostic information, location information, alarm/alert information, calibration information, and/or the like.
The term “sensor information” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to information associated with measurement, signal processing (including calibration), alarms, data transmission, and/or display associated with a sensor, such as a continuous analyte sensor. The term is broad enough to include raw sensor data (one or more raw analyte concentration values), as well as transformed sensor data. In some embodiments, sensor information includes displayable sensor information.
The term “displayable sensor information” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to information that is transmitted for display on one or more display devices. As is discussed elsewhere herein, the content of displayable sensor information that is transmitted to a particular display device may be customized for the particular display device. Additionally, formatting of displayable sensor information may be customized for respective display devices. Displayable sensor information may include any sensor data, including raw sensor data, transformed sensor data, and/or any information associated with measurement, signal processing (including calibration), and/or alerts associated with one or more sensors.
The term “data package” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a combination of data that is transmitted to one or more display devices, such as in response to triggering of an alert. A data package may include displayable sensor information (e.g., that has been selected and formatted for a particular display device) as well as header information, such as data indicating a delivery address, communication protocol, etc. Depending on the embodiment, a data package may comprises multiple packets of data that are separately transmitted to a display device (and reassembled at the display device) or a single block of data that is transmitted to the display device. Data packages may be formatted for transmission via any suitable communication protocol, including radio frequency, Bluetooth, universal serial bus, any of the wireless local area network (WLAN) communication standards, including the IEEE 802.11, 802.15, 802.20, 802.22 and other 802 communication protocols, and/or a proprietary communication protocol.
The term “direct wireless communication” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to a data transmission that goes from one device to another device without any intermediate data processing (e.g., data manipulation). For example, direct wireless communication between a sensor electronics module and a display device occurs when the sensor information transmitted from the sensor electronics module is received by the display device without intermediate processing of the sensor information. The term is broad enough to include wireless communication that is transmitted through a router, a repeater, a telemetry receiver (e.g., configured to re-transmit the sensor information without additional algorithmic processing), and the like. The term is also broad enough to include transformation of data format (e.g., via a Bluetooth receiver) without substantive transformation of the sensor information itself.
The term “prospective algorithm(s)” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to algorithms that process sensor information in real-time (e.g., continuously and/or periodically as sensor data is received from the continuous analyte sensor) and provide real-time data output (e.g., continuously and/or periodically as sensor data is processed in the sensor electronics module).
The term “retrospective algorithm(s)” as used herein is a broad term, and is to be given its ordinary and customary meaning to a person of ordinary skill in the art (and is not to be limited to a special or customized meaning), and furthermore refers without limitation to algorithms that process sensor information in retrospect, (e.g., analysis of a set of data for a time period previous to the present time period).
As employed herein, the following abbreviations apply: Eq and Eqs (equivalents); mEq (milliequivalents); M (molar); mM (millimolar) μM (micromolar); N (Normal); mol (moles); mmol (millimoles); μmol (micromoles); nmol (nanomoles); g (grams); mg (milligrams); μg (micrograms); Kg (kilograms); L (liters); mL (milliliters); dL (deciliters); μL (microliters); cm (centimeters); mm (millimeters); μm (micrometers); nm (nanometers); h and hr (hours); min. (minutes); s and sec. (seconds); ° C. (degrees Centigrade).
Overview
In some embodiments, a system is provided for continuous measurement of an analyte in a host that includes: a continuous analyte sensor configured to continuously measure a concentration of the analyte in the host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use. In one embodiment, the sensor electronics module includes electronics configured to process a data stream associated with an analyte concentration measured by the continuous analyte sensor in order to generate displayable sensor information that includes raw sensor data, transformed sensor data, and/or any other sensor data, for example. The sensor electronics module may further be configured to generate displayable sensor information that is customized for respective display devices, such that different display devices may receive different displayable sensor information.
Alerts
In one embodiment, one or more alerts are associated with a sensor electronics module. For example, each alert may include one or more alert conditions that indicate when the respective alert has been triggered. For example, a hypoglycemic alert may include alert conditions indicating a minimum glucose level. The alert conditions may also be based on transformed sensor data, such as trending data, and/or sensor data from multiple different sensors (e.g. an alert may be based on sensor data from both a glucose sensor and a temperature sensor). For example, a hypoglycemic alert may include alert conditions indicating a minimum required trend in the host's glucose level that must be present before triggering the alert. The term “trend,” as used herein refers generally to data indicating some attribute of data that is acquired over time, e.g., such as calibrated or filtered data from a continuous glucose sensor. A trend may indicate amplitude, rate of change, acceleration, direction, etc., of data, such as sensor data, including transformed or raw sensor data.
In one embodiment, each of the alerts is associated with one or more actions that are to be performed in response to triggering of the alert. Alert actions may include, for example, activating an alarm, such as displaying information on a display of the sensor electronics module or activating an audible or vibratory alarm coupled to the sensor electronics module, and/or transmitting data to one or more display devices external to the sensor electronics module. For any delivery action that is associated with a triggered alert, one or more delivery options define the content and/or format of the data to be transmitted, the device to which the data is to be transmitted, when the data is to be transmitted, and/or a communication protocol for delivery of the data.
In one embodiment, multiple delivery actions (each having respective delivery options) may be associated with a single alert such that displayable sensor information having different content and formatting, for example, is transmitted to respective display devices in response to triggering of a single alert. For example, a mobile telephone may receive a data package including minimal displayable sensor information (that may be formatted specifically for display on the mobile telephone), while a desktop computer may receive a data package including most (or all) of the displayable sensor information that is generated by the sensor electronics module in response to triggering of a common alert. Advantageously, the sensor electronics module is not tied to a single display device, rather it is configured to communicate with a plurality of different display devices directly, systematically, simultaneously (e.g., via broadcasting), regularly, periodically, randomly, on-demand, in response to a query, based on alerts or alarms, and/or the like.
In some embodiments, clinical risk alerts are provided that include alert conditions that combine intelligent and dynamic estimative algorithms that estimate present or predicted danger with greater accuracy, more timeliness in pending danger, avoidance of false alarms, and less annoyance for the patient. In general, clinical risk alerts include dynamic and intelligent estimative algorithms based on analyte value, rate of change, acceleration, clinical risk, statistical probabilities, known physiological constraints, and/or individual physiological patterns, thereby providing more appropriate, clinically safe, and patient-friendly alarms. Co-pending U.S. Patent Publication No. 2007/0208246, which is incorporated herein by reference in its entirety, describes some systems and methods associated with the clinical risk alerts (or alarms) described herein. In some embodiments, clinical risk alerts can be triggered for a predetermined time period to allow for the user to attend to his/her condition. Additionally, the clinical risk alerts can be de-activated when leaving a clinical risk zone so as not to annoy the patient by repeated clinical alarms (e.g., visual, audible or vibratory), when the patient's condition is improving. In some embodiments, dynamic and intelligent estimation determines a possibility of the patient avoiding clinical risk, based on the analyte concentration, the rate of change, and other aspects of the dynamic and intelligent estimative algorithms. If there is minimal or no possibility of avoiding the clinical risk, a clinical risk alert will be triggered. However, if there is a possibility of avoiding the clinical risk, the system is configured to wait a predetermined amount of time and re-analyze the possibility of avoiding the clinical risk. In some embodiments, when there is a possibility of avoiding the clinical risk, the system is further configured to provide targets, therapy recommendations, or other information that can aid the patient in proactively avoiding the clinical risk.
In some embodiments, the sensor electronics module is configured to search for one or more display devices within communication range of the sensor electronics module and to wirelessly communicate sensor information (e.g., a data package including displayable sensor information, one or more alarm conditions, and/or other alarm information) thereto. Accordingly, the display device is configured to display at least some of the sensor information and/or alarm the host (and/or care taker), wherein the alarm mechanism is located on the display device.
In some embodiments, the sensor electronics module is configured to provide one or a plurality of different alarms via the sensor electronics module and/or via transmission of a data packaging indicating an alarm should be initiated by one or a plurality of display devices (e.g., sequentially and/or simultaneously). In some embodiments, the sensor electronics module determines which of the one or more alarms to trigger based on one or more alerts that are triggered. For example, when an alert triggers that indicates severe hypoglycemia, the sensor electronics module can perform multiple actions, such as activating an alarm on the sensor electronics module, transmitting a data package to a small (key fob) indicating activation of an alarm on the display, and transmitting a data package as a text message to a care provider. As an example, a text message can appear on a small (key fob) display, cell phone, pager device, and/or the like, including displayable sensor information that indicates the host's condition (e.g., “severe hypoglycemia”).
In some embodiments, the sensor electronics module is configured to wait a time period for the host to respond to a triggered alert (e.g., by pressing or selecting a snooze and/or off function and/or button on the sensor electronics module and/or a display device), after which additional alerts are triggered (e.g., in an escalating manner) until one or more alerts are responded to. In some embodiments, the sensor electronics module is configured to send control signals (e.g., a stop signal) to a medical device associated with an alarm condition (e.g., hypoglycemia), such as an insulin pump, wherein the stop alert triggers a stop of insulin delivery via the pump.
In some embodiments, the sensor electronics module is configured to directly, systematically, simultaneously (e.g., via broadcasting), regularly, periodically, randomly, on-demand, in response to a query (from the display device), based on alerts or alarms, and/or the like transmit alarm information. In some embodiments, the system further includes a repeater such that the wireless communication distance of the sensor electronics module can be increased, for example, to 10, 20, 30, 50 75, 100, 150, or 200 meters or more, wherein the repeater is configured to repeat a wireless communication from the sensor electronics module to the display device located remotely from the sensor electronics module. A repeater can be useful to families having children with diabetes. For example, to allow a parent to carry, or place in a stationary position, a display device, such as in a large house wherein the parents sleep at a distance from the child.
Display Devices
In some embodiments, the sensor electronics module is configured to search for and/or attempt wireless communication with a display device from a list of display devices. In some embodiments, the sensor electronics module is configured to search for and/or attempt wireless communication with a list of display devices in a predetermined and/or programmable order (e.g., grading and/or escalating), for example, wherein a failed attempt at communication with and/or alarming with a first display device triggers an attempt at communication with and/or alarming with a second display device, and so on. In one exemplary embodiment, the sensor electronics module is configured to search for and attempt to alarm a host or care provider sequentially using a list of display devices, such as: 1) a default display device, 2) a key fob device, 3) a cell phone (via auditory and/or visual methods, such as, text message to the host and/or care provider, voice message to the host and/or care provider, and/or 911).
Depending on the embodiment, one or more display devices that receive data packages from the sensor electronics module are “dummy displays”, wherein they display the displayable sensor information received from the sensor electronics module without additional processing (e.g., prospective algorithmic processing necessary for real-time display of sensor information). In some embodiments, the displayable sensor information comprises transformed sensor data that does not require processing by the display device prior to display of the displayable sensor information. Some display devices may comprise software including display instructions (software programming comprising instructions configured to display the displayable sensor information and optionally query the sensor electronics module to obtain the displayable sensor information) configured to enable display of the displayable sensor information thereon. In some embodiments, the display device is programmed with the display instructions at the manufacturer and can include security and/or authentication to avoid plagiarism of the display device. In some embodiments, a display device is configured to display the displayable sensor information via a downloadable program (for example, a downloadable Java Script via the internet), such that any display device that supports downloading of a program (for example, any display device that supports Java applets) therefore can be configured to display displayable sensor information (e.g., mobile phones, PDAs, PCs and the like).
In some embodiments, certain display devices may be in direct wireless communication with the sensor electronics module, however intermediate network hardware, firmware, and/or software can be included within the direct wireless communication. In some embodiments, a repeater (e.g., a Bluetooth repeater) can be used to re-transmit the transmitted displayable sensor information to a location farther away than the immediate range of the telemetry module of the sensor electronics module, wherein the repeater enables direct wireless communication when substantive processing of the displayable sensor information does not occur. In some embodiments, a receiver (e.g., Bluetooth receiver) can be used to re-transmit the transmitted displayable sensor information, possibly in a different format, such as in a text message onto a TV screen, wherein the receiver enables direct wireless communication when substantive processing of the sensor information does not occur. In one embodiment, the sensor electronics module directly wirelessly transmits displayable sensor information to one or a plurality of display devices, such that the displayable sensor information transmitted from the sensor electronics module is received by the display device without intermediate processing of the displayable sensor information.
In one embodiment, one or more display devices comprise built-in authentication mechanisms, wherein authentication is required for communication between the sensor electronics module and the display device. In some embodiments, to authenticate the data communication between the sensor electronics module and display devices, a challenge-response protocol, such as a password authentication is provided, where the challenge is a request for the password and the valid response is the correct password, such that pairing of the sensor electronics module with the display devices can be accomplished by the user and/or manufacturer via the password. However, any known authentication system or method useful for telemetry devices can be used with the preferred embodiments.
In some embodiments, one or more display devices are configured to query the sensor electronics module for displayable sensor information, wherein the display device acts as a master device requesting sensor information from the sensor electronics module (e.g., a slave device) on-demand, for example, in response to a query. In some embodiments, the sensor electronics module is configured for periodic, systematic, regular, and/or periodic transmission of sensor information to one or more display devices (for example, every 1, 2, 5, or 10 minutes or more). In some embodiments, the sensor electronics module is configured to transmit data packages associated with a triggered alert (e.g., triggered by one or more alert conditions). However, any combination of the above described statuses of data transmission can be implemented with any combination of paired sensor electronics module and display device(s). For example, one or more display devices can be configured for querying the sensor electronics module database and for receiving alarm information triggered by one or more alarm conditions being met. Additionally, the sensor electronics module can be configured for periodic transmission of sensor information to one or more display devices (the same or different display devices as described in the previous example), whereby a system can include display devices that function differently with regard to how they obtain sensor information.
In some embodiments, as described in more detail elsewhere herein, a display device is configured to query the data storage memory in the sensor electronics module for certain types of data content, including direct queries into a database in the sensor electronics module's memory and/or requests for configured or configurable packages of data content therefrom; namely, the data stored in the sensor electronics module is configurable, queryable, predetermined, and/or pre-packaged, based on the display device with which the sensor electronics module is communicating. In some additional or alternative embodiments, the sensor electronics module generates the displayable sensor information based on its knowledge of which display device is to receive a particular transmission. Additionally, some display devices are capable of obtaining calibration information and wirelessly transmitting the calibration information to the sensor electronics module, such as through manual entry of the calibration information, automatic delivery of the calibration information, and/or an integral reference analyte monitor incorporated into the display device. U.S. Patent Publication Nos. 2006/0222566, 2007/0203966, 2007/0208245, and 2005/0154271, all of which are incorporated herein by reference in their entirety, describe systems and methods for providing an integral reference analyte monitor incorporated into a display device and/or other calibration methods that can be implemented with the preferred embodiments.
In general, a plurality of display devices (e.g., a small (key fob) display device, a larger (hand-held) display device, a mobile phone, a reference analyte monitor, a drug delivery device, a medical device and a personal computer) are configured to wirelessly communicate with the sensor electronics module, wherein the one or more display devices are configured to display at least some of the displayable sensor information wirelessly communicated from the sensor electronics module, wherein displayable sensor information includes sensor data, such as raw data and/or transformed sensor data, such as analyte concentration values, rate of change information, trend information, alert information, sensor diagnostic information and/or calibration information, for example.
Small (Key Fob) Display Device
In some embodiments, one the plurality of display devices is a small (e.g., key fob) display device 14 (
In general, the key fob device 14 includes electronics configured to receive and display displayable sensor information (and optionally configured to query the sensor electronics module for the displayable sensor information). In one embodiment, the electronics include a RAM and a program storage memory configured at least to display the sensor data received from the sensor electronics module. In some embodiments, the key fob device 14 includes an alarm configured to warn a host of a triggered alert (e.g., audio, visual and/or vibratory). In some embodiments, the key fob device 14 includes a user interface, such as an LCD 602 and one or more buttons 604 that allows a user to view data, such as a numeric value and/or an arrow, to toggle through one or more screens, to select or define one or more user parameters, to respond to (e.g., silence, snooze, turn off) an alert, and/or the like.
In some embodiments, the key fob display device has a memory (e.g., such as in a gig stick or thumb drive) that stores sensor, drug (e.g., insulin) and other medical information, enabling a memory stick-type function that allows data transfer from the sensor electronics module to another device (e.g., a PC) and/or as a data back-up location for the sensor electronics module memory (e.g., data storage memory). In some embodiments, the key fob display device is configured to be automatically readable by a network system upon entry into a hospital or other medical complex.
In some embodiments, the key fob display device includes a physical connector, such as USB port 606, to enable connection to a port (e.g., USB) on a computer, enabling the key fob to function as a data download device (e.g., from the sensor electronics module to a PC), a telemetry connector (e.g., Bluetooth adapter/connector for a PC), and/or enables configurable settings on the key fob device (e.g., via software on the PC that allows configurable parameters such as numbers, arrows, trend, alarms, font, etc.) In some embodiments, user parameters associated with the small (key fob) display device can be programmed into (and/or modified) by a display device such as a personal computer, personal digital assistant, or the like. In one embodiment, user parameters include contact information, alert/alarms settings (e.g., thresholds, sounds, volume, and/or the like), calibration information, font size, display preferences, defaults (e.g., screens), and/or the like. Alternatively, the small (key fob) display device can be configured for direct programming of user parameters. In some embodiments, wherein the small (key fob) display device comprises a telemetry module, such as Bluetooth, and a USB connector (or the like), such that the small (key fob) display device additionally functions as telemetry adapter (e.g., Bluetooth adapter) enabling direct wireless communication between the sensor electronics module and the PC, for example, wherein the PC does not include the appropriate telemetry adapter therein.
Large (Hand-Held) Display Device
In some embodiments, one the plurality of display devices is a hand-held display device 16 (
In some embodiments, a mobile phone (or PDA) is configured to display (as described above) and/or relay sensor information, such as via a voice or text message to the host and/or the host's care provider. In some embodiments, the mobile phone further comprises an alarm configured to warn a host of a triggered alert, such as in response to receiving a data package indicating triggering of the alert. Depending on the embodiment, the data package may include displayable sensor information, such as an on-screen message, text message, and/or pre-generated graphical representation of sensor data and/or transformed sensor data, as well as an indication of an alarm, such as an auditory alarm or a vibratory alarm, that should be activated by the mobile phone.
In some embodiments, one of the display devices is a drug delivery device, such as an insulin pump and/or insulin pen, configured to display sensor information. In some embodiments, the sensor electronics module is configured to wirelessly communicate sensor diagnostic information to the drug delivery device in order to enable to the drug delivery device to consider (include in its calculations/algorithms) a quality, reliability and/or accuracy of sensor information for closed loop and/or semi-closed loop systems, which are described in more detail in U.S. Patent Publication No. 2005/0192557, which is incorporated herein by reference in its entirety. In some alternative embodiments, the sensor electronic module is configured to wirelessly communicate with a drug delivery device that does not include a display, for example, in order to enable a closed loop and/or semi-closed loop system as described above.
In some embodiments, one of the display devices is a drug delivery device is a reference analyte monitor, such as a blood glucose meter, configured to measure a reference analyte value associated with an analyte concentration in a biological sample from the host.
Personal Computer Display Device
In some embodiments, one of the display devices is personal computer (PC) 20 (
Other Display Devices
In some embodiments, one of the display devices is an on-skin display device that is splittable from, releasably attached to, and/or dockable to the sensor housing (mounting unit, sensor pod, or the like). In some embodiments, release of the on-skin display turns the sensor off; in other embodiments, the sensor housing comprises sufficient sensor electronics to maintain sensor operation even when the on-skin display is released from the sensor housing.
In some embodiments, one of the display devices is a secondary device, such as a heart rate monitor, a pedometer, a temperature sensor, a car initialization device (e.g., configured to allow or disallow the car to start and/or drive in response to at least some of the sensor information wirelessly communicated from the sensor electronics module (e.g., glucose value above a predetermined threshold)). In some alternative embodiments, one of the display devices is designed for an alternative function device (e.g., a caller id device), wherein the system is configured to communicate with and/or translate displayable sensor information to a custom protocol of the alternative device such that displayable sensor information can be displayed on the alternative function device (display of caller id device).
Exemplary Configurations
In one embodiment, the sensor electronics module 12 includes electronic circuitry associated with measuring and processing the continuous analyte sensor data, including prospective algorithms associated with processing and calibration of the sensor data. The sensor electronics module 12 may be physically connected to the continuous analyte sensor 10 and can be integral with (non-releasably attached to) or releasably attachable to the continuous analyte sensor 10. The sensor electronics module 12 may include hardware, firmware, and/or software that enables measurement of levels of the analyte via a glucose sensor, such as an analyte sensor. For example, the sensor electronics module 12 can include a potentiostat, a power source for providing power to the sensor, other components useful for signal processing and data storage, and preferably a telemetry module for transmitting data from the sensor electronics module to one or more display devices. Electronics can be affixed to a printed circuit board (PCB), or the like, and can take a variety of forms. For example, the electronics can take the form of an integrated circuit (IC), such as an Application-Specific Integrated Circuit (ASIC), a microcontroller, and/or a processor. The sensor electronics module 12 includes sensor electronics that are configured to process sensor information ,such as sensor data, and generate transformed sensor data and displayable sensor information. Examples of systems and methods for processing sensor analyte data are described in more detail herein and in U.S. Pat. Nos. 7,310,544 and 6,931,327. and U.S. Patent Publication Nos. 2005/0043598, 2007/0032706, 2007/0016381, 2008/0033254, 2005/0203360, 2005/0154271, 2005/0192557, 2006/0222566, 2007/0203966 and 2007/0208245, all of which are incorporated herein by reference in their entirety.
Referring again to
In the embodiment of
Because different display devices provide different user interfaces, content of the data packages (e.g., amount, format, and/or type of data to be displayed, alarms, and the like) can be customized (e.g., programmed differently by the manufacture and/or by an end user) for each particular display device. Accordingly, in the embodiment of
Continuous Sensor
In some embodiments, a glucose sensor comprises a continuous sensor, for example a subcutaneous, transdermal (e.g., transcutaneous), or intravascular device. In some embodiments, the device can analyze a plurality of intermittent blood samples. The glucose sensor can use any method of glucose-measurement, including enzymatic, chemical, physical, electrochemical, spectrophotometric, polarimetric, calorimetric, iontophoretic, radiometric, immunochemical, and the like.
A glucose sensor can use any known method, including invasive, minimally invasive, and non-invasive sensing techniques (e.g., fluorescent monitoring), to provide a data stream indicative of the concentration of glucose in a host. The data stream is typically a raw data signal, which is converted into a calibrated and/or filtered data stream that is used to provide a useful value of glucose to a user, such as a patient or a caretaker (e.g., a parent, a relative, a guardian, a teacher, a doctor, a nurse, or any other individual that has an interest in the wellbeing of the host).
A glucose sensor can be any device capable of measuring the concentration of glucose. One exemplary embodiment is described below, which utilizes an implantable glucose sensor. However, it should be understood that the devices and methods described herein can be applied to any device capable of detecting a concentration of glucose and providing an output signal that represents the concentration of glucose.
In one embodiment, the analyte sensor is an implantable glucose sensor, such as described with reference to U.S. Pat. No. 6,001,067 and U.S. Patent Publication No. US-2005-0027463-A1. In another embodiment, the analyte sensor is a transcutaneous glucose sensor, such as described with reference to U.S. Patent Publication No. US-2006-0020187-A1. In still other embodiments, the sensor is configured to be implanted in a host vessel or extracorporeally, such as is described in U.S. Patent Publication No. US-2007-0027385-A1, co-pending U.S. patent application Ser. No. 11/543,396 filed Oct. 4, 2006, co-pending U.S. patent application Ser. No. 11/691,426 filed on Mar. 26, 2007, and co-pending U.S. patent application Ser. No. 11/675,063 filed on Feb. 14, 2007. In one alternative embodiment, the continuous glucose sensor comprises a transcutaneous sensor such as described in U.S. Pat. No. 6,565,509 to Say et al., for example. In another alternative embodiment, the continuous glucose sensor comprises a subcutaneous sensor such as described with reference to U.S. Pat. No. 6,579,690 to Bonnecaze et al. or U.S. Pat. No. 6,484,046 to Say et al., for example. In another alternative embodiment, the continuous glucose sensor comprises a refillable subcutaneous sensor such as described with reference to U.S. Pat. No. 6,512,939 to Colvin et al., for example. In another alternative embodiment, the continuous glucose sensor comprises an intravascular sensor such as described with reference to U.S. Pat. No. 6,477,395 to Schulman et al., for example. In another alternative embodiment, the continuous glucose sensor comprises an intravascular sensor such as described with reference to U.S. Pat. No. 6,424,847 to Mastrototaro et al., for example.
Sensor Electronics Module
In this embodiment, a potentiostat 210 is coupled to a glucose sensor via data line 212, for example, in order to receive sensor data from the glucose sensor. In one embodiment, the potentiostat 210 provides a voltage to the glucose sensor via the data line 22 in order to bias the sensor to enable measurement of a current value indicative of the analyte concentration in the host (also referred to as the analog portion). The potentiostat can have one channel or multiple channels (and a corresponding one or multiple data lines 212), depending on the number of working electrodes, for example. In some embodiments, the potentiostat 210 includes a resistor (not shown) that translates the current into voltage. In some embodiments, a current to frequency converter is provided that is configured to continuously integrate the measured current, for example, using a charge counting device. In some embodiments, an A/D converter digitizes the analog signal into “counts” for processing. Accordingly, the resulting raw data stream in counts is directly related to the current measured by the potentiostat 210.
A processor module 214 is the central control unit that controls the processing of the sensor electronics module 12. In some embodiments, the processor module 214 is formed as part of a custom chip, such as an ASIC, however a computer system other than an ASIC can be used to process data as described herein, for example a microprocessor can be used for some or all of the sensor electronics module processing. The processor module 214 typically provides a program memory 216, which provides semi-permanent storage of data, for example, storing data such as sensor identifier (ID) and programming to process data streams (for example, filtering, calibration, fail-safe checking, and the like). The processor additionally can be used for the system's cache memory, for example for temporarily storing recent sensor data. In some embodiments, the processor module comprises memory storage components such as ROM, RAM, dynamic-RAM, static-RAM, non-static RAM, EEPROM, rewritable ROMs, flash memory, and the like. In one exemplary embodiment, RAM 218 can be used for the system's cache memory, for example for temporarily storing recent sensor data.
In some embodiments, the processor module 214 comprises a digital filter, for example, an IIR or FIR filter, configured to smooth the raw data stream from the A/D converter. Generally, digital filters are programmed to filter data sampled at a predetermined time interval (also referred to as a sample rate). In some embodiments, such as when the potentiostat 210 is configured to measure the analyte at discrete time intervals, these time intervals determine the sample rate of the digital filter. In some alternative embodiments, wherein the potentiostat 210 is configured to continuously measure the analyte, for example, using a current-to-frequency converter, the processor module 214 can be programmed to request a digital value from the integrator at a predetermined time interval, also referred to as the acquisition time. In these alternative embodiments, the values obtained by the processor module 214 are advantageously averaged over the acquisition time due the continuity of the current measurement. Accordingly, the acquisition time determines the sample rate of the digital filter.
In an advantageous embodiment, the processor module 214 may be further configured to generate data packages for transmission to one or more display devices. Furthermore, the processor module 215 may generate data packets for transmission to these outside sources, e.g., via telemetry. As discussed above, the data packages may be customizable for each display device, for example, and may include any available data, such as displayable sensor information having customized sensor data and/or transformed sensor data, sensor/sensor electronics module ID code, raw data, filtered data, calibrated data, rate of change information, trend information, error detection or correction, and/or the like.
A data storage memory 220 is operably connected to the processor module 214 and is configured to store a variety of sensor information. In some embodiments, the data storage memory stores 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 20, 30 or more days of continuous analyte sensor data. In some embodiments, the data storage memory 220 stores sensor information such as raw sensor data (one or more raw analyte concentration values), calibrated data, filtered data, transformed sensor data, and/or any other displayable sensor information.
In some embodiments, sensor electronics module 12 is configured to receive and store contact information in the data storage memory (and/or program memory), including a phone number and/or email address for the sensor's host and/or health care providers for the host (e.g., family member(s), nurse(s), doctor(s), or other health care provider(s)), which enables communication with a contact person (e.g., via phone, pager and/or text messaging in response to an alarm (e.g., a hypoglycemic alarm that has not been responded to by the host)). In some embodiments, user parameters can be programmed into (and/or modified in) the data storage memory (and/or program memory) of the sensor electronics module, via a display device such as a personal computer, personal digital assistant, or the like. Preferably, user parameters include contact information, alert/alarms settings (e.g., thresholds, sounds, volume, and/or the like), calibration information, font size, display preferences, defaults (e.g., screens), and/or the like. Alternatively, the sensor electronics module can be configured for direct programming of certain user parameters.
In one embodiment, clinical data of a medical practitioner may be uploaded to the sensor electronics module 12 and stored on the data storage memory 220, for example. Thus, information regarding the host's condition, treatments, medications, etc., may be stored on the sensor electronics module 12 and may be viewable by the host or other authorized user. In one embodiment, certain of the clinical data may be included in a data package that is transmitted to a display device in response to triggering of an alert. The clinical data may be uploaded to the sensor electronics module 12 via any available communication protocol, such as direct transmission via a wireless Bluetooth, infrared, or RF connection, or via a wired USB connection, for example. Additionally, the clinical data may be uploaded to the sensor electronics module 12 via indirect transmission, such as via one or more networks (e.g., local area, personal area, or wide area networks, or the Internet) or via a repeater device that receives the clinical data from a device of the medical practitioner and retransmits the clinical data to the sensor electronics module.
Although separate data storage and program memories are shown in
In some embodiments, the sensor electronics module 12 is configured to perform smoothing and/or filtering algorithms on the sensor data (e.g., raw data stream and/or other sensor information), wherein the smoothed and/or filtered data is stored in the data storage memory as transformed data. Co-pending U.S. Patent Publication Nos. 2005/0043598, 2007/0032706, 2007/0016381 and 2008/0033254 describe some algorithms useful in performing data smoothing and/or filtering herein (including signal artifacts replacement), and are incorporated herein by reference in their entirety.
In some embodiments, the sensor electronics module 12 is configured to calibrate the sensor data, and the data storage memory 220 stores the calibrated sensor data points as transformed sensor data. In some further embodiments, the sensor electronics module 12 is configured to wirelessly receive calibration information from a display device, from which the sensor electronics module is configured to calibrate the sensor data. U.S. Pat. Nos. 7,310,544 and 6,931,327 describe some algorithms useful in sensor calibration herein, and are incorporated herein by reference in their entirety.
In some embodiments, the sensor electronics module 12 is configured to perform additional algorithmic processing on the sensor data (e.g., calibrated and/or filtered data and/or other sensor information) and the data storage memory 220 is configured to store the transformed sensor data and/or sensor diagnostic information associated with the algorithms. U.S. Pat. Nos. 7,310,544 and 6,931,327 describe some algorithms that can be processed by the sensor electronics module, and are incorporated herein by reference in their entirety.
Referring again to
In some embodiments, the audio transducer 230 is mounted to the circuit board and/or the sensor electronics module housing. In some embodiments, the sound produced by the audio transducer 230 exits the device from a sound port in the sensor electronics module 12, such as a hole on the sensor electronics module body 12. Preferably, the hole is waterproofed and/or otherwise protected from moisture by a waterproof material that easily allows sound waves there through. In one preferred embodiment, the hole is protected from moisture by an acoustically transparent venting material (wherein the material allows at least about 60%, 70%, 80%, 90%, 95%, or more of the transmitted sound waves there through), such as a screw-in vent, a press-fit vent, a snap-in vent, an o-ring vent, and adhesive vent, and/or the like. One manufacturer that provides acoustically transparent venting material is W.L. Gore & Associates (Elkton, MD) under the trade name Protective Vents (Acoustic Vents).
The vibrator 228 can include a motor that provides, for example, tactile signals or alerts for reasons such as described with reference to the audio transducer, above. In one embodiment, the vibrator motor 228 provides a signal in response to triggering of one or more alerts, which can be triggered by the processor module 214 that processes algorithms useful in determining whether alert conditions associated with one or more alerts have been met, for example, present and/or predicted hyper- and hypoglycemic conditions. In some embodiments, one or more different alerts are differentiated by intensity, quantity, pattern, duration, and/or the like. In some embodiments, the alarm is configured to be silenced (e.g., snoozed or turned off) by pressing one or more buttons 224 on the sensor electronics module 12 and/or by signaling the sensor electronics module 12 using a button or selection on a display device (e.g., key fob, cell phone, and/or the like).
In some embodiments, the vibrator motor 228 is mounted to the circuit board and/or the sensor electronics module 12 housing. Preferably the diameter of the motor is less than or equal to about 6 mm, 5 mm, 4 mm, 3.5 mm, 3 mm, 2.5 mm, 2 mm or less. Preferably the overall length of the vibrator motor is less than or equal to about 18 mm, 16 mm, 14 mm, 12 mm, 10 mm or less. By providing a low power vibrator motor, the motor can be place in the sensor electronics module 12 without significantly affecting the low profile nature of the on-skin sensor electronics module 12.
In some embodiments, the vibrator motor 228 may be used to provide a vibratory alarm that creates vibration and/or movement of the sensor within the host. While not wishing to be bound by theory, it is believed that a concentration increase of noise-causing electroactive species, such as electroactive metabolites from cellular metabolism and wound healing, can interfere with sensor function and cause noise observed during host start-up and/or sedentary periods. For example, local lymph pooling, which can occur when a part of the body is compressed or when the body is inactive, can cause, in part, this local build up of interferants (e.g., electroactive metabolites). Similarly, a local accumulation of wound healing metabolic products (e.g., at the site of sensor insertion) likely causes noise on the sensor during the first few hours to days after sensor insertion. Accordingly, it is believed vibration and/or movement of the sensor at the insertion site, after sensor insertion, can reduce or eliminate pooling of local interfering species caused by the wound healing process described above. In some embodiments, the sensor is vibrated and/or moved at predetermined intervals and/or in response to noise artifacts detected on the sensor signal. Co-pending U.S. patent application Ser. No. 2005/0043598, 2007/0032706, 2007/0016381 or 2008/0033254 describe systems and methods for detection of noise artifacts, noise episodes and/or classification of noise, which can be useful with the embodiments described herein.
Although audio and vibratory alarms are exemplified in
In another alternative embodiment, the sensor electronics module 12 is configured to transmit sound waves into the host's body (e.g., abdomen or other body part) that will be felt by the host, thereby allowing the host to be alerted without calling attention to himself and/or thereby allowing a hearing-impaired visually-impaired, and/or tactilely-impaired host to be alerted. In some embodiments, the sound waves can be transmitted into the host's body using the electrodes of the sensor itself. In some embodiments, one or more transcutaneous electrodes (other than the electrodes related to analyte measurement) are provided for transmitting sound waves. In some embodiments, electrodes can be provided in the adhesive patch that holds the sensor/sensor electronics module onto the host's body, which can be used to transmit the sound waves. In some embodiments, different sound waves are used to transmit different alarm conditions to the host. The sound waves could be differentiated by any sound characteristic, such as but not limited to amplitude, frequency and pattern.
In another alternative embodiment, mild electric shock could be used to transmit one or more alarms to the host. Preferably the level of shock would not be overly uncomfortable to the host; however, the intensity of the level of shock can be configured to increase when a host does not respond to (e.g., snooze or turn off) an alert within an amount of time. In some embodiments, the shock can be delivered to the host's body using the electrodes of the sensor itself. In some embodiments, the sensor system can include one or more additional electrodes configured for delivering the shock to the host (alone or in combination with the electrodes related to analyte measurement). In still another example, the one or more electrodes can be disposed on the host's skin, such as in the adhesive patch, for delivering the shock. Alternatively, one or more additional patches, each including an electrode, can be provided, for delivering the shock. The additional patches can be in wired and/or wireless communication with the sensor electronics module.
A telemetry module 232 is operably connected to the processor module 214 and provides the hardware, firmware, and/or software that enable wireless communication between the sensor electronics module 12 and one or more display devices. A variety of wireless communication technologies that can be implemented in the telemetry module 232 include radio frequency (RF), infrared (IR), Bluetooth, spread spectrum communication, frequency hopping communication, ZigBee, IEEE 802.11/802.16, wireless (e.g., cellular) telecommunication, paging network communication, magnetic induction, satellite data communication, GPRS, ANT, and/or the like. In one preferred embodiment, the telemetry module comprises a Bluetooth chip. In some embodiments, Bluetooth technology is implemented in a combination of the telemetry module 232 and the processor module 214.
A battery 234 is operatively connected to the processor module 214 (and possibly other components of the sensor electronics module 12) and provides the necessary power for the sensor electronics module 12. In one embodiment, the battery is a Lithium Manganese Dioxide battery, however any appropriately sized and powered battery can be used (e.g., AAA, Nickel-cadmium, Zinc-carbon, Alkaline, Lithium, Nickel-metal hydride, Lithium-ion, Zinc-air, Zinc-mercury oxide, Silver-zinc, or hermetically-sealed). In some embodiments the battery is rechargeable. In some embodiments, a plurality of batteries can be used to power the system. In yet other embodiments, the receiver can be transcutaneously powered via an inductive coupling, for example.
A battery charger and/or regulator 236 may be configured to receive energy from an internal and/or external charger. In one embodiment, a battery regulator (or balancer) 236 regulates the recharging process by bleeding off excess charge current to allow all cells or batteries in the sensor electronics module to be fully charged without overcharging other cells or batteries. In some embodiments, the battery 234 (or batteries) is configured to be charged via an inductive and/or wireless charging pad. One skilled in the art appreciates a variety of known methods of charging batteries, which can be implemented with the system described herein, including wired (cable/plug) and wireless methods.
One or more communication ports 238, also referred to as external connector(s), can be provided to allow communication with other devices, for example a PC communication (com) port can be provided to enable communication with systems that are separate from, or integral with, the sensor electronics module. The communication port, for example, may comprise a serial (e.g., universal serial bus or “USB”) communication port, allows for communicating with another computer system (e.g., PC, personal digital assistant or “PDA,” server, or the like). In one exemplary embodiment, the sensor electronics module 12 is able to transmit historical data to a PC or other computing device for retrospective analysis by a patient and/or physician.
In conventional continuous analyte sensor systems, the on-skin portion of the sensor electronics is generally simplified to minimize complexity and/or size of on-skin electronics, for example, providing only raw, calibrated, and/or filtered data to a secondary display device configured to run calibration and other algorithms required for displaying the sensor data. In contrast, the sensor electronics module 12 executes prospective algorithms used to generate transformed sensor data and/or displayable sensor information, including, for example, algorithms that: evaluate a clinical acceptability of reference and/or sensor data, evaluate calibration data for best calibration based on inclusion criteria, evaluate a quality of the calibration, compare estimated analyte values with time corresponding measured analyte values, analyze a variation of estimated analyte values, evaluate a stability of the sensor and/or sensor data, detect signal artifacts (noise), replace signal artifacts, determine a rate of change and/or trend of the sensor data, perform dynamic and intelligent analyte value estimation, perform diagnostics on the sensor and/or sensor data, set modes of operation, evaluate the data for aberrancies, and/or the like, which are described in more detail in U.S. Pat. Nos. 7,310,544 and 6,931,327. and U.S. Patent Publication Nos. 2005/0043598, 2007/0032706, 2007/0016381, 2008/0033254, 2005/0203360, 2005/0154271, 2005/0192557, 2006/0222566, 2007/0203966 and 2007/0208245, all of which are incorporated herein by reference in their entirety. Furthermore, the sensor electronics module 12 is configured to store the transformed sensor data (e.g., values, trend information) and to communicate the displayable sensor information to a plurality of different display devices. In some embodiments, the display devices are “dummy” devices, namely, they are configured to display the displayable sensor information as received from the sensor electronics module 12, without any additional sensor data processing.
Exemplary System Configurations
In the embodiment of
In some embodiments, a detachable connection between the mounting unit 314 and sensor electronics module 12 is provided, which enables improved manufacturability, namely, the relatively inexpensive mounting unit 314 can be disposed of when replacing the sensor system after its usable life, while the relatively more expensive sensor electronics module 12 can be reusable with multiple sensor systems. In some preferred embodiments, the sensor electronics module 12 is configured with signal processing (programming), for example, configured to filter, calibrate and/or other algorithms useful for calibration and/or display of sensor information. However, an integral (non-detachable) sensor electronics module can be configured.
In some embodiments, the contacts 338 are mounted on or in a subassembly hereinafter referred to as a contact subassembly 336 configured to fit within the base 334 of the mounting unit 314 and a hinge 348 that allows the contact subassembly 336 to pivot between a first position (for insertion) and a second position (for use) relative to the mounting unit 314. The term “hinge” as used herein is a broad term and is used in its ordinary sense, including, without limitation, to refer to any of a variety of pivoting, articulating, and/or hinging mechanisms, such as an adhesive hinge, a sliding joint, and the like; the term hinge does not necessarily imply a fulcrum or fixed point about which the articulation occurs. In preferred embodiments, the contacts 338 are formed from a conductive elastomeric material, such as a carbon black elastomer, through which the sensor 10 extends.
In certain embodiments, the mounting unit 314 is provided with an adhesive pad 308, preferably disposed on the mounting unit's back surface and preferably including a releasable backing layer. Thus, removing the backing layer and pressing the base portion 334 of the mounting unit onto the host's skin adheres the mounting unit 314 to the host's skin. Additionally or alternatively, an adhesive pad can be placed over some or all of the sensor system after sensor insertion is complete to ensure adhesion, and optionally to ensure an airtight seal or watertight seal around the wound exit-site (or sensor insertion site) (not shown). Appropriate adhesive pads can be chosen and designed to stretch, elongate, conform to, and/or aerate the region (e.g., host's skin). The embodiments described with reference to
The sensor electronics module 412 is configured to generate and transmit customized data packages to each of a plurality of display devices, including display devices 450A, 450B and 450N. As discussed further below, the timing, content, and formatting of displayable sensor information that is included in respective data packages may be based on one or more of a plurality of factors. For example, one or more alerts may be established based on default alert conditions or custom alert conditions that are designated by the device manufacturer, the host, or a guardian of the host. An alert is said to be “triggered” when the alert conditions associated with the alert are met by the sensor data and/or transformed sensor data. For example, a near hypoglycemic alert may include an alert condition that requires that the host's current glucose level is below 80 mg/dL. Thus, the particular near hypoglycemic alert would be triggered when the host's current glucose level is below 80 mg/dL, and, in response to triggering of the alert, any actions associated with the particular alert are initiated. In one embodiment, actions associated with an alert may include generation of displayable sensor information, transmission of a data package to one or more display devices, activating one or more alarms (e.g., auditory or vibratory), communicating data to another device, or any other action. For example an action that transmits a customized data package to each of a plurality of display devices may be associated with a near hypoglycemic alert. Thus, when the alert conditions for the near hypoglycemic alert are triggered, the actions initiate compilation and transmission of the indicated data packages to the respective display devices. In one embodiment, the content and formatting of each data package may be customized, such that displayable sensor information included in the respective data packages may include quite different displayable sensor information.
In the embodiment of
In the embodiment of
In the embodiment of
Beginning in block 610, the sensor electronics module intermittently receives and/or processes sensor data from one or more sensors, such as a glucose sensor, accelerometer, altimeter, or any other sensor. Each of the sensors that transmit sensor data to the sensor electronics module may have a predetermined or dynamic schedule for transmitting sensor data. For example, a first sensor may transmit sensor data to the sensor electronics module on a consistent periodic basis, such as one sensor data point per minute, 5 minutes, 10 minutes, 30 minutes etc., while a second sensor may transmit sensor data to the sensor electronics module only when the sensor data reaches a certain threshold. For example, an altimeter may only transmit sensor data to the sensor electronics module 512 when an altitude of the altimeter is above a predetermined threshold.
Moving to block 620, the sensor data received from the one or more sensors is stored, such as in one or more memories and/or storage devices of the sensor electronics module. With reference to the embodiment of
Next, in block 630 the sensor electronics module determines if one or more alerts have been triggered. As noted above, each alert is associated alert conditions that must be met in order for the respective alert to trigger. The alert conditions could be any characteristic of the sensor data, transformed sensor data, a display device, a host, or an operator of a display device, along with other characteristics. For example, two different alerts that are each related to the host reaching a hypoglycemic glucose level may have slightly different alert conditions that must be satisfied in order to trigger the alerts. For example, a first hypoglycemic alert may require that the host's glucose level is below a first threshold and that a temperature of the host is above a certain threshold, while a second hypoglycemic alert may only require that the host's glucose level is below a second threshold (which may be slightly lower than the first threshold). In this embodiment, the first and second hypoglycemic alerts may be associated with actions that are quite different, such as transmission of data packages of various content and formatting to different display devices.
If the sensor electronics module determines that an alert has triggered in block 630, the method continues to block 640 where one or more actions associated with the triggered alert are initiated. For an action that includes transmission of one or more data packages to a respective one or more display devices, each of the data packages may be associated with one or more delivery options indicating the content (e.g., which displayable sensor information, such as sensor data and/or transformed sensor data, should be included in the data package) and/or formatting requirements for the indicated displayable sensor information, such as whether the displayable sensor information should be in a textual or graphical format. Other actions might include alarms that are associated with the sensor electronics module or a display device, such as activation of a vibrator motor or audio transducer, for example.
In block 650, the sensor electronics module determines the delivery options associated with the actions of the triggered alert and generates the appropriate displayable sensor information in response to the delivery options. In one embodiment, the sensor electronics module performs algorithmic operations on the sensor data in order to generate transformed sensor data, such as trending data, which is stored in the sensor electronics module for later access. In other embodiments, the sensor electronics module executes algorithms on the sensor data in response to triggering of an alert, such that the transformed sensor data included in the data package is generated after the alert is triggered. Alternatively, the sensor electronics module may generate some transformed sensor data as the sensor data is received and may also generate additional transformed sensor data in response to triggering of an alert. In one embodiment, the displayable sensor information is selected according to parameters of the alert action, and the displayable sensor information is combined into one or more data packages for transmission to the display device indicated in the action.
Next, in block 660, the generated data package is transmitted to display device indicated in the alert action. If more than one action is associated with a triggered alert, multiple data packages may be generated and transmitted to respective display devices. Accordingly, the sensor electronics module allows customization of alert notifications including various levels of detail that are desired by the host or other interested parties.
Beginning in block 710, the sensor electronics module periodically receives sensor data from one or more sensors. As noted above, the sensor electronics module may be configured to receive data from any type of sensor via any suitable wired and/or wireless communication protocols.
Next, in block 720, the received sensor data is stored. Depending on embodiment, sensor data may be stored for predetermined time periods and/or predetermined quantities. For example, data from one sensor may be removed from the sensor electronics module after it is more than 30 days old, while data from another sensor may remain in the sensor electronics module until storage space on the sensor electronics module reaches a certain threshold.
Continuing to block 730, the sensor electronics module determines if a request for displayable sensor information has been received from a display device. If no request for displayable sensor information has been received, the method returns to block 710 where sensor data from the one or more sensors continues to be received. If, however, a request for displayable sensor information has been received from a display device, or from another device, the method continues to block 740.
In block 740, the sensor electronics module determines if the request for displayable sensor information includes custom delivery options for the displayable sensor information. For example, the delivery options may include indications of particular sensor data and/or transformed sensor data that are to be included in the displayable sensor information, as well as possibly formatting instructions for the displayable sensor information.
If the request does include delivery options, the delivery options are selected in block 750. If, however, the request does not include delivered options, the method continues to block 760, where default delivery options are selected. In one embodiment, the default delivery options comprise a standard set of displayable sensor information with formatting options that are compatible with many/most display devices. In another embodiment, default delivery options may be specific to one or more attributes of the requesting display device, such as a type, make, or model of the display device. In other embodiments, the default delivery options may be based on other attributes, such as a time of day at which the request is received, a status of the requesting display device, or a transmission protocol by which the data package will be transmitted to the requesting display device, for example. In other embodiments, default delivery options may be determined based on any other relevant factors.
In block 770, the sensor electronics module generates and/or retrieves the requested content, such as sensor data and/or transformed sensor data, and formats the data according to the selected default and/or custom delivery options. If delivery options were received in the request, displayable sensor information is selected and formatted according to the receive delivered options. Alternatively, if no delivery options were received in the request, displayable sensor information is selected and formatted according to one or more default delivery options.
In block 780, the displayable sensor information is packaged into one or more data packages and transmitted to the requesting display device. In one embodiment, a requesting display device may indicate a different recipient of the requested displayable sensor information. For example, a first display device, e.g., a mobile telephone, may send a request for displayable sensor information to a sensor electronics module indicating that the requested displayable sensor information be transmitted to a notebook computer rather than, or in addition to, transmitting the requested displayable sensor information to the requesting mobile telephone. In one embodiment, the request may include multiple sets of delivery options associated with multiple recipients of displayable sensor information.
The method of
Beginning in block 810, the sensor electronics module determines if a delivery option is associated with a triggered alert. If a delivery option is associated with a triggered alert, the method continues to block 815 wherein the appropriate delivery options are selected. In certain embodiments, depending on the alert, certain sensor data and/or transformed sensor data may be important to transmit to the corresponding delivery device. For example, key information associated with a first alert may include a series of sensor data points from a glucose monitor, while key information associated with a second alert may include transformed data indicating a 60 minute trend in the glucose level of the host. Thus, each alert may be associated with different displayable sensor information and/or options for formatting the displayable sensor information.
Continuing to block 820, the sensor electronics module determines if a delivery option is associated with the delivery device and/or one or more users of the delivery device. For sample, if an alert action indicates that a data package should be transmitted to an electronic medical records (EMR) system, a sensor electronics module may select certain displayable sensor information for delivery to the EMR. Similarly, if an alert action indicates that a data package should be transmitted to a cell phone, a sensor electronics module may select different (e.g. a much smaller subset) displayable sensor information for delivery to the cell phone. Additionally, the formatting of the displayable sensor information for delivery to an EMR and a cell phone, for example, may be customized by the sensor electronics module based on the type of display device.
In certain embodiments, the sensor electronics module may determine respective users of receiving displayed devices and customize the displayable sensor information transmitted to the respective display devices accordingly. For example, a mother of a diabetic child that wears a sensor electronics module may always be interested in knowing the location of her child when alerts are transmitted to her. Accordingly, if the sensor electronics module determines that the mother is the user of a receiving display device, whether the display device is a cell phone, a notebook computer, or desktop computer, for example, the sensor electronics module may include the child's location in the displayable sensor information that is included in the corresponding data package. If delivery options are associated with the receiving delivery device and/or the user of the delivery device, the method continues to block 825 where the corresponding delivery options are selected.
Moving to block 830, the sensor electronics module determines if a delivery option is associated with a location of the host and/or the delivery device. In one embodiment, the sensor electronics module includes a global positioning system (GPS) sensor that determines an approximate or precise location of the sensor electronics module. In other embodiments, the sensor electronics module may include other circuitry that determines a location of the sensor electronics module, such as using cell phone communication signals, for example. In one embodiment, the delivery options for a data package may be modified based on the current location of the associated host. For example, if the host is at home, the delivery options may indicate that a minimal set of displayable sensor information is included in the transmitted data package. However, if the host is at an unknown location, the delivery options may indicate that a more comprehensive set of displayable sensor information is included in the transmitted data package. If delivery options are associated with the location of the patient and/or recipient, the method continues to block 835 where those delivery options are selected.
Continuing to block 840, the sensor electronics module determines if a delivery option is associated with a temporal characteristics, such as a time of day or day of the week, for example. Thus, the delivery options may be adjusted based on the time at which the alert is triggered. For example, if a near hypoglycemic alert is triggered at 7 a.m. and the host typically eats breakfast at about 7:30 a.m., the delivery options may indicate only a minimal set of displayable sensor information for transmission to a display device of the host. However, if the near hypoglycemic alert is triggered at 10 p.m., a more complete set of displayable sensor information may be selected for transmission to the display device of the host. Similarly, a display device, either of the host or another interested party, may receive data packages with displayable sensor information that is customized based on the day of the week on which the corresponding alert was triggered. For example, the content of displayable sensor information may vary depending on whether the alert is triggered on a weekday or a weekend. If delivery options are associated with the one or more temporal characteristics the method continues to block 845 where those temporal characteristics are selected.
Next, in block 850 the sensor electronics module generates a data package according to the selected delivery options (e.g., in blocks 815, 825, 835, 845) and initiates transmission of the data package to the delivery device indicated in the delivery action. Accordingly, the data package comprises displayable sensor information that is customized based on one or more of multiple parameters, including those parameters discussed with respect to
In other embodiments, certain delivery options may be included as alert conditions of respective alerts. Thus, if a delivery option is included as an alert condition (e.g., do not deliver data packages during a certain time period), the alert would not trigger unless the alert condition is satisfied.
In one embodiment, the status of the host may affect alert conditions associated with one or more alerts, such that certain sensor data and/or certain transformed sensor data might trigger an alert when the host is in a first status, but would not trigger an alert when the host is in a second status. For example, when a person is exercising, his/her glucose levels may increase or decrease in trends that would be abnormal under any other circumstances; by setting the appropriate status, the sensor electronics module is configured to modify its processing associated with the user in a particular status, e.g., “exercise status” to trigger alerts, analyte estimates, trend information, therapy recommendations, and the like, customized with one or more criteria associated with exercise. Additional disclosure of statuses that are associated with a host of a glucose sensor are discussed in commonly own U.S. patent application Ser. No. 12/258,345, entitled “systems and methods for processes sensory data,” filed on Oct. 24, 2008, which is hereby incorporated by reference in its entirety.
In one embodiment, a user (e.g., the host to which the sensor electronics module is coupled) may enter events in real time (or retrospectively) in a display device and the events may be transmitted to the sensor electronics module. In one embodiment, the events are useful when the historical sensor data and/or transformed sensor data is later analyzed. Events may be entered to indicate when a particular action was taken by the host, such as when carbohydrates were consumed, when insulin was taken, when exercise was performed, when any relevant change in the health of the host occurs, and/or any other event that might possible effect the sensor data. These events may include more detailed information regarding the respective event, such as an indication of an insulin dosage associated with an insulin event or an indication of a particular type of exercise performed and a total exercise time that are associated with an exercise event. The events could then be represented textually and/or pictorially in the displayable sensor information that is transmitted to display devices. Accordingly, triggering of an alert that would otherwise raise great concern may not be as worrisome when events surrounding the alert trigger are viewable by the user of the display device.
In some embodiments, the event data may be used to modify when alerts are triggered and/or when/how data packages are transmitted to respective display devices. For example, entry of an event may cause adjustments to algorithms that are used in real-time generation of transformed sensor data. Thus, similar to the use of statuses discussed above, the events associated with the host may be used in the real-time determination of alert triggers and delivery of displayable sensor information, as well as being useful in later analysis of sensor information associated with the host.
In the method of
Beginning in block 910, the sensor electronics module determines if an alert is triggered. As discussed above, alerts may be triggered based on raw sensor data, transformed sensor data (e.g., calibrated and/or filtered data), or any other data from one or more sensors.
Next, in block 920, the sensor electronics module identifies a delivery action associated with a triggered alert. As discussed above, a delivery action is a specific type of action wherein a data package comprising displayable sensor information is generated and transmitted to an indicated display device. Thus, with identification of a delivery action, a corresponding display device is also identified in block 920.
Continuing to block 930, the sensor electronics module determines a current status of a display device indicated in the identified delivery action. In one embodiment, a status of certain display devices may be determined without receiving real-time information from the respective display device. For example, a status schedule indicating statuses of a display device that are associated with various times/dates may be accessed in order to determine a current status of the display device. Similarly, a status rule may indicate that a particular display device is always in night status between 9 p.m. and 9 a.m. Other formats and types of status schedules may also be used.
In one embodiment, the sensor electronics module determines a current status of the display device by requesting status information from the display device. For example, a status request signal may be transmitted to the display device (or to a service provider associated with the display device or another device that maintains updated status information) prior to transmission of the indicated data package. In one embodiment, the status request signal does not cause the display device to perform any functions that are readily detectable by the user of the display device, but only causes the display device to respond to the sensor electronics module with an indication of a current status of the display device. Thus, the sensor electronics module may determine a status of the display device without interrupting the user of the display device in the event that a current status of the display device indicates that the user does not wish to be interrupted with data packages (or at least data packages associated with certain types of alerts). In some embodiments, the display device may transmit an indication of when the current status will change to a different status, such as when a sleep status will change to an awake status. Thus, the sensor electronics module may delay transmission of a data package until the display device is in a status wherein transmission of the data package is appropriate. In other embodiments, a status of a display device may be determined in any other manner.
Moving to block 940, the sensor electronics module determines delivery options associated with the current status of the display device. For example, certain statuses may include no delivery options, such that the delivery options already associated with the delivery action are used in generating the data package. Other statuses, however may include delivery options that limit or expand the content of the displayable sensor information, adjust the formatting of the displayable sensor information, and/or adjust the method by which the displayable sensor information is transmitted to the display device. Accordingly, the user of the display device may customize the displayable sensor information that is delivered to the display device by adjusting a status of the display device.
Continuing to block 950, the sensor electronics module initiates transmission of the data package that is generated according to the delivery options associated with the current status of the display device. In some embodiments, certain statuses may cause the sensor electronics module to not generate a data package for transmission to the delivery device in response.
Next, in block 960, the sensor electronics module determines if additional delivery actions are associated with the triggered alert. For example, certain alerts have multiple associated delivery actions, each indicating delivery options for respective display devices. If the triggered alert is associated with one or more additional delivery actions, the method returns to blocks 920-950 wherein the status of another display device is determined and an appropriate data package, if any, is generated and transmitted.
The exemplary sensor module 1012 comprises a sensor 1014, which may be integral to the sensor module 1012 or may be attached to one or more electrodes (or other connection port) of the sensor module 1012. The sensor module 1012 also includes a processor 1018, such as a conventional microprocessor, an ASIC, an FPGA, or any other processing logic, as well as a storage device 1016 that stores sensor data from the sensor 1014 and possibly transformed sensor data that is determined by the processor 1018. In one embodiment, the storage device 1016 is configured to store only a small portion of the data that data storage memory 220 of the sensor electronic module 12 (
Advantageously, the sensor module 1012 comprises a module interface 1019 comprising both a physical and an electrical interface for coupling with modular devices, such as those of
Modular devices that may be coupled to the sensor module 1012 vary greatly and may include a Wi-Fi/Bluetooth module 1020 that is configured to add additional communication capabilities to the sensor module 1012. In other embodiments, the module 1020 may be configured to communicate using additional communication protocols. With the module 1020 attached to the sensor module 1012, the sensor module 1012 may transmit data packages, such as in response to triggered alerts, to one or more display devices using Wi-Fi, ANT and/or Bluetooth communications. Another modular device is a GPS module 1030 that provides location data to the sensor module 1012. As described above, in certain embodiments location conditions are included in alert conditions for certain alerts and might be included in displayable sensor information that is transmitted to one or more display devices. Thus, the sensor module 1012 may use the location data from the GPS module 1030 in order to determine if such alert conditions have been met.
Modular devices that may be attached to the sensor module 1012 may also include a display device 1040, which may include any size of display panel, such as an LCD or OLED display, for example. Depending on the embodiment, the display module 1040 may be able to display different types of displayable sensor information formatted using various formatting options. A sensor electronics module 1060 comprising additional processing logic, data storage space, and user interface controls, for example, may also be removably coupled to the sensor module 1012. Depending on embodiment, the sensor electronics module 1060 may have all, or some subset of, the features discussed herein with respect to other sensor electronics modules. In one embodiment, a glucose meter reference module 1050 may be coupled to the sensor module 1012. The glucose meter reference module 1050 may be configured to determine a reference glucose level of the host in order to calibrate the sensor data received from the sensor 1014.
In one embodiment, the sensor module 1012 also includes an alarm device, such as a light or speaker that is activated in response to triggering of certain alerts. Thus, if an alert is triggered, such as based on sensor data and/or GPS location data provided by the GPS module 1030, the sensor module 1012 may activate a light of the sensor module 1012 in order to alert the host to the triggering of the alarm. Depending on embodiment, different patterns of activation/deactivation of the light and/or speaker may be used to indicate triggering of different alerts.
The exemplary user interface 1100 includes a glucose conditions portion 1120, a temperature conditions portions 1130, and a pulse conditions portion 1140, where each of the portions allow the user to set conditions associated with the respective sensor data and/or transformed sensor data. In the embodiment of
The pulse conditions portion 1140 indicates that the pulse of the host must be below 80 beats per minute and the pulse must have changed at least 15 beats per minute over the last five minutes. Accordingly, based on the conditions indicated in exemplary
In the embodiment of
In the exemplary user interface 1300, the user has selected the “joesphone” display device to receive a data package in response to triggering of the Hypo1 alert. The lower portion of the user interface 1300 allows the user to establish delivery options, such as which sensor data and/or transformed sensor data should be included in the displayable sensor information that is transmitted to the selected display device. In this embodiment, the user may select a minimum and/or maximum frequency at which data packages associated with the selected alert should be transmitted to the selected display device. The frequency of sending alerts may change depending on one or more attributes of the sample data, the triggered alert, actions taken by the host in response to the alert, a status of the host or display device, and any other characteristic of the host. For example, a data package associated with a severe hypoglycemia condition may be transmitted frequently (e.g., every 5 minutes), while a data package associated with a near hypoglycemia condition may be transmitted only once each hour (assuming the alert conditions associated with near hypoglycemia are still matched by the sensor data at each one hour interval). Additionally, the frequency of retransmitting data packages associated with an alert may accelerate (or decelerate) over time, such as sending a severe hypoglycemia data package every minute for the first 10 minutes after the alert conditions are matched and thereafter sending a data package every 5 minutes. Depending on the embodiment, (re)transmissions of data packages that are associated with delivery options indicating multiple (re)transmissions of the data packages may be delayed and/or halted in response to triggering of other alerts associated with the host, performing of an action by the host, or actions by the receiving display device. For example, delivery options may indicate that data packages associated with a hyperglycemic condition are stopped in response to the host receiving insulin (either manually or automatically). Additionally, a user of a particular display device may indicate that they do not wish to receive further data packages associated with a triggered alert, such as after receiving a first data package including information regarding the triggered alert.
Additionally, the user may select displayable sensor information that will be transmitted to be selected display device in response to triggering of the selected alert. The data content portion 1340 lists only a few of the content items that may be selected for inclusion in displayable sensor information that is transmitted to the display device. In other embodiments, the format of the selected data content may also be established in a user interface similar to that of
Returning to
In other embodiments, various other arrangements of data may be utilized to allow the sensor electronics module to customize displayable sensor data for each of a plurality of display devices in response to triggering of alerts (that may be customized also).
Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in U.S. Pat. Nos. 4,994,167; 4,757,022; 6,001,067; 6,741,877; 6,702,857; 6,558,321; 6,931,327; 6,862,465; 7,074,307; 7,081,195; 7,108,778; 7,110,803; 7,192,450; 7,226,978; and 7,310,544.
Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in U.S. Patent Publication No. US-2005-0176136-A1; U.S. Patent Publication No. US-2005-0251083-A1; U.S. Patent Publication No. US-2005-0143635-A1; U.S. Patent Publication No. US-2005-0181012-A1; U.S. Patent Publication No. US-2005-0177036-A1; U.S. Patent Publication No. US-2005-0124873-A1; U.S. Patent Publication No. US-2005-0115832-A1; U.S. Patent Publication No. US-2005-0245799-A1; U.S. Patent Publication No. US-2005-0245795-A1; U.S. Patent Publication No. US-2005-0242479-A1; U.S. Patent Publication No. US-2005-0182451-A1; U.S. Patent Publication No. US-2005-0056552-A1; U.S. Patent Publication No. US-2005-0192557-A1; U.S. Patent Publication No. US-2005-0154271-A1; U.S. Patent Publication No. US-2004-0199059-A1; U.S. Patent Publication No. US-2005-0054909-A1; U.S. Patent Publication No. US-2005-0051427-A1; U.S. Patent Publication No. US-2003-0032874-A1; U.S. Patent Publication No. US-2005-0103625-A1; U.S. Patent Publication No. US-2005-0203360-A1; U.S. Patent Publication No. US-2005-0090607-A1; U.S. Patent Publication No. US-2005-0187720-A1; U.S. Patent Publication No. US-2005-0161346-A1; U.S. Patent Publication No. US-2006-0015020-A1; U.S. Patent Publication No. US-2005-0043598-A1; U.S. Patent Publication No. US-2005-0033132-A1; U.S. Patent Publication No. US-2005-0031689-A1; U.S. Patent Publication No. US-2004-0186362-A1; U.S. Patent Publication No. US-2005-0027463-A1; U.S. Patent Publication No. US-2005-0027181-A1; U.S. Patent Publication No. US-2005-0027180-A1; U.S. Patent Publication No. US-2006-0020187-A1; U.S. Patent Publication No. US-2006-0036142-A1; U.S. Patent Publication No. US-2006-0020192-A1; U.S. Patent Publication No. US-2006-0036143-A1; U.S. Patent Publication No. US-2006-0036140-A1; U.S. Patent Publication No. US-2006-0019327-A1; U.S. Patent Publication No. US-2006-0020186-A1; U.S. Patent Publication No. US-2006-0036139-A1; U.S. Patent Publication No. US-2006-0020191-A1; U.S. Patent Publication No. US-2006-0020188-A1; U.S. Patent Publication No. US-2006-0036141-A1; U.S. Patent Publication No. US-2006-0020190-A1; U.S. Patent Publication No. US-2006-0036145-A1; U.S. Patent Publication No. US-2006-0036144-A1; U.S. Patent Publication No. US-2006-0016700-A1; U.S. Patent Publication No. US-2006-0142651-A1; U.S. Patent Publication No. US-2006-0086624-A1; U.S. Patent Publication No. US-2006-0068208-A1; U.S. Patent Publication No. US-2006-0040402-A1; U.S. Patent Publication No. US-2006-0036142-A1; U.S. Patent Publication No. US-2006-0036141-A1; U.S. Patent Publication No. US-2006-0036143-A1; U.S. Patent Publication No. US-2006-0036140-A1; U.S. Patent Publication No. US-2006-0036139-A1; U.S. Patent Publication No. US-2006-0142651-A1; U.S. Patent Publication No. US-2006-0036145-A1; U.S. Patent Publication No. US-2006-0036144-A1; U.S. Patent Publication No. US-2006-0200022-A1; U.S. Patent Publication No. US-2006-0198864-A1; U.S. Patent Publication No. US-2006-0200019-A1; U.S. Patent Publication No. US-2006-0189856-A1; U.S. Patent Publication No. US-2006-0200020-A1; U.S. Patent Publication No. US-2006-0200970-A1; U.S. Patent Publication No. US-2006-0183984-A1; U.S. Patent Publication No. US-2006-0183985-A1; U.S. Patent Publication No. US-2006-0195029-A1; U.S. Patent Publication No. US-2006-0229512-A1; U.S. Patent Publication No. US-2006-0222566-A1; U.S. Patent Publication No. US-2007-0032706-A1; U.S. Patent Publication No. US-2007-0016381-A1; U.S. Patent Publication No. US-2007-0027370-A1; U.S. Patent Publication No. US-2007-0027384-A1; U.S. Patent Publication No. US-2007-0032717-A1; U.S. Patent Publication No. US-2007-0032718-A1; U.S. Patent Publication No. US-2007-0059196-A1; U.S. Patent Publication No. US-2007-0066873-A1; U.S. Patent Publication No. US-2007-0093704-A1; U.S. Patent Publication No. US-2007-0197890-A1; U.S. Patent Publication No. US-2007-0173710-A1; U.S. Patent Publication No. US-2007-0163880-A1; U.S. Patent Publication No. US-2007-0203966-A1; U.S. Patent Publication No. US-2007-0213611-A1; U.S. Patent Publication No. US-2007-0232879-A1; U.S. Patent Publication No. US-2007-0235331-A1; U.S. Patent Publication No. US-2008-0021666-A1; and U.S. Patent Publication No. US-2008-0033254-A1.
Methods and devices that are suitable for use in conjunction with aspects of the preferred embodiments are disclosed in U.S. patent application Ser. No. 09/447,227 filed Nov. 22, 1999 and entitled “DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS”; U.S. patent application Ser. No. 11/654,135 filed Jan. 17, 2007 and entitled “POROUS MEMBRANES FOR USE WITH IMPLANTABLE DEVICES”; U.S. patent application Ser. No. 11/654,140 filed Jan. 17, 2007 and entitled “MEMBRANES FOR AN ANALYTE SENSOR”; U.S. patent application Ser. No. 11/543,396 filed Oct. 4, 2006 and entitled “ANALYTE SENSOR”; U.S. patent application Ser. No. 11/543,490 filed Oct. 4, 2006 and entitled “ANALYTE SENSOR”; U.S. patent application Ser. No. 11/543,404 filed Oct. 4, 2006 and entitled “ANALYTE SENSOR”; U.S. patent application Ser. No. 11/691,426 filed Mar. 26, 2007 and entitled “ANALYTE SENSOR”; U.S. patent application Ser. No. 11/691,432 filed Mar. 26, 2007 and entitled “ANALYTE SENSOR”; U.S. patent application Ser. No. 11/691,424 filed Mar. 26, 2007 and entitled “ANALYTE SENSOR”; and U.S. patent application Ser. No. 11/691,466 filed Mar. 26, 2007 and entitled “ANALYTE SENSOR”.
All references cited herein, including but not limited to published and unpublished applications, patents, and literature references, are incorporated herein by reference in their entirety and are hereby made a part of this specification. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
All numbers expressing quantities of ingredients, reaction conditions, and so forth used in the specification are to be understood as being modified in all instances by the term “about.” Accordingly, unless indicated to the contrary, the numerical parameters set forth herein are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of any claims in any application claiming priority to the present application, each numerical parameter should be construed in light of the number of significant digits and ordinary rounding approaches.
The above description discloses several methods and materials of the present invention. This invention is susceptible to modifications in the methods and materials, as well as alterations in the fabrication methods and equipment. Such modifications will become apparent to those skilled in the art from a consideration of this disclosure or practice of the invention disclosed herein. Consequently, it is not intended that this invention be limited to the specific embodiments disclosed herein, but that it cover all modifications and alternatives coming within the true scope and spirit of the invention.
This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application Ser. No. 61/030,499, filed on Feb. 21, 2008, which is hereby expressly incorporated by reference in its entirety. This application is related to and incorporates by reference in their entirety commonly owned U.S. application Ser. No. 12/390,205, filed on even date herewith, entitled “SYSTEMS AND METHODS FOR CUSTOMIZING DELIVERY OF SENSOR DATA,” and U.S. application Ser. No. 12/390,290, filed on even date herewith, entitled “SYSTEMS AND METHODS FOR BLOOD GLUCOSE MONITORING AND ALERT DELIVERY,”.
Number | Name | Date | Kind |
---|---|---|---|
3210578 | Sherer | Oct 1965 | A |
3219533 | Mullins | Nov 1965 | A |
3381371 | Russell | May 1968 | A |
3775182 | Patton et al. | Nov 1973 | A |
3826244 | Salcman et al. | Jul 1974 | A |
3837339 | Aisenberg | Sep 1974 | A |
3874850 | Sorensen et al. | Apr 1975 | A |
3898984 | Mandel et al. | Aug 1975 | A |
3943918 | Lewis | Mar 1976 | A |
3957613 | Macur | May 1976 | A |
3964974 | Banauch et al. | Jun 1976 | A |
3979274 | Newman | Sep 1976 | A |
4024312 | Korpman | May 1977 | A |
4040908 | Clark, Jr. | Aug 1977 | A |
4052754 | Homsy | Oct 1977 | A |
4073713 | Newman | Feb 1978 | A |
4172770 | Semersky et al. | Oct 1979 | A |
4197840 | Beck et al. | Apr 1980 | A |
4206755 | Klein | Jun 1980 | A |
4215703 | Willson | Aug 1980 | A |
4240438 | Updike et al. | Dec 1980 | A |
4245634 | Albisser et al. | Jan 1981 | A |
4253469 | Aslan | Mar 1981 | A |
4255500 | Hooke | Mar 1981 | A |
4259540 | Sabia | Mar 1981 | A |
4319578 | Enger | Mar 1982 | A |
4374013 | Enfors | Feb 1983 | A |
4388166 | Suzuki et al. | Jun 1983 | A |
4403984 | Ash et al. | Sep 1983 | A |
4442841 | Uehara et al. | Apr 1984 | A |
4477314 | Richter et al. | Oct 1984 | A |
4494950 | Fischell | Jan 1985 | A |
RE31916 | Oswin et al. | Jun 1985 | E |
4534355 | Potter | Aug 1985 | A |
4535786 | Kater | Aug 1985 | A |
4554927 | Fussell | Nov 1985 | A |
4655880 | Liu | Apr 1987 | A |
4663824 | Kenmochi | May 1987 | A |
4675656 | Narcisse | Jun 1987 | A |
4684558 | Keusch et al. | Aug 1987 | A |
4702732 | Powers et al. | Oct 1987 | A |
4703756 | Gough et al. | Nov 1987 | A |
4731726 | Allen | Mar 1988 | A |
4750496 | Reinhart et al. | Jun 1988 | A |
4753652 | Langer et al. | Jun 1988 | A |
4757022 | Shults et al. | Jul 1988 | A |
4777953 | Ash et al. | Oct 1988 | A |
4786394 | Enzer et al. | Nov 1988 | A |
4787398 | Garcia et al. | Nov 1988 | A |
4805625 | Wyler | Feb 1989 | A |
4810243 | Howson | Mar 1989 | A |
4810470 | Burkhardt et al. | Mar 1989 | A |
4820281 | Lawler | Apr 1989 | A |
4823808 | Clegg et al. | Apr 1989 | A |
4832034 | Pizziconi | May 1989 | A |
4852573 | Kennedy | Aug 1989 | A |
4854322 | Ash et al. | Aug 1989 | A |
4858615 | Meinema | Aug 1989 | A |
4871440 | Nagata et al. | Oct 1989 | A |
4883057 | Broderick | Nov 1989 | A |
4889744 | Quaid | Dec 1989 | A |
4890621 | Hakky | Jan 1990 | A |
4902294 | Gosserez | Feb 1990 | A |
4907857 | Giuliani et al. | Mar 1990 | A |
4919141 | Zier et al. | Apr 1990 | A |
4925444 | Orkin et al. | May 1990 | A |
4927407 | Dorman | May 1990 | A |
4927516 | Yamaguchi et al. | May 1990 | A |
4944299 | Silvian | Jul 1990 | A |
4946439 | Eggers | Aug 1990 | A |
4953552 | DeMarzo | Sep 1990 | A |
4974592 | Branco | Dec 1990 | A |
4974929 | Curry | Dec 1990 | A |
4984929 | Rock et al. | Jan 1991 | A |
4989607 | Keusch et al. | Feb 1991 | A |
4992794 | Brouwers | Feb 1991 | A |
4994167 | Shults et al. | Feb 1991 | A |
5007929 | Quaid | Apr 1991 | A |
5033864 | Lasecki et al. | Jul 1991 | A |
5034112 | Murase et al. | Jul 1991 | A |
5050612 | Matsumura | Sep 1991 | A |
5055171 | Peck | Oct 1991 | A |
5059654 | Hou et al. | Oct 1991 | A |
5067491 | Taylor, II et al. | Nov 1991 | A |
5088981 | Howson et al. | Feb 1992 | A |
5096669 | Lauks et al. | Mar 1992 | A |
5097834 | Skrabal | Mar 1992 | A |
5101814 | Palti | Apr 1992 | A |
5137028 | Nishimura | Aug 1992 | A |
5165407 | Wilson et al. | Nov 1992 | A |
5178142 | Harjunmaa et al. | Jan 1993 | A |
5190041 | Palti | Mar 1993 | A |
5208147 | Kagenow et al. | May 1993 | A |
5235003 | Ward et al. | Aug 1993 | A |
5243983 | Tarr et al. | Sep 1993 | A |
5249576 | Goldberger et al. | Oct 1993 | A |
5264104 | Gregg et al. | Nov 1993 | A |
5265594 | Olsson et al. | Nov 1993 | A |
5266179 | Nankai et al. | Nov 1993 | A |
5269891 | Colin | Dec 1993 | A |
5271736 | Picha | Dec 1993 | A |
5281319 | Kaneko et al. | Jan 1994 | A |
5282848 | Schmitt | Feb 1994 | A |
5284140 | Allen et al. | Feb 1994 | A |
5284570 | Savage et al. | Feb 1994 | A |
5285513 | Kaufman et al. | Feb 1994 | A |
5287753 | Routh et al. | Feb 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5307263 | Brown | Apr 1994 | A |
5310469 | Cunningham | May 1994 | A |
5312361 | Zadini et al. | May 1994 | A |
5314471 | Brauker et al. | May 1994 | A |
5316008 | Suga et al. | May 1994 | A |
5326356 | Della Valle et al. | Jul 1994 | A |
5330521 | Cohen | Jul 1994 | A |
5330634 | Wong et al. | Jul 1994 | A |
5331555 | Hashimoto et al. | Jul 1994 | A |
5335658 | Bedingham | Aug 1994 | A |
5337747 | Neftel | Aug 1994 | A |
5342409 | Mullett | Aug 1994 | A |
5343869 | Pross et al. | Sep 1994 | A |
5344454 | Clarke et al. | Sep 1994 | A |
5348788 | White | Sep 1994 | A |
5352351 | White | Oct 1994 | A |
5354449 | Band et al. | Oct 1994 | A |
5356786 | Heller et al. | Oct 1994 | A |
5368028 | Palti | Nov 1994 | A |
5368224 | Richardson et al. | Nov 1994 | A |
5368562 | Blomquist et al. | Nov 1994 | A |
5372135 | Mendelson et al. | Dec 1994 | A |
5376070 | Purvis et al. | Dec 1994 | A |
5380536 | Hubbell et al. | Jan 1995 | A |
5380665 | Cusack et al. | Jan 1995 | A |
5384028 | Ito | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5394879 | Gorman | Mar 1995 | A |
5397848 | Yang et al. | Mar 1995 | A |
5404877 | Nolan et al. | Apr 1995 | A |
5411647 | Johnson et al. | May 1995 | A |
5411866 | Luong | May 1995 | A |
5421328 | Bedingham | Jun 1995 | A |
5421923 | Clarke et al. | Jun 1995 | A |
5429602 | Hauser | Jul 1995 | A |
5448992 | Kupershmidt | Sep 1995 | A |
5453278 | Chan et al. | Sep 1995 | A |
5462051 | Oka et al. | Oct 1995 | A |
5462064 | D'Angelo et al. | Oct 1995 | A |
5469846 | Khan | Nov 1995 | A |
5474552 | Palti | Dec 1995 | A |
5476776 | Wilkins | Dec 1995 | A |
5482008 | Stafford et al. | Jan 1996 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5482473 | Lord et al. | Jan 1996 | A |
5484404 | Schulman et al. | Jan 1996 | A |
5491474 | Suni et al. | Feb 1996 | A |
5494562 | Maley et al. | Feb 1996 | A |
5496453 | Uenoyama et al. | Mar 1996 | A |
5497772 | Schulman et al. | Mar 1996 | A |
5502396 | Desarzens et al. | Mar 1996 | A |
5507288 | Bocker et al. | Apr 1996 | A |
5508203 | Fuller et al. | Apr 1996 | A |
5513636 | Palti | May 1996 | A |
5527288 | Gross | Jun 1996 | A |
5531679 | Schulman et al. | Jul 1996 | A |
5531878 | Vadgama et al. | Jul 1996 | A |
5545220 | Andrews et al. | Aug 1996 | A |
5551850 | Williamson et al. | Sep 1996 | A |
5553616 | Ham et al. | Sep 1996 | A |
5562614 | O'Donnell | Oct 1996 | A |
5562615 | Nassif | Oct 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569186 | Lord et al. | Oct 1996 | A |
5575293 | Miller et al. | Nov 1996 | A |
5575930 | Tietje-Girault et al. | Nov 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5584876 | Bruchman et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5590651 | Shaffer et al. | Jan 1997 | A |
5593440 | Brauker et al. | Jan 1997 | A |
5611900 | Worden | Mar 1997 | A |
5628619 | Wilson | May 1997 | A |
5640470 | Iyer et al. | Jun 1997 | A |
5653756 | Clarke et al. | Aug 1997 | A |
5658250 | Blomquist et al. | Aug 1997 | A |
5660163 | Schulman et al. | Aug 1997 | A |
5665065 | Colman et al. | Sep 1997 | A |
5667504 | Baumann et al. | Sep 1997 | A |
5676820 | Wang et al. | Oct 1997 | A |
5682884 | Hill | Nov 1997 | A |
5683562 | Schaffar et al. | Nov 1997 | A |
5686829 | Girault | Nov 1997 | A |
5695623 | Michel et al. | Dec 1997 | A |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5749832 | Vadgama et al. | May 1998 | A |
5749907 | Mann | May 1998 | A |
5768696 | Law | Jun 1998 | A |
5771890 | Tamada | Jun 1998 | A |
5782880 | Lahtinen et al. | Jul 1998 | A |
5782912 | Brauker et al. | Jul 1998 | A |
5787900 | Butler et al. | Aug 1998 | A |
5791344 | Schulman et al. | Aug 1998 | A |
5791880 | Wilson | Aug 1998 | A |
5795774 | Matsumoto et al. | Aug 1998 | A |
5798065 | Picha | Aug 1998 | A |
5800383 | Chandler et al. | Sep 1998 | A |
5800420 | Gross | Sep 1998 | A |
5800529 | Brauker et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5807406 | Brauker et al. | Sep 1998 | A |
5811487 | Schulz, Jr. et al. | Sep 1998 | A |
5814599 | Mitragotri et al. | Sep 1998 | A |
5820622 | Gross et al. | Oct 1998 | A |
5822715 | Worthington et al. | Oct 1998 | A |
5836887 | Oka et al. | Nov 1998 | A |
5836989 | Shelton | Nov 1998 | A |
5840026 | Uber et al. | Nov 1998 | A |
5840148 | Campbell et al. | Nov 1998 | A |
5848991 | Gross | Dec 1998 | A |
5851197 | Marano et al. | Dec 1998 | A |
5858747 | Schinstine et al. | Jan 1999 | A |
5861019 | Sun et al. | Jan 1999 | A |
5863400 | Drummond et al. | Jan 1999 | A |
5867688 | Simmon et al. | Feb 1999 | A |
5882494 | Van Antwerp | Mar 1999 | A |
5895235 | Droz | Apr 1999 | A |
5899855 | Brown | May 1999 | A |
5904708 | Goedeke | May 1999 | A |
5917346 | Gord | Jun 1999 | A |
5928155 | Eggers et al. | Jul 1999 | A |
5928195 | Malamud et al. | Jul 1999 | A |
5931814 | Alex et al. | Aug 1999 | A |
5933136 | Brown | Aug 1999 | A |
5944661 | Swette et al. | Aug 1999 | A |
5954954 | Houck et al. | Sep 1999 | A |
5957854 | Besson et al. | Sep 1999 | A |
5957903 | Mirzaee et al. | Sep 1999 | A |
5961451 | Reber et al. | Oct 1999 | A |
5963132 | Yoakum | Oct 1999 | A |
5964993 | Blubaugh et al. | Oct 1999 | A |
5971922 | Arita et al. | Oct 1999 | A |
5985693 | Leedy | Nov 1999 | A |
5987352 | Klein et al. | Nov 1999 | A |
5995208 | Sarge et al. | Nov 1999 | A |
5997501 | Gross | Dec 1999 | A |
5999848 | Gord et al. | Dec 1999 | A |
6001067 | Shults et al. | Dec 1999 | A |
6001471 | Bries et al. | Dec 1999 | A |
6011984 | Van Antwerp et al. | Jan 2000 | A |
6014577 | Henning et al. | Jan 2000 | A |
6016448 | Busacker et al. | Jan 2000 | A |
6018674 | Aronow | Jan 2000 | A |
6023629 | Tamada | Feb 2000 | A |
6024720 | Chandler et al. | Feb 2000 | A |
6027445 | Von Bahr | Feb 2000 | A |
6032059 | Henning et al. | Feb 2000 | A |
6049727 | Crothall | Apr 2000 | A |
6059946 | Yukawa et al. | May 2000 | A |
6063637 | Arnold et al. | May 2000 | A |
6066448 | Wohlstadter et al. | May 2000 | A |
6071391 | Gotoh et al. | Jun 2000 | A |
6081735 | Diab et al. | Jun 2000 | A |
6081736 | Colvin et al. | Jun 2000 | A |
6083523 | Dionne et al. | Jul 2000 | A |
6083710 | Heller et al. | Jul 2000 | A |
6088608 | Schulman et al. | Jul 2000 | A |
6091975 | Daddona et al. | Jul 2000 | A |
6093172 | Funderburk et al. | Jul 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6115634 | Donders et al. | Sep 2000 | A |
6117290 | Say | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6121009 | Heller et al. | Sep 2000 | A |
6122536 | Sun et al. | Sep 2000 | A |
6123827 | Wong et al. | Sep 2000 | A |
6127154 | Mosbach et al. | Oct 2000 | A |
6134461 | Say et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6164921 | Moubayed et al. | Dec 2000 | A |
6167614 | Tuttle et al. | Jan 2001 | B1 |
6168568 | Gavriely | Jan 2001 | B1 |
6171276 | Lippe et al. | Jan 2001 | B1 |
6175752 | Say et al. | Jan 2001 | B1 |
6175767 | Doyle et al. | Jan 2001 | B1 |
6180416 | Kurnik et al. | Jan 2001 | B1 |
6187062 | Oweis et al. | Feb 2001 | B1 |
6189536 | Martinez et al. | Feb 2001 | B1 |
6201980 | Darrow et al. | Mar 2001 | B1 |
6201993 | Kruse et al. | Mar 2001 | B1 |
6206856 | Mahurkar | Mar 2001 | B1 |
6214185 | Offenbacher et al. | Apr 2001 | B1 |
6230059 | Duffin | May 2001 | B1 |
6231879 | Li et al. | May 2001 | B1 |
6233471 | Berner et al. | May 2001 | B1 |
6241863 | Monbouquette | Jun 2001 | B1 |
6248067 | Causey, III et al. | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6263222 | Diab et al. | Jul 2001 | B1 |
6264825 | Blackburn et al. | Jul 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6274285 | Gries et al. | Aug 2001 | B1 |
6275717 | Gross et al. | Aug 2001 | B1 |
6280408 | Sipin | Aug 2001 | B1 |
6284478 | Heller et al. | Sep 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6299583 | Eggers et al. | Oct 2001 | B1 |
6300002 | Webb et al. | Oct 2001 | B1 |
6302855 | Lav et al. | Oct 2001 | B1 |
6325978 | Labuda et al. | Dec 2001 | B1 |
6326160 | Dunn et al. | Dec 2001 | B1 |
6329929 | Weijand et al. | Dec 2001 | B1 |
6365670 | Fry | Apr 2002 | B1 |
6366794 | Moussy et al. | Apr 2002 | B1 |
6379301 | Worthington et al. | Apr 2002 | B1 |
6387709 | Mason et al. | May 2002 | B1 |
6403944 | Mackenzie et al. | Jun 2002 | B1 |
6413393 | Van Antwerp et al. | Jul 2002 | B1 |
6416651 | Miller | Jul 2002 | B1 |
6424847 | Mastrototaro et al. | Jul 2002 | B1 |
6427088 | Bowman et al. | Jul 2002 | B1 |
6430437 | Marro | Aug 2002 | B1 |
6432050 | Porat et al. | Aug 2002 | B1 |
6447448 | Ishikawa et al. | Sep 2002 | B1 |
6447542 | Weadock | Sep 2002 | B1 |
6461496 | Feldman et al. | Oct 2002 | B1 |
6464849 | Say et al. | Oct 2002 | B1 |
6477392 | Honigs et al. | Nov 2002 | B1 |
6477395 | Schulman et al. | Nov 2002 | B2 |
6481440 | Gielen et al. | Nov 2002 | B2 |
6484046 | Say et al. | Nov 2002 | B1 |
6488652 | Weijand et al. | Dec 2002 | B1 |
6494830 | Wessel | Dec 2002 | B1 |
6498043 | Schulman et al. | Dec 2002 | B1 |
6498941 | Jackson | Dec 2002 | B1 |
6501976 | Sohrab | Dec 2002 | B1 |
6510329 | Heckel | Jan 2003 | B2 |
6512939 | Colvin et al. | Jan 2003 | B1 |
6520997 | Pekkarinen et al. | Feb 2003 | B1 |
6534711 | Pollack | Mar 2003 | B1 |
6537318 | Ita et al. | Mar 2003 | B1 |
6541266 | Modzelewski et al. | Apr 2003 | B2 |
6544212 | Galley et al. | Apr 2003 | B2 |
6545085 | Kilgour et al. | Apr 2003 | B2 |
6546268 | Ishikawa et al. | Apr 2003 | B1 |
6546269 | Kurnik | Apr 2003 | B1 |
6551496 | Moles et al. | Apr 2003 | B1 |
6553241 | Mannheimer et al. | Apr 2003 | B2 |
6553244 | Lesho et al. | Apr 2003 | B2 |
6558320 | Causey | May 2003 | B1 |
6558321 | Burd et al. | May 2003 | B1 |
6558351 | Steil et al. | May 2003 | B1 |
6560471 | Heller et al. | May 2003 | B1 |
6561978 | Conn et al. | May 2003 | B1 |
6565509 | Say et al. | May 2003 | B1 |
6569521 | Sheridan et al. | May 2003 | B1 |
6572545 | Knobbe et al. | Jun 2003 | B2 |
6572579 | Raghavan et al. | Jun 2003 | B1 |
6574490 | Abbink et al. | Jun 2003 | B2 |
6579498 | Eglise | Jun 2003 | B1 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6585644 | Lebel et al. | Jul 2003 | B2 |
6585675 | O'Mahony et al. | Jul 2003 | B1 |
6585763 | Keilman et al. | Jul 2003 | B1 |
6587705 | Kim et al. | Jul 2003 | B1 |
6592745 | Feldman et al. | Jul 2003 | B1 |
6605072 | Struys et al. | Aug 2003 | B2 |
6607509 | Bobroff et al. | Aug 2003 | B2 |
6609071 | Shapiro et al. | Aug 2003 | B2 |
6612984 | Kerr | Sep 2003 | B1 |
6613379 | Ward et al. | Sep 2003 | B2 |
6618934 | Feldman et al. | Sep 2003 | B1 |
6633772 | Ford et al. | Oct 2003 | B2 |
6641533 | Causey et al. | Nov 2003 | B2 |
6642015 | Vachon et al. | Nov 2003 | B2 |
6645181 | Lavi et al. | Nov 2003 | B1 |
6648821 | Lebel et al. | Nov 2003 | B2 |
6653091 | Dunn et al. | Nov 2003 | B1 |
6654625 | Say et al. | Nov 2003 | B1 |
6656157 | Duchon et al. | Dec 2003 | B1 |
6683535 | Utke | Jan 2004 | B1 |
6687522 | Tamada | Feb 2004 | B2 |
6694191 | Starkweather et al. | Feb 2004 | B2 |
6695860 | Ward et al. | Feb 2004 | B1 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6699383 | Lemire et al. | Mar 2004 | B2 |
6702857 | Brauker et al. | Mar 2004 | B2 |
6721587 | Gough | Apr 2004 | B2 |
6731976 | Penn et al. | May 2004 | B2 |
6740075 | Lebel et al. | May 2004 | B2 |
6741877 | Shults et al. | May 2004 | B1 |
6743635 | Neel et al. | Jun 2004 | B2 |
6749587 | Flaherty | Jun 2004 | B2 |
6773565 | Kunimoto et al. | Aug 2004 | B2 |
6793632 | Sohrab | Sep 2004 | B2 |
6802957 | Jung et al. | Oct 2004 | B2 |
6809653 | Mann et al. | Oct 2004 | B1 |
6810290 | Lebel et al. | Oct 2004 | B2 |
6811548 | Jeffrey | Nov 2004 | B2 |
6813519 | Lebel et al. | Nov 2004 | B2 |
6862465 | Shults et al. | Mar 2005 | B2 |
6869413 | Langley et al. | Mar 2005 | B2 |
6893396 | Schulze et al. | May 2005 | B2 |
6893552 | Wang et al. | May 2005 | B1 |
6895263 | Shin et al. | May 2005 | B2 |
6895265 | Silver | May 2005 | B2 |
6925393 | Kalatz et al. | Aug 2005 | B1 |
6931327 | Goode et al. | Aug 2005 | B2 |
6936006 | Sabra | Aug 2005 | B2 |
6948492 | Wermeling et al. | Sep 2005 | B2 |
6952604 | DeNuzzio et al. | Oct 2005 | B2 |
6954662 | Freger et al. | Oct 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6965791 | Hitchcock et al. | Nov 2005 | B1 |
6978171 | Goetz et al. | Dec 2005 | B2 |
6989891 | Braig et al. | Jan 2006 | B2 |
6990366 | Say et al. | Jan 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7016713 | Gardner et al. | Mar 2006 | B2 |
7022072 | Fox et al. | Apr 2006 | B2 |
7022219 | Mansouri et al. | Apr 2006 | B2 |
7025743 | Mann et al. | Apr 2006 | B2 |
7027848 | Robinson et al. | Apr 2006 | B2 |
7033322 | Silver | Apr 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7061593 | Braig et al. | Jun 2006 | B2 |
7066884 | Custer et al. | Jun 2006 | B2 |
7074307 | Simpson et al. | Jul 2006 | B2 |
7081195 | Simpson et al. | Jul 2006 | B2 |
7092891 | Maus et al. | Aug 2006 | B2 |
7098803 | Mann et al. | Aug 2006 | B2 |
7108778 | Simpson et al. | Sep 2006 | B2 |
7110803 | Shults et al. | Sep 2006 | B2 |
7134999 | Brauker et al. | Nov 2006 | B2 |
7144496 | Meserol et al. | Dec 2006 | B2 |
7162290 | Levin | Jan 2007 | B1 |
7163511 | Conn et al. | Jan 2007 | B2 |
7166074 | Reghabi et al. | Jan 2007 | B2 |
7169289 | Schulein et al. | Jan 2007 | B2 |
7183102 | Monfre et al. | Feb 2007 | B2 |
7184810 | Caduff et al. | Feb 2007 | B2 |
7192450 | Brauker et al. | Mar 2007 | B2 |
7221970 | Parker | May 2007 | B2 |
7226978 | Tapsak et al. | Jun 2007 | B2 |
7267665 | Steil et al. | Sep 2007 | B2 |
7276029 | Goode et al. | Oct 2007 | B2 |
7295867 | Berner et al. | Nov 2007 | B2 |
7299082 | Feldman et al. | Nov 2007 | B2 |
7310544 | Brister et al. | Dec 2007 | B2 |
7315767 | Caduff et al. | Jan 2008 | B2 |
7317939 | Fine et al. | Jan 2008 | B2 |
7338464 | Blischak et al. | Mar 2008 | B2 |
7343565 | Ying et al. | Mar 2008 | B2 |
7344500 | Talbot et al. | Mar 2008 | B2 |
7354420 | Steil et al. | Apr 2008 | B2 |
7364562 | Braig et al. | Apr 2008 | B2 |
7367942 | Grage et al. | May 2008 | B2 |
7399277 | Saidara et al. | Jul 2008 | B2 |
7426408 | DeNuzzio et al. | Sep 2008 | B2 |
7433727 | Ward et al. | Oct 2008 | B2 |
7494465 | Brister et al. | Feb 2009 | B2 |
7497827 | Brister et al. | Mar 2009 | B2 |
7519408 | Rasdal et al. | Apr 2009 | B2 |
7519478 | Bartkowiak et al. | Apr 2009 | B2 |
7523004 | Bartkowiak et al. | Apr 2009 | B2 |
7604593 | Parris et al. | Oct 2009 | B2 |
7618369 | Hayter et al. | Nov 2009 | B2 |
7647237 | Malave et al. | Jan 2010 | B2 |
7695434 | Malecha | Apr 2010 | B2 |
7731659 | Malecha | Jun 2010 | B2 |
7761126 | Gardner et al. | Jul 2010 | B2 |
7766830 | Fox et al. | Aug 2010 | B2 |
7927274 | Rasdal et al. | Apr 2011 | B2 |
8005524 | Brauker et al. | Aug 2011 | B2 |
8005525 | Goode et al. | Aug 2011 | B2 |
8010174 | Goode, Jr. et al. | Aug 2011 | B2 |
8229535 | Mensinger et al. | Jul 2012 | B2 |
20010016682 | Berner et al. | Aug 2001 | A1 |
20010041830 | Varalli et al. | Nov 2001 | A1 |
20010051768 | Schulman et al. | Dec 2001 | A1 |
20020009810 | O'Connor et al. | Jan 2002 | A1 |
20020016535 | Martin et al. | Feb 2002 | A1 |
20020019022 | Dunn et al. | Feb 2002 | A1 |
20020019330 | Murray et al. | Feb 2002 | A1 |
20020022883 | Burg | Feb 2002 | A1 |
20020026110 | Parris et al. | Feb 2002 | A1 |
20020026111 | Ackerman | Feb 2002 | A1 |
20020042561 | Schulman et al. | Apr 2002 | A1 |
20020045808 | Ford et al. | Apr 2002 | A1 |
20020065453 | Lesho et al. | May 2002 | A1 |
20020084196 | Liamos et al. | Jul 2002 | A1 |
20020099282 | Knobbe et al. | Jul 2002 | A1 |
20020099997 | Piret | Jul 2002 | A1 |
20020119711 | VanAntwerp et al. | Aug 2002 | A1 |
20020123048 | Gau | Sep 2002 | A1 |
20020128546 | Silver | Sep 2002 | A1 |
20020151796 | Koulik | Oct 2002 | A1 |
20020161288 | Shin et al. | Oct 2002 | A1 |
20020182241 | Boerenstein et al. | Dec 2002 | A1 |
20020188185 | Sohrab | Dec 2002 | A1 |
20020193885 | Legeay et al. | Dec 2002 | A1 |
20020198513 | Lebel et al. | Dec 2002 | A1 |
20030004432 | Assenheimer | Jan 2003 | A1 |
20030023171 | Sato et al. | Jan 2003 | A1 |
20030028089 | Galley et al. | Feb 2003 | A1 |
20030032874 | Rhodes et al. | Feb 2003 | A1 |
20030036773 | Whitehurst et al. | Feb 2003 | A1 |
20030050546 | Desai et al. | Mar 2003 | A1 |
20030054428 | Monfre et al. | Mar 2003 | A1 |
20030060765 | Campbell et al. | Mar 2003 | A1 |
20030072741 | Berglund et al. | Apr 2003 | A1 |
20030076082 | Morgan et al. | Apr 2003 | A1 |
20030078481 | McIvor et al. | Apr 2003 | A1 |
20030091433 | Tam et al. | May 2003 | A1 |
20030100040 | Bonnecaze et al. | May 2003 | A1 |
20030100821 | Heller et al. | May 2003 | A1 |
20030117296 | Seely | Jun 2003 | A1 |
20030119208 | Yoon et al. | Jun 2003 | A1 |
20030120152 | Omiya | Jun 2003 | A1 |
20030125612 | Fox et al. | Jul 2003 | A1 |
20030130616 | Steil et al. | Jul 2003 | A1 |
20030134347 | Heller et al. | Jul 2003 | A1 |
20030176183 | Drucker et al. | Sep 2003 | A1 |
20030187338 | Say et al. | Oct 2003 | A1 |
20030188427 | Say et al. | Oct 2003 | A1 |
20030199744 | Buse et al. | Oct 2003 | A1 |
20030211625 | Cohan | Nov 2003 | A1 |
20030212317 | Kovatchev et al. | Nov 2003 | A1 |
20030212346 | Yuzhakov et al. | Nov 2003 | A1 |
20030212347 | Sohrab | Nov 2003 | A1 |
20030225324 | Anderson et al. | Dec 2003 | A1 |
20030228681 | Ritts et al. | Dec 2003 | A1 |
20030231550 | Macfarlane | Dec 2003 | A1 |
20030235817 | Bartkowiak et al. | Dec 2003 | A1 |
20040006263 | Anderson et al. | Jan 2004 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040015063 | DeNuzzio et al. | Jan 2004 | A1 |
20040015134 | Lavi et al. | Jan 2004 | A1 |
20040023317 | Motamedi et al. | Feb 2004 | A1 |
20040024327 | Brodnick | Feb 2004 | A1 |
20040030285 | Lavi et al. | Feb 2004 | A1 |
20040030294 | Mahurkar | Feb 2004 | A1 |
20040039298 | Abreu | Feb 2004 | A1 |
20040039406 | Jessen | Feb 2004 | A1 |
20040040840 | Mao et al. | Mar 2004 | A1 |
20040052689 | Yao | Mar 2004 | A1 |
20040054352 | Adames et al. | Mar 2004 | A1 |
20040068230 | Estes et al. | Apr 2004 | A1 |
20040074785 | Holker | Apr 2004 | A1 |
20040078219 | Kaylor et al. | Apr 2004 | A1 |
20040122353 | Shahmirian et al. | Jun 2004 | A1 |
20040143173 | Reghabi et al. | Jul 2004 | A1 |
20040146909 | Duong et al. | Jul 2004 | A1 |
20040152187 | Haight et al. | Aug 2004 | A1 |
20040152622 | Keith et al. | Aug 2004 | A1 |
20040153289 | Casey et al. | Aug 2004 | A1 |
20040158138 | Kilcoyne et al. | Aug 2004 | A1 |
20040167801 | Say et al. | Aug 2004 | A1 |
20040173472 | Jung et al. | Sep 2004 | A1 |
20040176672 | Silver et al. | Sep 2004 | A1 |
20040186362 | Brauker et al. | Sep 2004 | A1 |
20040186365 | Jin et al. | Sep 2004 | A1 |
20040193025 | Steil et al. | Sep 2004 | A1 |
20040204687 | Mogensen | Oct 2004 | A1 |
20040219664 | Heller et al. | Nov 2004 | A1 |
20040220517 | Starkweather et al. | Nov 2004 | A1 |
20040253365 | Warren et al. | Dec 2004 | A1 |
20040254433 | Bandis | Dec 2004 | A1 |
20050003399 | Blackburn et al. | Jan 2005 | A1 |
20050010087 | Banet et al. | Jan 2005 | A1 |
20050027180 | Goode et al. | Feb 2005 | A1 |
20050027182 | Siddiqui et al. | Feb 2005 | A1 |
20050027462 | Goode et al. | Feb 2005 | A1 |
20050027463 | Goode et al. | Feb 2005 | A1 |
20050031689 | Shults et al. | Feb 2005 | A1 |
20050033132 | Shults et al. | Feb 2005 | A1 |
20050038332 | Saidara et al. | Feb 2005 | A1 |
20050043598 | Goode et al. | Feb 2005 | A1 |
20050051427 | Brauker et al. | Mar 2005 | A1 |
20050054909 | Petisce et al. | Mar 2005 | A1 |
20050056552 | Simpson et al. | Mar 2005 | A1 |
20050065464 | Talbot et al. | Mar 2005 | A1 |
20050090607 | Tapsak et al. | Apr 2005 | A1 |
20050096519 | DeNuzzio et al. | May 2005 | A1 |
20050103625 | Rhodes et al. | May 2005 | A1 |
20050107677 | Ward et al. | May 2005 | A1 |
20050112358 | Potyrailo et al. | May 2005 | A1 |
20050113653 | Fox et al. | May 2005 | A1 |
20050121322 | Say | Jun 2005 | A1 |
20050124873 | Shults et al. | Jun 2005 | A1 |
20050139489 | Davies et al. | Jun 2005 | A1 |
20050143635 | Kamath et al. | Jun 2005 | A1 |
20050143671 | Hastings et al. | Jun 2005 | A1 |
20050143675 | Neel et al. | Jun 2005 | A1 |
20050176136 | Burd et al. | Aug 2005 | A1 |
20050177036 | Shults et al. | Aug 2005 | A1 |
20050177398 | Watanabe et al. | Aug 2005 | A1 |
20050181012 | Saint et al. | Aug 2005 | A1 |
20050182451 | Griffin et al. | Aug 2005 | A1 |
20050183954 | Hitchcock et al. | Aug 2005 | A1 |
20050187720 | Goode et al. | Aug 2005 | A1 |
20050192557 | Brauker et al. | Sep 2005 | A1 |
20050196747 | Stiene | Sep 2005 | A1 |
20050197585 | Brockway et al. | Sep 2005 | A1 |
20050203360 | Brauker et al. | Sep 2005 | A1 |
20050211571 | Schulein et al. | Sep 2005 | A1 |
20050215872 | Berner et al. | Sep 2005 | A1 |
20050233407 | Pamidi et al. | Oct 2005 | A1 |
20050239154 | Feldman et al. | Oct 2005 | A1 |
20050242479 | Petisce et al. | Nov 2005 | A1 |
20050245795 | Goode et al. | Nov 2005 | A1 |
20050245799 | Brauker et al. | Nov 2005 | A1 |
20050251083 | Carr-Brendel et al. | Nov 2005 | A1 |
20050261563 | Zhou et al. | Nov 2005 | A1 |
20060001550 | Mann et al. | Jan 2006 | A1 |
20060015020 | Neale et al. | Jan 2006 | A1 |
20060015024 | Brister et al. | Jan 2006 | A1 |
20060016700 | Brister et al. | Jan 2006 | A1 |
20060019327 | Brister et al. | Jan 2006 | A1 |
20060020186 | Brister et al. | Jan 2006 | A1 |
20060020188 | Kamath et al. | Jan 2006 | A1 |
20060020190 | Kamath et al. | Jan 2006 | A1 |
20060020191 | Brister et al. | Jan 2006 | A1 |
20060020192 | Brister et al. | Jan 2006 | A1 |
20060025663 | Talbot et al. | Feb 2006 | A1 |
20060036139 | Brister et al. | Feb 2006 | A1 |
20060036140 | Brister et al. | Feb 2006 | A1 |
20060036141 | Kamath et al. | Feb 2006 | A1 |
20060036142 | Brister et al. | Feb 2006 | A1 |
20060036143 | Brister et al. | Feb 2006 | A1 |
20060036144 | Brister et al. | Feb 2006 | A1 |
20060040402 | Brauker et al. | Feb 2006 | A1 |
20060051736 | Shields et al. | Mar 2006 | A1 |
20060052745 | Van Antwerp et al. | Mar 2006 | A1 |
20060068208 | Tapsak et al. | Mar 2006 | A1 |
20060079740 | Silver et al. | Apr 2006 | A1 |
20060079809 | Goldberger et al. | Apr 2006 | A1 |
20060086624 | Tapsak et al. | Apr 2006 | A1 |
20060094946 | Kellogg et al. | May 2006 | A1 |
20060100588 | Brunnberg et al. | May 2006 | A1 |
20060142651 | Brister et al. | Jun 2006 | A1 |
20060183984 | Dobbles et al. | Aug 2006 | A1 |
20060183985 | Brister et al. | Aug 2006 | A1 |
20060189856 | Petisce et al. | Aug 2006 | A1 |
20060189863 | Peyser et al. | Aug 2006 | A1 |
20060195029 | Shults et al. | Aug 2006 | A1 |
20060198864 | Shults et al. | Sep 2006 | A1 |
20060200019 | Petisce et al. | Sep 2006 | A1 |
20060200020 | Brister et al. | Sep 2006 | A1 |
20060200022 | Brauker et al. | Sep 2006 | A1 |
20060200970 | Brister et al. | Sep 2006 | A1 |
20060222566 | Brauker et al. | Oct 2006 | A1 |
20060224141 | Rush et al. | Oct 2006 | A1 |
20060229512 | Petisce et al. | Oct 2006 | A1 |
20060258929 | Goode et al. | Nov 2006 | A1 |
20060263839 | Ward et al. | Nov 2006 | A1 |
20060281982 | Grata et al. | Dec 2006 | A1 |
20060281985 | Ward et al. | Dec 2006 | A1 |
20060293576 | Van Antwerp et al. | Dec 2006 | A1 |
20070016381 | Kamath et al. | Jan 2007 | A1 |
20070027370 | Brauker et al. | Feb 2007 | A1 |
20070027384 | Brister et al. | Feb 2007 | A1 |
20070027385 | Brister et al. | Feb 2007 | A1 |
20070032706 | Kamath et al. | Feb 2007 | A1 |
20070032717 | Brister et al. | Feb 2007 | A1 |
20070032718 | Shults et al. | Feb 2007 | A1 |
20070038044 | Dobbles et al. | Feb 2007 | A1 |
20070049873 | Hansen et al. | Mar 2007 | A1 |
20070059196 | Brister et al. | Mar 2007 | A1 |
20070060870 | Tolle et al. | Mar 2007 | A1 |
20070066873 | Kamath et al. | Mar 2007 | A1 |
20070085995 | Pesach et al. | Apr 2007 | A1 |
20070093704 | Brister et al. | Apr 2007 | A1 |
20070100222 | Mastrototaro et al. | May 2007 | A1 |
20070116600 | Kochar et al. | May 2007 | A1 |
20070129621 | Kellogg et al. | Jun 2007 | A1 |
20070163880 | Woo et al. | Jul 2007 | A1 |
20070173706 | Neinast et al. | Jul 2007 | A1 |
20070173709 | Petisce et al. | Jul 2007 | A1 |
20070173710 | Petisce et al. | Jul 2007 | A1 |
20070179436 | Braig et al. | Aug 2007 | A1 |
20070197889 | Brister et al. | Aug 2007 | A1 |
20070197890 | Boock et al. | Aug 2007 | A1 |
20070203966 | Brauker et al. | Aug 2007 | A1 |
20070208244 | Brauker et al. | Sep 2007 | A1 |
20070208245 | Brauker et al. | Sep 2007 | A1 |
20070208246 | Brauker et al. | Sep 2007 | A1 |
20070213610 | Say et al. | Sep 2007 | A1 |
20070213611 | Simpson et al. | Sep 2007 | A1 |
20070232879 | Brister et al. | Oct 2007 | A1 |
20070235331 | Simpson et al. | Oct 2007 | A1 |
20070249916 | Pesach et al. | Oct 2007 | A1 |
20070255116 | Mehta et al. | Nov 2007 | A1 |
20070255126 | Moberg et al. | Nov 2007 | A1 |
20080021666 | Goode et al. | Jan 2008 | A1 |
20080027301 | Ward et al. | Jan 2008 | A1 |
20080029390 | Roche | Feb 2008 | A1 |
20080033254 | Kamath et al. | Feb 2008 | A1 |
20080071157 | Mcgarraugh et al. | Mar 2008 | A1 |
20080071158 | Mcgarraugh et al. | Mar 2008 | A1 |
20080072663 | Keenan et al. | Mar 2008 | A1 |
20080086040 | Heller et al. | Apr 2008 | A1 |
20080086041 | Heller et al. | Apr 2008 | A1 |
20080086043 | Heller et al. | Apr 2008 | A1 |
20080091094 | Heller et al. | Apr 2008 | A1 |
20080091095 | Heller et al. | Apr 2008 | A1 |
20080119703 | Brister et al. | May 2008 | A1 |
20080119704 | Brister et al. | May 2008 | A1 |
20080119706 | Brister et al. | May 2008 | A1 |
20080139910 | Mastrototaro et al. | Jun 2008 | A1 |
20080154101 | Jain et al. | Jun 2008 | A1 |
20080171941 | Huelskamp et al. | Jul 2008 | A1 |
20080183061 | Goode et al. | Jul 2008 | A1 |
20080183399 | Goode et al. | Jul 2008 | A1 |
20080188731 | Brister et al. | Aug 2008 | A1 |
20080189051 | Goode et al. | Aug 2008 | A1 |
20080194935 | Brister et al. | Aug 2008 | A1 |
20080194936 | Goode et al. | Aug 2008 | A1 |
20080194937 | Goode et al. | Aug 2008 | A1 |
20080195967 | Goode et al. | Aug 2008 | A1 |
20080208025 | Shults et al. | Aug 2008 | A1 |
20080214915 | Brister et al. | Sep 2008 | A1 |
20080242961 | Brister et al. | Oct 2008 | A1 |
20080262334 | Dunn et al. | Oct 2008 | A1 |
20080262469 | Brister et al. | Oct 2008 | A1 |
20080287764 | Rasdal et al. | Nov 2008 | A1 |
20080287765 | Rasdal et al. | Nov 2008 | A1 |
20080287766 | Rasdal et al. | Nov 2008 | A1 |
20080296155 | Shults et al. | Dec 2008 | A1 |
20080300572 | Rankers et al. | Dec 2008 | A1 |
20080306368 | Goode et al. | Dec 2008 | A1 |
20080306434 | Dobbles et al. | Dec 2008 | A1 |
20080306435 | Kamath et al. | Dec 2008 | A1 |
20080306444 | Brister et al. | Dec 2008 | A1 |
20090005666 | Shin et al. | Jan 2009 | A1 |
20090012379 | Goode et al. | Jan 2009 | A1 |
20090018424 | Kamath et al. | Jan 2009 | A1 |
20090030294 | Petisce et al. | Jan 2009 | A1 |
20090036758 | Brauker et al. | Feb 2009 | A1 |
20090036763 | Brauker et al. | Feb 2009 | A1 |
20090043181 | Brauker et al. | Feb 2009 | A1 |
20090043182 | Brauker et al. | Feb 2009 | A1 |
20090043525 | Brauker et al. | Feb 2009 | A1 |
20090043541 | Brauker et al. | Feb 2009 | A1 |
20090043542 | Brauker et al. | Feb 2009 | A1 |
20090062633 | Brauker et al. | Mar 2009 | A1 |
20090062635 | Brauker et al. | Mar 2009 | A1 |
20090076356 | Simpson | Mar 2009 | A1 |
20090076360 | Brister et al. | Mar 2009 | A1 |
20090076361 | Kamath et al. | Mar 2009 | A1 |
20090099436 | Brister et al. | Apr 2009 | A1 |
20090124877 | Goode, Jr. et al. | May 2009 | A1 |
20090124878 | Goode, Jr. et al. | May 2009 | A1 |
20090156924 | Shariati et al. | Jun 2009 | A1 |
20090177068 | Stivoric et al. | Jul 2009 | A1 |
20090264856 | Lebel et al. | Oct 2009 | A1 |
20100174158 | Kamath et al. | Jul 2010 | A1 |
20100179401 | Rasdal et al. | Jul 2010 | A1 |
20100179404 | Kamath et al. | Jul 2010 | A1 |
20100179407 | Goode, Jr. et al. | Jul 2010 | A1 |
20100179408 | Kamath et al. | Jul 2010 | A1 |
20100179409 | Kamath et al. | Jul 2010 | A1 |
20100234707 | Goode, Jr. et al. | Sep 2010 | A1 |
20100235106 | Goode, Jr. et al. | Sep 2010 | A1 |
20100240975 | Goode, Jr. et al. | Sep 2010 | A1 |
20100240976 | Goode, Jr. et al. | Sep 2010 | A1 |
20100331656 | Mensinger et al. | Dec 2010 | A1 |
20100331657 | Mensinger et al. | Dec 2010 | A1 |
20110009727 | Mensinger et al. | Jan 2011 | A1 |
20110118579 | Goode, Jr. et al. | May 2011 | A1 |
20110124997 | Goode, Jr. et al. | May 2011 | A1 |
20110130970 | Goode, Jr. et al. | Jun 2011 | A1 |
20110137601 | Goode, Jr. et al. | Jun 2011 | A1 |
20110201910 | Rasdal et al. | Aug 2011 | A1 |
20110218414 | Kamath et al. | Sep 2011 | A1 |
20110231140 | Goode, Jr. et al. | Sep 2011 | A1 |
20110231141 | Goode, Jr. et al. | Sep 2011 | A1 |
20110231142 | Goode, Jr. et al. | Sep 2011 | A1 |
20110270158 | Brauker et al. | Nov 2011 | A1 |
Number | Date | Country |
---|---|---|
2127172 | Jul 1998 | CA |
0 098 592 | Jan 1984 | EP |
0 107 634 | May 1984 | EP |
0 127 958 | Dec 1984 | EP |
0 286 118 | Oct 1988 | EP |
0 288 793 | Nov 1988 | EP |
0 320 109 | Jun 1989 | EP |
0 352 610 | Jan 1990 | EP |
0 352 631 | Jan 1990 | EP |
0 353 328 | Feb 1990 | EP |
0 390 390 | Oct 1990 | EP |
0 396 788 | Nov 1990 | EP |
0 406 473 | Jan 1991 | EP |
0 440 044 | Aug 1991 | EP |
0 441 252 | Aug 1991 | EP |
0 441 394 | Aug 1991 | EP |
0 467 078 | Jan 1992 | EP |
0 155 813 | Jul 1992 | EP |
0 323 605 | Jan 1994 | EP |
0 595 474 | Jul 1994 | EP |
0 647 849 | Apr 1995 | EP |
0 424 633 | Jan 1996 | EP |
0 776 628 | Jun 1997 | EP |
0 880 936 | Dec 1998 | EP |
0 587 008 | Feb 1999 | EP |
0 967 788 | Dec 1999 | EP |
0 995 805 | Apr 2000 | EP |
1 102 194 | May 2001 | EP |
1 112 717 | Jul 2001 | EP |
1 112 718 | Jul 2001 | EP |
1 120 084 | Aug 2001 | EP |
1 120 085 | Aug 2001 | EP |
1 153 571 | Nov 2001 | EP |
1 205 753 | May 2002 | EP |
1 251 137 | Oct 2002 | EP |
1 258 728 | Nov 2002 | EP |
1 266 607 | Dec 2002 | EP |
0 680 727 | Jun 2003 | EP |
0 774 658 | Oct 2003 | EP |
1 413 245 | Apr 2004 | EP |
1 437 086 | Jul 2004 | EP |
1 672 070 | Jun 2006 | EP |
1 411 346 | Oct 2006 | EP |
1 722 310 | Nov 2006 | EP |
1 759 726 | Mar 2007 | EP |
1 234 053 | Apr 2007 | EP |
1 850 226 | Oct 2007 | EP |
1 862 112 | Dec 2007 | EP |
1 870 026 | Dec 2007 | EP |
1 905 514 | Apr 2008 | EP |
1 522 255 | May 2008 | EP |
1 918 837 | May 2008 | EP |
1 933 246 | Jun 2008 | EP |
1 949 849 | Jul 2008 | EP |
1 972 270 | Sep 2008 | EP |
1 982 644 | Oct 2008 | EP |
1 281 351 | Nov 2008 | EP |
1 457 913 | Dec 2008 | EP |
2 226 086 | Aug 2010 | EP |
2 223 710 | Sep 2010 | EP |
2656423 | Jun 1991 | FR |
2760962 | Sep 1998 | FR |
2149918 | Jun 1985 | GB |
62083649 | Apr 1987 | JP |
62083849 | Apr 1987 | JP |
2000-060826 | Feb 2000 | JP |
2002-189015 | Jul 2002 | JP |
2003-108679 | Apr 2003 | JP |
WO 8902720 | Apr 1989 | WO |
WO 8905977 | Jun 1989 | WO |
WO 8907263 | Aug 1989 | WO |
WO 9002938 | Mar 1990 | WO |
WO 9010861 | Sep 1990 | WO |
WO 9213271 | Aug 1992 | WO |
WO 9314693 | Aug 1993 | WO |
WO 9422367 | Oct 1994 | WO |
WO 9507109 | Mar 1995 | WO |
WO 9511454 | Apr 1995 | WO |
WO 9513838 | May 1995 | WO |
WO 9614026 | May 1996 | WO |
WO 9625089 | Aug 1996 | WO |
WO 9635697 | Nov 1996 | WO |
WO 9637246 | Nov 1996 | WO |
WO 9701986 | Jan 1997 | WO |
WO 9706727 | Feb 1997 | WO |
WO 9715227 | May 1997 | WO |
WO 9722291 | Jun 1997 | WO |
WO 9728737 | Aug 1997 | WO |
WO 9734521 | Sep 1997 | WO |
WO 9738625 | Oct 1997 | WO |
WO 9824358 | Jun 1998 | WO |
WO 9824366 | Jun 1998 | WO |
WO 9838904 | Sep 1998 | WO |
WO 9838906 | Sep 1998 | WO |
WO 9845427 | Oct 1998 | WO |
WO 9904043 | Jan 1999 | WO |
WO 9913574 | Mar 1999 | WO |
WO 9956613 | Apr 1999 | WO |
WO 9927100 | Jun 1999 | WO |
WO 9927848 | Jun 1999 | WO |
WO 9948419 | Sep 1999 | WO |
WO 9949039 | Sep 1999 | WO |
WO 9959657 | Nov 1999 | WO |
WO 9963328 | Dec 1999 | WO |
WO 9964620 | Dec 1999 | WO |
WO 0007013 | Feb 2000 | WO |
WO 0012720 | Mar 2000 | WO |
WO 0013002 | Mar 2000 | WO |
WO 0013003 | Mar 2000 | WO |
WO 0018449 | Apr 2000 | WO |
WO 0019887 | Apr 2000 | WO |
WO 0020626 | Apr 2000 | WO |
WO 0032098 | Jun 2000 | WO |
WO 0033065 | Jun 2000 | WO |
WO 0040144 | Jul 2000 | WO |
WO 0049941 | Aug 2000 | WO |
WO 0049942 | Aug 2000 | WO |
WO 0059373 | Oct 2000 | WO |
WO 0072181 | Nov 2000 | WO |
WO 0074753 | Dec 2000 | WO |
WO 0116579 | Mar 2001 | WO |
WO 0136666 | May 2001 | WO |
WO 0140466 | Jun 2001 | WO |
WO 0152727 | Jul 2001 | WO |
WO 0152935 | Jul 2001 | WO |
WO 0154753 | Aug 2001 | WO |
WO 0159425 | Aug 2001 | WO |
WO 0174968 | Oct 2001 | WO |
WO 0188534 | Nov 2001 | WO |
WO 0191634 | Dec 2001 | WO |
WO 0205702 | Jan 2002 | WO |
WO 0207596 | Jan 2002 | WO |
WO 0078210 | May 2002 | WO |
WO 02056751 | Jul 2002 | WO |
WO 02058537 | Aug 2002 | WO |
WO 02062210 | Aug 2002 | WO |
WO 02074161 | Sep 2002 | WO |
WO 02078512 | Oct 2002 | WO |
WO 02082989 | Oct 2002 | WO |
WO 02087681 | Nov 2002 | WO |
WO 02089666 | Nov 2002 | WO |
WO 02100262 | Dec 2002 | WO |
WO 02100266 | Dec 2002 | WO |
WO 02100474 | Dec 2002 | WO |
WO 03000127 | Jan 2003 | WO |
WO 03008013 | Jan 2003 | WO |
WO 03008014 | Jan 2003 | WO |
WO 03009207 | Jan 2003 | WO |
WO 03009208 | Jan 2003 | WO |
WO 03022327 | Mar 2003 | WO |
WO 03053498 | Jul 2003 | WO |
WO 03057027 | Jul 2003 | WO |
WO 03063700 | Aug 2003 | WO |
WO 03074107 | Sep 2003 | WO |
WO 03094714 | Nov 2003 | WO |
WO 03101862 | Dec 2003 | WO |
WO 03106966 | Dec 2003 | WO |
WO 2004008956 | Jan 2004 | WO |
WO 2004009161 | Jan 2004 | WO |
WO 2004028337 | Apr 2004 | WO |
WO 2004042364 | May 2004 | WO |
WO 2004060455 | Jul 2004 | WO |
WO 2004061420 | Jul 2004 | WO |
WO 2004110256 | Dec 2004 | WO |
WO 2004113912 | Dec 2004 | WO |
WO 2005001462 | Jan 2005 | WO |
WO 2005011489 | Feb 2005 | WO |
WO 2005020797 | Mar 2005 | WO |
WO 2005032400 | Apr 2005 | WO |
WO 2005041766 | May 2005 | WO |
WO 2005048834 | Jun 2005 | WO |
WO 2005058028 | Jun 2005 | WO |
WO 2005065537 | Jul 2005 | WO |
WO 2005065538 | Jul 2005 | WO |
WO 2005078424 | Aug 2005 | WO |
WO 2005084546 | Sep 2005 | WO |
WO 2005089103 | Sep 2005 | WO |
WO 2005026689 | Oct 2005 | WO |
WO 2005101994 | Nov 2005 | WO |
WO 2005112619 | Dec 2005 | WO |
WO 2005121785 | Dec 2005 | WO |
WO 2005124331 | Dec 2005 | WO |
WO 2006001929 | Jan 2006 | WO |
WO 2006019623 | Feb 2006 | WO |
WO 2006020212 | Feb 2006 | WO |
WO 2006026222 | Mar 2006 | WO |
WO 2006029293 | Mar 2006 | WO |
WO 2006023241 | May 2006 | WO |
WO 2006049854 | May 2006 | WO |
WO 2006050405 | May 2006 | WO |
WO 2006060806 | Jun 2006 | WO |
WO 2006076412 | Jul 2006 | WO |
WO 2006079114 | Jul 2006 | WO |
WO 2006083831 | Aug 2006 | WO |
WO 2006083885 | Aug 2006 | WO |
WO 2006098887 | Sep 2006 | WO |
WO 2006102412 | Sep 2006 | WO |
WO 2006104843 | Oct 2006 | WO |
WO 2006105146 | Oct 2006 | WO |
WO 2006108811 | Oct 2006 | WO |
WO 2006108858 | Oct 2006 | WO |
WO 2006118713 | Nov 2006 | WO |
WO 2006124759 | Nov 2006 | WO |
WO 2006130268 | Dec 2006 | WO |
WO 2006131288 | Dec 2006 | WO |
WO 2006132899 | Dec 2006 | WO |
WO 2006133851 | Dec 2006 | WO |
WO 2007002579 | Jan 2007 | WO |
WO 2007005170 | Jan 2007 | WO |
WO 2007005219 | Jan 2007 | WO |
WO 2007021423 | Feb 2007 | WO |
WO 2007021892 | Feb 2007 | WO |
WO 2007021894 | Feb 2007 | WO |
WO 2007025088 | Mar 2007 | WO |
WO 2007028138 | Mar 2007 | WO |
WO 2007028271 | Mar 2007 | WO |
WO 2007033010 | Mar 2007 | WO |
WO 2007037970 | Apr 2007 | WO |
WO 2007037989 | Apr 2007 | WO |
WO 2007038464 | Apr 2007 | WO |
WO 2007053497 | May 2007 | WO |
WO 2007053832 | May 2007 | WO |
WO 2007056638 | May 2007 | WO |
WO 2007058921 | May 2007 | WO |
WO 2007059061 | May 2007 | WO |
WO 2007061992 | May 2007 | WO |
WO 2007062013 | May 2007 | WO |
WO 2007065285 | Jun 2007 | WO |
WO 2007076940 | Jul 2007 | WO |
WO 2007079025 | Jul 2007 | WO |
WO 2007081608 | Jul 2007 | WO |
WO 2007097754 | Aug 2007 | WO |
WO 2007101260 | Sep 2007 | WO |
WO 2007114943 | Oct 2007 | WO |
WO 2007114979 | Oct 2007 | WO |
WO 2007120363 | Oct 2007 | WO |
WO 2007126444 | Nov 2007 | WO |
WO 2007126920 | Nov 2007 | WO |
WO 2007127606 | Nov 2007 | WO |
WO 2007127879 | Nov 2007 | WO |
WO 2007127880 | Nov 2007 | WO |
WO 2007130239 | Nov 2007 | WO |
WO 2007137286 | Nov 2007 | WO |
WO 2007143225 | Dec 2007 | WO |
WO 2008003003 | Jan 2008 | WO |
WO 2008005780 | Jan 2008 | WO |
WO 2008016486 | Feb 2008 | WO |
WO 2008016501 | Feb 2008 | WO |
WO 2008021913 | Feb 2008 | WO |
WO 2008028644 | Mar 2008 | WO |
WO 2008036437 | Mar 2008 | WO |
WO 2008037485 | Apr 2008 | WO |
WO 2008039944 | Apr 2008 | WO |
WO 2008039946 | Apr 2008 | WO |
WO 2008039949 | Apr 2008 | WO |
WO 2008042760 | Apr 2008 | WO |
WO 2008048452 | Apr 2008 | WO |
WO 2007143225 | May 2008 | WO |
WO 2008051924 | May 2008 | WO |
WO 2008052057 | May 2008 | WO |
WO 2008052199 | May 2008 | WO |
WO 2008052374 | May 2008 | WO |
WO 2008054608 | May 2008 | WO |
WO 2008054676 | May 2008 | WO |
WO 2008054677 | May 2008 | WO |
WO 2008055037 | May 2008 | WO |
WO 2008060827 | May 2008 | WO |
WO 2008067291 | Jun 2008 | WO |
WO 2008067314 | Jun 2008 | WO |
WO 2008069931 | Jun 2008 | WO |
WO 2008069932 | Jun 2008 | WO |
WO 2008073813 | Jun 2008 | WO |
WO 2008076868 | Jun 2008 | WO |
WO 2008079616 | Jul 2008 | WO |
WO 2008079849 | Jul 2008 | WO |
WO 2008080591 | Jul 2008 | WO |
WO 2008083179 | Jul 2008 | WO |
WO 2008083379 | Jul 2008 | WO |
WO 2008064053 | Aug 2008 | WO |
WO 2008092286 | Aug 2008 | WO |
WO 2008101211 | Aug 2008 | WO |
WO 2008101217 | Aug 2008 | WO |
WO 2008101229 | Aug 2008 | WO |
WO 2008103620 | Aug 2008 | WO |
WO 2008104397 | Sep 2008 | WO |
WO 2008112375 | Sep 2008 | WO |
WO 2007079015 | Oct 2008 | WO |
WO 2008116329 | Oct 2008 | WO |
WO 2008118257 | Oct 2008 | WO |
WO 2008124597 | Oct 2008 | WO |
WO 2008128210 | Oct 2008 | WO |
WO 2008130895 | Oct 2008 | WO |
WO 2008130896 | Oct 2008 | WO |
WO 2008130897 | Oct 2008 | WO |
WO 2008130898 | Oct 2008 | WO |
WO 2008134146 | Nov 2008 | WO |
WO 2008134561 | Nov 2008 | WO |
WO 2008134587 | Nov 2008 | WO |
WO 2008135128 | Nov 2008 | WO |
WO 2008137405 | Nov 2008 | WO |
WO 2008138006 | Nov 2008 | WO |
WO 2008150280 | Dec 2008 | WO |
WO 2008150436 | Dec 2008 | WO |
WO 2008150633 | Dec 2008 | WO |
Entry |
---|
Alcock & Turner. 1994. Continuous Analyte Monitoring to Aid Clinical Practice. IEEE Engineering in Med. & Biol. Mag. 13:319-325. |
American Heritage Dictionary, 4th Edition. 2000. Houghton Mifflin Company, p. 82. |
Assolant-Vinet et al. 1986. New Immoblized Enzyme Membranes for Tailor-Made Biosensors, Anal Letters 19(7&8): 875-885. |
Bardeletti et al. 1986. A Reliable L-Lactate Electrode with a New Membrane for Enzyme Immobilization for Amperometric Assay of Lactate. Analyt Chim Acta, 187: 47-54. |
Bertrand et al. 1981. Multipurpose Electrode with Different Enzyme Systems Bound to Collagen Films. Anal Chim Acta 126: 23-34. |
Boedeker Plastics, Inc. 2009. Polyethylene Specifications Data Sheet, http://www.boedeker.com/polye—p.htm [Aug. 19, 2009 3:36:33 PM]. |
Coulet et al. 1981. Enzymes immobilized on collagen membranes: A tool for fundamental research and enzyme engineering. J Chromatography 215: 65-72. |
Coulet, P.R. 1992. Polymeric membranes and coupled enzymes in the design of biosensors. J Membr Science 68: 217-228. |
Freedman et al. 1991. Statistics, Second Edition, W.W. Norton & Company, p. 74. |
Gough. May 2001. The implantable glucose sensor: An example of bioengineering design. Introduction to Bioengineering, Chapter 3, pp. 57-66. |
Hamilton Syringe Selection Guide. 2006. Syringe Selection. www.hamiltoncompany.com, 20 pages. |
Hoel, Paul G. 1976. Elementary Statistics, Fourth Edition. John Wiley & Sons, Inc.. pp. 113-114. |
Jaffari et al. 1995. Recent advances in amperometric glucose biosensors for in vivo monitoring, Physiol. Meas. 16: 1-15. |
Jobst et al., (1996) Thin-Film Microbiosensors for Glucose-Lactate Monitoring, Anal Chem. 8(18): 3173-3179. |
Mazzola et al., Video Diabetes: A Teaching Tool for Children with Insulin-Dependent Diabetes, Proceedings—7th Annual Symposium on Computer Applications in Medical Care; Washington, D.C.; Dialog:, (Oct. 1983), File 8, Acc# 01624462. |
Merriam-Webster Online Dictionary. Jan. 11, 2010. Definition of “acceleration”. http://www.merriam-webster.com/dictionary/Acceleration. |
Merriam-Webster Online Dictionary. Jan. 11, 2010. Definition of “system”. http://www.merriam-webster.com/dictionary/System. |
Moussy et al. 1993. Performance of subcutaneously implanted needle-type glucose sensors employing a novel trilayer coating, Anal Chem. 85: 2072-2077. |
Moussy, Francis (Nov. 2002) Implantable Glucose Sensor: Progress and Problems, Sensors, 1:270-273. |
Nintendo Healthcare, Wired, Dec. 1993, 1 page. |
Oxford English Dictionary Online. Jan. 11, 2010. Definition of “impending”. http://www.askoxford.com/results/?view=dev dict&field-12668446 Impending&branch=. |
Peguin et al. 1989. Pyruvate Oxidase and Oxaloacetate Decarbozylase Enzyme Electrodes—Simultaneous Determination of Transaminases with a Two-electrode-based Analyzer, Anal Chim Acta 222: 83-93. |
Phillips. 1995. A high capacity transcutaneous energy transmission system. ASAIO Journal 41:M259-M262. |
Pickup et al. 1993. Developing glucose sensors for in vivo use. Elsevier Science Publishers Ltd (UK), Tibtech vol. 11: 285-291. |
Raya Systems Pioneers Healthy Video Games, PlayRight, Nov. 1993 (pp. 14-15). |
Reusch. 2004. Chemical Reactivity. Organometallic Compounds. Virtual Textbook of Organic Chem. pp. 1-16, http://www.cem.msu.edu/˜reusch/VirtualText/orgmetal.htm. |
Samuels, M.P. 2004. The effects of flight and altitude. Arch Dis Child. 89: 448-455. |
San Diego Plastics, Inc. 2009. Polyethylene Data Sheet, http://www.sdplastics.com/polyeth.html. |
Schaffar, Bernhard P.H. (Dec. 2001). Thick film biosensors for metabolites in undiluted whole blood and plasma samples, Anal Bioanal Chem. 372: 254-260. |
Schmidt et al. 1992. Calibration of a wearable glucose sensor. The International Journal of Artificial Organs 15(1):55-61. |
Schmidtke et al. 1998. Accuracy of the one-point in vivo calibration of “wired” glucose oxidase electrodes implanted in jugular veins of rats in periods of rapid rise and decline of the glucose concentration. Anal Chem 70(10):2149-2155. |
Smith et al. 1998. An externally powered, multichannel, implantable stimulator-telemeter for control of paralyzed muscle. IEEE Transactions on Biomedical Engineering 45(4):463-475. |
Sokolov et al. 1995. Metrological opportunities of the dynamic mode of operating an enzyme amperometric biosensor. Med. Eng. Phys. 17(6):471-476. |
Sparacino et al., 2008. Continuous glucose monitoring time series and hypo/hyperglycemia prevention: requirements, methods, open problems, Current Diabetes Reviews, 4:181-192. |
Sproule et al. 2002. Fuzzy pharmacology: Theory and applications. Trends in Pharmacological Sciences, 23(9):412-417. |
Street et al. 1988. A note on computing robust regression estimates via iteratively reweighted least squares. The American Statistician 42(2):152-154. |
Takatsu et al. 1987. Solid State Biosensors Using Thin-Film Electrodes. Sens Actuators 11: 309-317. |
Thijssen et al. 1984. A Kalman Filter for Calibration, Evaluation of Unknown Samples and Quality Control in Drifting Systems, Part 1. Theory and Simulations, Anal Chim Acta 156: 87-101. |
Thijssen et al. 1985. A Kalman Filter for Calibration, Evaluation of Unknown Samples and Quality Control in Drifting Systems, Part 3. Variance Reduction, Anal Chim Acta. 173: 265-272. |
Thijssen et al. 1985. A Kalman Filter for Calibration, Evaluation of Unknown Samples and Quality Control in Drifting Systems, Part 4. Flow Injection Analysis, Anal Chim Acta. 174: 27-40. |
Thijssen, P.C. 1984. A Kalman Filder for Calibration, Evaluation of Unknown Samples and Quality Control in Drifting Systems, Part 2. Optimal Designs, Anal Chim Acta. 162: 253-262. |
Tilbury et al. 2000. Receiver operating characteristic analysis for intelligent medical systems—A new approach for finding confidence intervals. IEEE Transactions on Biomedical Engineering 47(7):952-963. |
Trajanoski et al. 1998. Neural predictive controller for insulin delivery using the subcutaneous route. IEEE Transactions on Biomedical Engineering 45(9):1122-1134. |
Turner et al. 1984. Carbon Monoxide: Acceptor Oxidoreductase from Pseudomonas Thermocarboxydovorans Strain C2 and its use in a Carbon Monoxide Sensor. Analytica Chimica Acta, 163: 161-174. |
Vadgama. 1988. Diffusion limited enzyme electrodes. NATO ASI Series: Series C, Math and Phys. Sci. 226:359-377. |
Ward et al. 2004. A wire-based dual-analyte sensor for Glucose and Lactate: In Vitro and In Vivo Evaluation, Diab Tech Therapeut. 6(3): 389-401. |
Wiley Electrical and Electronics Engineering Dictionary. 2004. John Wiley & Sons, Inc. pp. 141, 142, 548, 549. |
Yang et al. 1995. Glucose Biosensors with enzyme entrapped in polymer coating, Biomed Instrum Technol. 29(2): 125-133. |
Ye et al. 1993. High Current Density ‘Wired’ Quinoprotein Glucose Dehydrogenase Electrode. Anal. Chem. 65:238-241. |
Zavalkoff et al. 2002. Evaluation of conventional blood glucose monitoring as an indicator of integrated glucose values using a continuous subcutaneous sensor. Diabetes Care 25(9):1603-1606. |
Zhang et al. 1993. In vitro and in vivo evaluation of oxygen effects on a glucose oxidase based implantable glucose sensor. Analytica Chimica Acta, 281:513-520. |
ISR dated Jan. 16, 2002 for PCT/US01/23850 filed Jul. 30, 2001. |
IPER dated Jun. 4, 2003 for PCT/US01/23850 filed Jul. 30, 2001. |
ISR and WO dated Nov. 29, 2004 for PCT/US04/24263, filed Jul. 27, 2004. |
IPRP dated Feb. 6, 2006 for PCT/US04/24263, filed Jul. 27, 2004. |
ISR and WO for PCT/US06/034284, filed Sep. 1, 2006. |
IPRP for PCT/US06/034284, filed Sep. 1, 2006. |
ISR and WO dated Oct. 7, 2008 for PCT/US08/66600, filed Jun. 11, 2008. |
IPRP dated Dec. 17, 2009 for PCT/US08/66600, filed Jun. 11, 2008. |
ISR and WO dated Jun. 1, 2005 for PCT/US04/41095, filed Dec. 8, 2004. |
ISR and WO dated Jan. 9, 2006 for PCT/US04/38724 filed Nov. 17, 2004. |
IPRP dated Mar. 5, 2009 for PCT/US04/38724 filed Nov. 17, 2004. |
ISR and WO for PCT/US05/006301 filed Feb. 24, 2005. |
IPRP for PCT/US05/006301 filed Feb. 24, 2005. |
ISR and WO dated Nov. 4, 2005 for PCT/US05/024993 filed Jul. 13, 2005. |
IPRP dated Jan. 16, 2007 for PCT/US05/024993 filed Jul. 13, 2005. |
ISR and WO dated Jul. 20, 2007 for PCT/US06/24132 filed Jun. 20, 2006. |
IPRP dated Dec. 24, 2007 for PCT/US06/24132, filed Jun. 20, 2006. |
ISR and WO dated Apr. 14, 2009 for PCT/US2009/034773, filed Feb. 20, 2009. |
IPRP dated Aug. 24, 2010 for PCT/US2009/034773, filed Feb. 20, 2009. |
ISR and WO dated Aug. 8, 2008 for PCT/US08/058158, filed Mar. 25, 2008. |
IPRP dated Sep. 29, 2009 for PCT/US08/058158, filed Mar. 25, 2008. |
EPO Communication dated Sep. 7, 2010 in EP App. No. 05723951.9. |
EPO Communication dated Jan. 28, 2011 for EP 05723951.9, filed Feb. 24, 2005. |
EPO Communication dated Aug. 3, 2010 for EP 10163675.1, Filed Feb. 24, 2005. |
EPO Communication dated Mar. 17, 2011 for EP 10163675.1, filed Feb. 24, 2005. |
EPO Communication dated Aug. 19, 2009 in European App. No. 05771646.6, filed Jul. 13, 2005. |
EPO Communication dated Aug. 17, 2011 in European App. No. 05771646.6, filed Jul. 13, 2005. |
EPO Extended Search Report dated Mar. 9, 2010 for EP App. No. 06718980.3, filed Jan. 17, 2006. |
Japanese Office Action dated Aug. 31, 2010 for Application No. 2006-522016, filed Jul. 27, 2004. |
JIPO Office Action dated Jun. 28, 2011 for JP Application No. 2006-522016, filed Jul. 27, 2004. |
Office Action dated Jul. 29, 2010 in U.S. Appl. No. 12/364,786. |
Office Action dated Oct. 29, 2009 in U.S. Appl. No. 11/360,819. |
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 11/360,819. |
Office Action dated Apr. 7, 2010 in U.S. Appl. No. 11/360,819. |
Electronic File History of U.S. Appl. No. 12/098,353, filed Apr. 4, 2008 containing Office Action(s) dated Aug. 26, 2010 and May 4, 2011 and Applicant Response(s) filed Nov. 24, 2010 and Jun. 3, 2011 as of Jun. 3, 2011. |
Electronic File History of U.S. Appl. No. 12/579,385, filed Oct. 14, 2009 containing Office Action(s) dated Aug. 23, 2010, Feb. 17, 2011 and Jul. 14, 2011 and Applicant(s) Response(s) filed Nov. 16, 2010, Apr. 18, 2011 and Jul. 25, 2011 as of Jul. 25, 2011. |
Electronic File History of U.S. Appl. No. 12/536,852, filed Aug. 6, 2009 (now U.S. Pat. No. 7,976,492 issued Jul. 12, 2011) containing Office Action(s) dated Jun. 25, 2010, Oct. 18, 2010, and Feb. 25, 2011 and Applicant(s) Response(s) filed Aug. 3, 2010, Dec. 8, 2010, and May 11, 2011. |
Electronic File History of U.S. Appl. No. 12/133,738, filed Jun. 5, 2008 containing Office Action(s) dated Aug. 23, 2010, Sep. 10, 2010 and Feb. 14, 2011 and Applicant(s) Response(s) filed Aug. 31, 2010, Dec. 7, 2010 and May 16, 2011 as of May 18, 2011. |
Electronic File History of U.S. Appl. No. 12/133,761, filed Jun. 5, 2008 containing Office Action(s) dated Aug. 23, 2010, Sep. 7, 2010 and Feb. 14, 2011 and Applicant Response(s) filed Aug. 25, 2010, Dec. 6, 2010, Apr. 14, 2011 and May 16, 2011 as of May 19, 2011. |
Electronic File History of U.S. Appl. No. 12/133,786, filed Jun. 5, 2008 containing Office Action(s) dated Aug. 23, 2010, Sep. 8, 2010 and Feb. 14, 2011 and Applicant Response(s) filed Aug. 25, 2010, Dec. 7, 2010, Apr. 13, 2011 and May 13, 2011 as of May 19, 2011. |
Electronic File History of U.S. Appl. No. 12/390,290, filed Feb. 20, 2009 containing Office Actions dated May 4, 2011 and Sep. 7, 2011 and Applicant(s) Response(s) dated Jun. 15, 2011 as of Nov. 29, 2011. |
US 7,530,950, 05/2009, Brister et al. (withdrawn). |
Aalders et al. 1991. Development of a wearable glucose sensor; studies in healthy volunteers and in diabetic patients. The International Journal of Artificial Organs 14(2):102-108. |
Abe et al. 1992. Characterization of glucose microsensors for intracellular measurements. Alan. Chem. 64(18):2160-2163. |
Abel et al. 1984. Experience with an implantable glucose sensor as a prerequisite of an artifical beta cell, Biomed. Biochim. Acta 43(5):577-584. |
Abel et al. 2002. Biosensors for in vivo glucose measurement: can we cross the experimental stage. Biosens Bioelectron 17:1059-1070. |
Amin et al. 2003. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: Use of continuous glucose monitoring system. Diabetes Care 26(3):662-667. |
Armour et al. Dec. 1990. Application of Chronic Intravascular Blood Glucose Sensor in Dogs. Diabetes 39:1519-1526. |
Atanasov et al. 1994. Biosensor for continuous glucose monitoring. Biotechnology and Bioengineering 43:262-266. |
Atanasov et al. 1997. Implantation of a refillable glucose monitoring-telemetry device. Biosens Bioelectron 12:669-680. |
Aussedat et al. 1997. A user-friendly method for calibrating a subcutaneous glucose sensor-based hypoglycaemic alarm. Biosensors & Bioelectronics 12(11):1061-1071. |
Bailey et al. 2007. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technology & Therapeutics 9(3):203-210. |
Bard et al. 1980. Electrochemical Methods. John Wiley & Sons, pp. 173-175. |
Beach et al. 1999. Subminiature implantable potentiostat and modified commercial telemetry device for remote glucose monitoring. IEEE Transactions on Instrumentation and Measurement 48(6):1239-1245. |
Bellucci et al. Jan. 1986. Electrochemical behaviour of graphite-epoxy composite materials (GECM) in aqueous salt solutions, Journal of Applied Electrochemistry, 16(1):15-22. |
Bessman et al., Progress toward a glucose sensor for the artificial pancreas, Proceedings of a Workshop on Ion-Selective Microelectrodes, Jun. 4-5, 1973, Boston, MA, 189-197. |
Biermann et al. 2008. How would patients behave if they were continually informed of their blood glucose levels? A simulation study using a “virtual” patient. Diab. Thechnol. & Therapeut., 10:178-187. |
Bindra et al. 1991. Design and In Vitro Studies of a Needle-Type Glucose Senso for Subcutaneous Monitoring. Anal. Chem 63:1692-96. |
Bisenberger et al. 1995. A triple-step potential waveform at enzyme multisensors with thick-film gold electrodes for detection of glucose and sucrose. Sensors and Actuators, B 28:181-189. |
Bland et al. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310. |
Bland et al. 1990. A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput. Biol. Med. 20(5):337-340. |
Bobbioni-Harsch et al. 1993. Lifespan of subcutaneous glucose sensors and their performances during dynamic glycaemia changes in rats, J. Biomed. Eng. 15:457-463. |
Bode et al. 1999. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study. Diabetes Research and Clinical Practice 46:183-190. |
Bode et al. 2000. Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technology & Therapeutics, 2(Suppl 1):S43-48. |
Bode, B. W. 2000. Clinical utility of the continuous glucose monitoring system. Diabetes Technol Ther, 2(Suppl 1):S35-41. |
Boland et al. 2001. Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care 24(11):1858-1862. |
Bowman, L.; Meindl, J. D. 1986. The packaging of implantable integrated sensors. IEEE Trans Biomed Eng BME33(2):248-255. |
Brauker et al. Jun. 27, 1996. Local Inflammatory Response Around Diffusion Chambers Containing Xenografts Transplantation 61(12):1671-1677. |
Braunwald, 2008. Biomarkers in heart failure. N. Engl. J. Med., 358: 2148-2159. |
Bremer et al. 2001. Benchmark data from the literature for evaluation of new glucose sensing technologies. Diabetes Technology & Therapeutics 3(3):409-418. |
Brooks et al. “Development of an on-line glucose sensor for fermentation monitoring,” Biosensors, 3:45-56 (1987/88). |
Bruckel et al. 1989. In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr 67:491-495. |
Cai et al. 2004. A wireless, remote query glucose biosensor based on a pH-sensitive polymer. Anal Chem 76(4):4038-4043. |
Campanella et al. 1993. Biosensor for direct determination of glucose and lactate in undiluted biological fluids. Biosensors & Bioelectronics 8:307-314. |
Candas et al (1994). “An adaptive plasma glucose controller basedon on a nonlinear insulin/glucose model.” IEEE Transactions on Biomedical Engineering, 41(2): 116-124. |
Cass et al. “Ferrocene-mediated enzyme electrodes for amperometric determination of glucose,” Anal. Chem., 36:667-71 (1984). |
Cassidy et al., Apr. 1993. Novel electrochemical device for the detection of cholesterol or glucose, Analyst, 118:415-418. |
Chase et al. 2001. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 107:222-226. |
Chia et al. 2004. Glucose sensors: toward closed loop insulin delivery. Endocrinol Metab Clin North Am 33:175-95. |
Choleau et al. 2002. Calibration of a subcutaneous amperometric glucose sensor implanted for 7 days in diabetic patients. Part 2. Superiority of the one-point calibration method. Biosensors and Bioelectronics 17:647-654. |
Ciba® Irgacure 2959 Photoinitiator Product Description, Ciba Specialty Chemicals Inc., Basel, Switzerland. |
Claremont et al. 1986. Subcutaneous implantation of a ferrocene-mediated glucose sensor in pigs. Diabetologia 29:817-821. |
Claremont et al. Jul. 1986. Potentially-impintable, ferrocene-mediated glucose sensor. J. Biomed. Eng. 8:272-274. |
Clark et al. 1987. Configurational cyclic voltammetry: increasing the specificity and reliablity of implanted electrodes, IEEE/Ninth Annual Conference of the Engineering in Medicine and Biology Society, pp. 0782-0783. |
Clark et al. 1988. Long-term stability of electroenzymatic glucose sensors implanted in mice. Trans Am Soc Artif Intern Organs 34:259-265. |
Clark et al., 1981. One-minute electrochemical enzymic assay for cholesterol in biological materials, Clin. Chem. 27(12):1978-1982. |
Colangelo et al. 1967. Corrosion rate measurements in vivo, Journal of Biomedical Materials Research, 1:405-414. |
Colowick et al. 1976. Methods in Enzymlology, vol. XLIV, Immobilized Enzymes. New York: Academic Press. |
Cox et al. 1985. Accuracy of perceiving blood glucose in IDDM. Diabetes Care 8(6):529-536. |
Csöregi et al. 1994. Amperometric microbiosensors for detection of hydrogen peroxide and glucose based on peroxidase-modified carbon fibers. Electroanalysis 6:925-933. |
Csoregi et al., 1994. Design, characterization, and one-point in vivo calibration of a subcutaneously implanted glucose electrode. Anal Chem. 66(19):3131-3138. |
Danielsson et al. 1988. Enzyme thermistors, Methods in Enzymology, 137:181-197. |
Dassau et al., In silico evaluation platform for artifical pancreatic β-cell development-a dynamic simulator for closed loop control with hardware-in-the-loop, Diabetes Technology & Therapeutics, 11(3):1-8, 2009. |
Davies, et al. 1992. Polymer membranes in clinical sensor applications. I. An overview of membrane function, Biomaterials, 13(14):971-978. |
Direct 30/30® meter (Markwell Medical) (Catalog). |
Dixon et al. 2002. Characterization in vitro and in vivo of the oxygen dependence of an enzyme/polymer biosensor for monitoring brain glucose. Journal of Neuroscience Methods 119:135-142. |
DuPont' Dimension AR® (Catalog), 1998. |
Durliat et al. 1976. Spectrophotometric and electrochemical determinations of L(+)-lactate in blood by use of lactate dehydrogenase from yeast, Clin. Chem. 22(11):1802-1805. |
Edwards Lifesciences. Accuracy for your and your patients. Marketing materials, 4 pp. 2002. |
El Degheidy et al. 1986. Optimization of an implantable coated wire glucose sensor. J. Biomed Eng. 8: 121-129. |
El-Khatib et al. 2007. Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine, Journal of Diabetes Science and Technology, 1(2):181-192. |
Ei-Sa'ad et al. 1990. Moisture Absorption by Epoxy Resins: the Reverse Thermal Effect Journal of Materials Science 25:3577-3582. |
Ernst et ai. 2002. Reliable glucose monitoring through the use of microsystem technology. Anal. Bioanal. Chem. 373:758-761. |
Fabietti et al. 2007. Clinical validation of a new control-oriented model of insulin and glucose dynamcs in subjects with type 1 diabetes, Diabetes Technology & Therapeutics, 9(4):327-338. |
Fahy et al., An analysis: hyperglycemic intensive care patients need continuous glocuse monitoring—easier said than done, Journal of Diabetese Science and Technology, 2(2):201-204, Mar. 2008. |
Fare et al. 1998. Functional characterization of a conducting polymer-based immunoassay system. Biosensors & Bioelectronics 13(3-4):459-470. |
Feldman et al. 2003. A continuous glucose sensor based on wired enzyme technology—results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 5(5):769-779. |
Fischer et al. 1987. Assessment of subcutaneous glucose concentration: validation of the wick technique as a reference for implanted electrochemical sensors in normal and diabetic dogs, Diabetologia 30:940-945. |
Fischer et al. 1989. Oxygen Tension at the Subcutaneous Implantation Site of Glucose Sensors. Biomed. Biochem 11/12:965-972. |
Fischer et al. 1995. Hypoglycaemia-warning by means of subcutaneous electrochemical glucose sensors: an animal study, Harm. Metab. Rese. 27:53. |
Frohnauer et al. 2001. Graphical human insulin time-activity profiles using standardized definitions. Diabetes Technology & Therapeutics 3(3):419-429. |
Frost et al. 2002, Implantable chemical sensors for real-time clinical monitoring: Progress and challenges. Current Opinion in Chemical Biology 6:633-641. |
Gabbay et al. 2008. Optical coherence tomography-based continuous noninvasive glucose monitoring in patients with diabetes. Diab. Thechnol. & Therapeut., 10:188-193. |
Ganesan et al., Gold layer-based dual crosslinking procedure of glucose oxidase with ferrocene monocarboxylic acid provides a stable biosensor, Analytical Biochemistry 343:188-191, 2005. |
Ganesh et al., Evaluation of the VIA® blood chemistry monitor for glucose in healthy and diabetic volunteers, Journal of Diabetese Science and Technology, 2(2):182-193, Mar. 2008. |
Garg et al. 2004. Improved Glucose Excursions Using an Implantable Real-Time continuous Glucose Sensor in Adults with Type I Diabetes. Diabetes Care 27:734-738. |
Gerritsen et al. 1999. Performance of subcutaneously implanted glucose sensors for continuous monitoring. The Netherlands Journal of Medicine 54:167-179. |
Gerritsen, M. 2000. Problems associated with subcutaneously implanted glucose sensors. Diabetes Care 23(2):143-145. |
Gilligan et al. 1994. Evaluation of a subcutaneous glucose sensor out to 3 months in a dog model. Diabetes Care 17(8):882-887. |
Gilligan et al. 2004, Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol Ther 6:378-386. |
Godsland et al. 2001. Maximizing the Success Rate of Minimal Model Insulin Sensitivity Measurement in Humans: The Importance of Basal Glucose Levels. The Biochemical Society and the Medical Research Society, 1-9. |
Gouda et al., Jul. 4, 2003. Thermal inactiviation of glucose oxidase, The Journal of Biological Chemistry, 278(27):24324-24333. |
Gough et al. 2000. Immobilized glucose oxidase in implantable glucose sensor technology. Diabetes Technology & Therapeutics 2(3):377-380. |
Gough et al. 2003. Frequency characterization of blood glucose dynamics. Annals of Biomedical Engineering 31:91-97. |
Gross et al. 2000. Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technology & Therapeutics, 2(Suppl 1):S19-26. |
Gross et al. 2000. Performance evaluation of the MiniMed® continuous glucose monitoring system during patient home use. Diabetes Technology & Therapeutics 2(1):49-56. |
Guerci et al., Clinical performance of CGMS in type 1 diabetic patents treated by continuous subcutaneous insulin infusion using insulin analogs, Diabetes Care, 26:582-589, 2003. |
Hall et al. 1998. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part II: Effect of potential. Electrochimica Acta 43(14-15):2015-2024. |
Hall et al. 1998. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part I: An adsorption-controlled mechanism. Electrochimica Acta, 43(5-6):579-588. |
Hall et al. 1999. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part III: Effect of temperature. Electrochimica Acta, 44:2455-2462. |
Hall et al. 1999. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part IV: Phosphate buffer dependence. Electrochimica Acta, 44:4573-4582. |
Hall et al. 2000. Electrochemical oxidation of hydrogen peroxide at platinum electrodes. Part V: Inhibition by chloride. Electrochimica Acta, 45:3573-3579. |
Hashiguchi et al. (1994). “Development of a miniaturized glucose monitoring system by combining a needle-type glucose sensor with microdialysis sampling method: Long-term subcutaneous tissue glucose monitoring in ambulatory diabetic patients,” Diabetes Care, 17(5): 387-396. |
Heller, “Electrical wiring of redox enzymes,” Acc. Chem. Res., 23:128-134 (1990). |
Heller, A. 1992. Electrical Connection of Enzyme Redox Centers to Electrodes. J. Phys. Chem. 96:3579-3587. |
Heller, A. 1999. Implanted electrochemical glucose sensors for the management of diabetes. Annu Rev Biomed Eng 1:153-175. |
Heller, A. 2003. Plugging metal connectors into enzymes. Nat Biotechnol 21:631-2. |
Hicks, 1985. In Situ Monitoring, Clinical Chemistry, 31(12):1931-1935. |
Hitchman, M. L. 1978. Measurement of Dissolved Oxygen. In Elving et al. (Eds.). Chemical Analysis, vol. 49, Chap. 3, pp. 34-49, 59-123. New York: John Wiley & Sons. |
Hrapovic et al. 2003. Picoamperometric detection of glucose at ultrasmall platinum-based biosensors: preparation and characterization. Anal Chem 75:3308-3315. |
Hu, et al. 1993. A needle-type enzyme-based lactate sensor for in vivo monitoring, Analytica Chimica Acta, 281:503-511. |
Huang et al. A 0.5mV passive telemetry IC for biomedical applications. Swiss Federal Institute of Technology. 4 pp. |
Huang et al. Aug. 1975. Electrochemical Generation of Oxygen. 1: The Effects of Anions and Cations on Hydrogen Chemisorption and Aniodic Oxide Film Formation on Platinum Electrode. 2: The Effects of Anions and Cations on Oxygen Generation on Platinum Electrode, pp. 1-116. |
Hunter et al. 2000. Minimally Invasive. Glucose Sensor and Insulin Delivery System. MIT Home Automation and Healthcare Consortium. Progress Report No. 25. |
lshikawa et al. 1998. Initial evaluation of a 290-mm diameter subcutaneous glucose sensor: Glucose monitoring with a biocompatible, flexible-wire, enzyme-based amperometric microsensor in diabetic and nondiabetic humans. Journal of Diabetes and Its Complications, 12:295-301. |
Jensen et al. 1997. Fast wave forms for pulsed electrochemical detection of glucose by incorporation of reductive desorption of oxidation products. Analytical Chemistry 69(9)1776-1781. |
Jeutter, D. C. 1982. A transcutaneous implanted battery recharging and biotelemeter power switching system. IEEE Trans Biomed Eng 29:314-321. |
Johnson (1991). “Reproducible electrodeposition of biomolecules for the fabrication of miniature electroenzymatic biosensors,” Sensors and Actuators B, 5:85-89. |
Johnson et al. 1992. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosensors & Bioelectronics, 7:709-714. |
Jovanovic, L. 2000. The role of continuous glucose monitoring in gestational diabetes mellitus. Diabetes Technology & Therapeutics, 2 Suppl 1, S67-71. |
Kacaniklic May-Jun. 1994. Electroanalysis, 6(5-6):381-390. |
Kamath et al. Calibration of a continuous glucose monitor: effect of glucose rate of change, Eighth Annual Diabetes Technology Meeting, Nov. 13-15, 2008, p. A88. |
Kang et al. 2003. In vitro and short-term in vivo characteristics of a Kel-F thin film modified glucose sensor. Anal Sci 19:1481-1486. |
Kaufman et al. 2001. A pilot study of the continuous glucose monitoring system. Diabetes Care 24(12):2030-2034. |
Kaufman. 2000. Role of the continuous glucose monitoring system in pediatric patients. Diabetes Technology & Therapeutics 2(1):S-49-S-52. |
Kawagoe et al. 1991. Enzyme-modified organic conducting salt microelectrode, Anal. Chem. 63:2961-2965. |
Kerner et al. “The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma,” Biosensors & Bioelectronics, 8:473-482 (1993). |
Kerner et al. 1988. A potentially implantable enzyme electrode for amperometric measurement of glucose, Horm Metab Res Suppl. 20:8-13. |
Kiechle, F.L. 2001. The impact of continuous glucose monitoring on hospital point-of-care testing programs. Diabetes Technol Ther 3:647-649. |
Klueh et al. 2003. Use of Vascular Endothelia Cell Growth Factor Gene Transfer to Enhance Implantable Sensor Function in Vivo, Biosensor Function and Vegf-Gene Transfer, pp. 1072-1086. |
Kondo et al. 1982. A miniature glucose sensor, implantable in the blood stream. Diabetes Care. 5(3):218-221. |
Koschinsky et al. 1988. New approach to technical and clinical evaluation of devices for self-monitoring of blood glucose. Diabetes Care 11(8): 619-619. |
Koschinsky et al. 2001. Sensors for glucose monitoring: Technical and clinical aspects. Diabetes Metab. Res. Rev. 17:113-123. |
Kost et al. 1985. Glucose-sensitive membranes containing glucose oxidase: activitiy, swelling, and permeability studies, Journal of Biomedical Materials Research 19:1117-1133. |
Koudelka et al. 1989. In vivo response of microfabricated glucose sensors to glycemia changes in normal rats. Biomed Biochim Acta 48(11-12):953-956. |
Koudelka et al. 1991. In-vivo behaviour of hypodermically implanted microfabricated glucose sensors. Biosensors & Bioelectronics 6:31-36. |
Kraver et al. 2001. A mixed-signal sensor interface microinstrument. Sensors and Actuators A 91:266-277. |
Kruger et al. 2000. Psychological motivation and patient education: A role for continuous glucose monitoring. Diabetes Technology & Therapeutics, 2(Suppl 1):S93-97. |
Kulys et al., 1994. Carbon-paste biosensors array for long-term glucose measurement, Biosensors& Beioelectronics, 9:491-500. |
Kunjan et al., Automated blood sampling and glocuse sensing in critical care settings, Journal of Diabetes Science and Technology 2(3):194-200, Mar. 2008. |
Kurnik et al. 1999. Application of the mixtures of experts algorithm for signal processing in a noninvasive glucose monitoring system. Sensors and Actuators B, 60:19-26. |
Kurtz et al. 2005. Recommendations for blood pressure measurement in humans and experimental animals, Part 2: Blood pressure measurement in experimental animals, A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 45:299-310. |
Ladd et al., Structure Determination by X-ray Crystallography, 3rd ed. Plenum, 1996, Ch. 1, pp. xxi-xxiv and 1-58. |
Lehmann et al. May 1994. Retrospective valication of a physiological model of glucose-iunsulin interaaction in tyhpe 1 diabetes mellitus, Med. Eng. Phys. 16:193-202. |
Lerner et al. 1984. An implantable electrochemical glucose sensor. Ann. N. Y. Acad. Sci. 428:263-278. |
Lewandowski et al. 1988. Evaluation of a miniature blood glucose sensor. Trans Am Svc Artif Intern Organs 34:255-258. |
Leypoldt et al. 1984. Model of a two-substrate enzyme electrode for glucose. Anal. Chem. 56:2896-2904. |
Linke et al. 1994. Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosensors & Bioelectronics 9:151-158. |
Lohn et al., A knowledge-based system for real-time validation of calibrations and measurements, Chemometrics and intelligent Laboratory Systems, 1999 46, 57-66. |
Lowe, 1984. Biosensors, Trends in Biotechnology, 2(3):59-65. |
Luong et al. 2004. Solubilization of Multiwall Carbon Nanotubes by 3-Aminopropyltriethoxysilane Towards the Fabrication of Electrochemical Biosensors with Promoted Electron Transfer. Electronanalysis 16(1-2):132-139. |
Lyandres et al. (2008). Progress toward an in vivo surface-enhanced raman spectroscopy glucose sensor. Diabetes Technology & Therapeutics, 10(4): 257-265. |
Maiden et al. 1992. Elimination of Electrooxidizable Interferent-Produced Currents in Amperometric Biosensors, Analytical Chemistry, 64:2889-2896. |
Makale et al. 2003. Tissue window chamber system for validation of implanted oxygen sensors. Am. J. Physiol. Heart Circ. Physiol. 284:H2288-2294. |
Malin et al. 1999. Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectroscopy. Clinical Chemistry 45:9, 1651-1658. |
Maran et al. 2002. Continuous subcutaneous glucose monitoring in diabetic patients: A multicenter analysis. Diabetes Care 25(2):347-352. |
March, W. F. 2002. Dealing with the delay. Diabetes Technol Them 4(1):49-50. |
Marena et al. 1993. The artifical endocrine pancreas in clinical practice and research. Panminerva Medica 35(2):67-74. |
Martin, R. F. 2000. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clinical Chemistry, 46(1):100-104. |
Mastrototaro et al. “An electroenzymatic glucose sensor fabricated on a flexible substrate,” Sensors and Actuators B, 5:139-44 (1991). |
Mastrototaro et al. 2003. Reproducibility of the continuous glucose monitoring system matches previous reports and the intended use of the product. Diabetes Care 26:256; author reply p. 257. |
Mastrototaro, J. J. 2000. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther 2(Suppl 1):S13-8. |
Matsumoto et al. 1998. A micro-planar amperometeric glucose sensor unsusceptible to interference species. Sensors and Actuators B 49:68-72. |
Matthews et al. 1988. An amperometric needle-type glucose sensor testing in rats and man. Diabetic Medicine 5:248-252. |
Mazze et al. 2008. Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diab. Thechnol. & Therapeut., 10:149-159. |
McCartney et al. 2001. Near-infrared fluorescence lifetime assay for serum glucose based on allophycocyanin-labeled concanavalin A. Anal Biochem 292:216-221. |
McGrath et al. 1995. The use of differential measurements with a glucose biosensor for interference compensation during glucose determinations by flow injection analysis. Biosens Bioelectron 10:937-943. |
McKean, at al. Jul. 7, 1988. A Telemetry Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors. Transactions on Biomedical Engineering 35:526-532. |
Memoli et al. 2002. A comparison between different immobilised glucoseoxidase-based electrodes. J Pharm Biomed Anal 29:1045-1052. |
Meyerhoff et al. 1992. On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia 35:1087-1092. |
Moatti-Sirat et al. 1992. Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor, Biosensors & Bioelectronics 7:345-352. |
Moatti-Sirat et al. 1992. Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue. Diabetologia 35:224-230. |
Moatti-Sirat et al., Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man, Diabetologia 37(6):610-616, Jun. 1994. |
Morff et al. 1990. Microfabrication of reproducible, economical, electroenzymatic glucose sensors, Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 12(2):0483-0484. |
Mosbach et al. 1975. Determination of heat changes in the proximity of immobilized enzymes with an enzyme termistor and its use for the assay of metobolites, Biochim. Biophys. Acta. (Enzymology), 403:256-265. |
Motonaka et al. 1993. Determination of cholesteral and cholesteral ester with novel enzyme microsensors, Anal. Chem. 65:3258-3261. |
Murphy, et al. 1992. Polymer membranes in clinical sensor applications. II. The design and fabrication of permselective hydrogels for electrochemical devices, Biomaterials, 13(14):979-990. |
Muslu. 1991. Trickling filter performance. Apllied Biochemistry and Biotechnology 37:211-224. |
Nafion® 117 Solution Product Description, Product No. 70160, Sigma-Aldrich Corp., St. Louis, MO. |
Ohara et al. 1994. “Wired” enzyme electrodes for amperometric determination of glucose or lactate in 1013 the presence of interfering substances. Anal Chem 66:2451-2457. |
Ohara, et al. Dec. 1993. Glucose electrodes based on cross-linked bis(2,2′-bipyridine)chloroosmium(+/2+) complexed poly(1-vinylimidazole) films, Analytical Chemistry, 65:3512-3517. |
Okuda et al. 1971. Mutarotase effect on micro determinations of D-glucose and its anomers with β-D- glucose oxidase. Anal Biochem 43:312-315. |
Palmisano et al. 2000. Simultaneous monitoring of glucose and lactate by an interference and cross-talk free dual electrode amperometric biosensor based on electropolymerized thin films. Biosensors & Bioelectronics 15:531-539. |
Patel et al. 2003. Amperometric glucose sensors based on ferrocene containing polymeric electron transfer systems—a preliminary report. Biosens Bioelectron 18:1073-6. |
Peacock et al. 2008. Cardiac troponin and outcome in acute heart failure. N. Engl. J. Med., 358: 2117-2126. |
Pfeiffer et al. 1992. On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm, Metab. Res. 25:121-124. |
Pfeiffer, E.F. 1990. The glucose sensor: the missing link in diabetes therapy, Horm Metab Res Suppl. 24:154-164. |
Pichert et al. 2000. Issues for the coming age of continuous glucose monitoring Diabetes Educ 26(6):969-980. |
Pickup et al. “Implantable glucose sensors: choosing the appropriate sensing strategy,” Biosensors, 3:335-346 (1987/88). |
Pickup et al. “In vivo molecular sensing in diabetes mellitus: an implantable glucose sensor with direct electron transfer,” Diabetologia, 32:213-217 (1989). |
Pickup et al. 1989. Potentially-implantable, amperometric glucose sensors with mediated electron transfer: improving the operating stability. Biosensors 4:109-119. |
Pinner et al., Cross-linking of cellulose acetate by ionizing radiation, Nature, vol. 184, 1303-1304, Oct. 24, 1959. |
Pishko et al. “Amperometric glucose microelectrodes prepared through immobilization of glucose oxidase in redox hydrogels,” Anal. Chem., 63:2268-72 (1991). |
Pitzer et al. 2001. Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care 24(5):881-885. |
Poitout et al. 1993. A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit. Diabetologia 36:658-663. |
Poitout et al. 1994. Development of a glucose sensor for glucose monitoring in man: the disposable implant concept. Clinical Materials 15:241-246. |
Poitout, et al. 1991. In Vitro and in Vivo Evaluation in Dogs of a Miniaturized Glucose Sensor, ASAIO Transactions, 37:M298-M300. |
Postlethwaite et al. 1996. Interdigitated array electrode as an alternative to the rotated ring-disk electrode for determination of the reaction products of dioxygen reduction. Analytical Chemistry 68:2951-2958. |
Prabhu et al. 1981. Electrochemical studies of hydrogen peroxide at a platinum disc electrode, Electrochimica Acta 26(6):725-729. |
Quinn et al. 1995. Kinetics of glucose delivery to subcutaneous tissue in rats measured with 0.3-mm amperometric microsensors. The American Physiological Society E155-E161. |
Quinn et al. 1997. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials 18:1665-1670. |
Rabah et al., 1991. Electrochemical wear of graphite anodes during electrolysis of brine, Carbon, 29(2):165-171. |
Reach et al. 1986. A Method for Evaluating in vivo the Functional Characteristics of Glucose Sensors. Biosensors 2:211-220. |
Reach et al. 1992. Can continuous glucose monitoring be used for the treatment of diabetes? Analytical Chemistry 64(5):381-386. |
Reach, G. 2001. Which threshold to detect hypoglycemia? Value of receiver-operator curve analysis to find a compromise between sensitivity and specificity. Diabetes Care 24(5):803-804. |
Reach, Gerard. 2001. Letters to the Editor Re: Diabetes Technology & Therapeutics, 2000;2:49-56. Diabetes Technology & Therapeutics 3(1):129-130. |
Rebrin et al. “Automated feedback control of subcutaneous glucose concentration in diabetic dogs,” Diabetologia, 32:573-76 (1989). |
Rebrin et al. 1992. Subcutaenous glucose monitoring by means of electrochemical sensors: fiction or reality? J. Biomed. Eng. 14:33-40. |
Rhodes et al. 1994. Prediction of pocket-portable and implantable glucose enzyme electrode performance from combined species permeability and digital simulation analysis. Analytical Chemistry 66(9):1520-1529. |
Rigla et al. 2008. Real-time continuous glucose monitoring together with telemedical assitance improves glycemic control and glucose stability in pump-treated patients. Diab. Thechnol. & Therapeut., 10:194-199. |
Rinken et al. 1998. Calibration of glucose biosensors by using pre-steady state kinetic data. Biosensors & Bioelectronics, 13:801-807. |
Rivers et al., Central venous oxygen saturation monitoring in the critically ill patient, Current Opinion in Critical Care, 7:204-211, 2001. |
Sakakida et al. 1992. Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations. Artif. Organs Today 2(2):145-158. |
Sakakida et al. 1993. Ferrocene-Mediated Needle Type Glucose Sensor Covered with Newly Designed Biocompatible Membran, Sensors and Actuators B 13-14:319-322. |
Salardi et al. 2002. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA1c in pediatric type 1 diabetic patients. Diabetes Care 25(10):1840-1844. |
Sansen et al. 1985. “Glucose sensor with telemetry system.” In Ko, W. H. (Ed.). Implantable Sensors for Closed Loop Prosthetic Systems. Chap. 12, pp. 167-175, Mount Kisco, NY: Future Publishing Co. |
Sansen et al. 1990. A smart sensor for the voltammetric measurement of oxygen or glucose concentrations. Sensors and Actuators B 1:298-302. |
Schmidt et al. 1993. Glucose concentration in subcutaneous extracellular space. Diabetes Care 16(5):695-700. |
Schmidtke et al., Measurement and modeling of the transient difference between blood and subcutaneous glucose concentrations in the rat after injection of insulin. Proc Natl Acad Sci U S A 1998, 95, 294-299. |
Schoemaker et al. 2003. The SCGM1 system: Subcutaneous continuous glucose monitoring based on microdialysis technique. Diabetes Technology & Therapeutics 5(4):599-608. |
Schoonen et al. 1990 Development of a potentially wearable glucose sensor for patients with diabetes mellitus: design and in-vitro evaluation. Biosensors & Bioelectronics 5:37-46. |
Service et al. 1970. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes, 19: 644-655. |
Service et al. 1987. Measurements of glucose control. Diabetes Care, 10: 225-237. |
Service, R. F. 2002. Can sensors make a home in the body? Science 297:962-3. |
Sharkawy et al. 1996. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties, J Biomed Mater Res, 37:401-412. |
Shaw et al. “In vitro testing of a simply constructed, highly stable glucose sensor suitable for implantation in diabetic patients,” Biosensors & Bioelectronics, 6:401-406 (1991). |
Shichiri et al. 1982. Wearable artificial endocrine pancrease with needle-type glucose sensor. Lancet 2:1129-1131. |
Shichiri et al. 1983. Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas. Diabetologia 24:179-184. |
Shichiri et al. 1985. Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas in Implantable Sensors 197-210. |
Shichiri et al. 1986, Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals. Diabetes Care, Inc. 9(3);298-301. |
Shichiri et al. 1989. Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor. Diab. Nutr. Metab. 2:309-313. |
Shults et al. 1994. A telemetry-instrumentation system for monitoring multiple subcutaneously implanted glucose sensors. IEEE Transactions on Biomedical Engineering 41(10):937-942. |
Skyler, J. S. 2000. The economic burden of diabetes and the benefits of improved glycemic control: The potential role of a continuous glucose monitoring system. Diabetes Technology & Therapeutics 2 Suppl 1:S7-12. |
Slater-Maclean et al. 2008. Accuracy of glycemic measurements in the critically ill. Diab. Thechnol. & Therapeut., 10:169-177. |
Sokol et al. 1980, Immobilized-enzyme rate-determination method for glucose analysis, Clin. Chem. 26(1):89-92. |
Sriyudthsak et al. 1996. Enzyme-epoxy membrane based glucose analyzing system and medical applications. Biosens Bioelectron 11:735-742. |
Steil et al. 2003. Determination of plasma glucose during rapid glucose excursions with a subcutaneous glucose sensor. Diabetes Technology & Therapeutics 5(1):27-31. |
Stern et al., 1957. Electrochemical polarization: 1. A theoretical analysis of the shape of polarization curves, Journal of the Electrochemical Society, 104(1):56-63. |
Sternberg et al. 1988. Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors. Biosensors 4:27-40. |
Sumino T. et al. 1998. Preliminary study of continuous glucose monitoring with a microdialysis technique. Proceedings of the IEEE, 20(4)1775-1778. |
Takegami et al. 1992. Pervaporation of ethanol water mixtures using novel hydrophobic membranes containing polydimethylsiloxane, Journal of Membrance Science, 75(93-105). |
Tanenberg et al. 2000. Continuous glucose monitoring system: A new approach to the diagnosis of diabetic gastroparesis. Diabetes Technology & Therapeutics, 2 Suppl 1:S73-80. |
Tatsuma et al. 1991. Oxidase/peroxidase bilayer-modified electrodes as sensors for lactate, pyruvate, cholesteral and uric acid, Analytica Chimica Acta, 242:85-89. |
Thome et al. 1995. Can the decrease in subcutaneous glucose concentration precede the decrease in blood glucose level? Proposition for a push-pull kinetics hypothesis, Harm. Metab. Res. 27:53. |
Thomé-Duret et al. 1996. Modification of the sensitivity of glucose sensor implanted into subcutaneous tissue. Diabetes Metabolism, 22:174-178. |
Thome-Duret et al. 1996. Use of a subcutaneous glucose sensor to detect decreases in glucose concentration prior to observation in blood, Anal. Chem. 68:3822-3826. |
Thomé-Duret et al. 1998. Continuous glucose monitoring in the free-moving rat. Metabolism, 47:799-803. |
Thompson et al., In Vivo Probes: Problems and Perspectives, Department of Chemistry, University of Toronto, Canada, pp. 255-261, 1986. |
Tierney et al. 2000. Effect of acetaminophen on the accuracy of glucose measurements obtained with the GlucoWatch biographer. Diabetes Technol Ther 2:199-207. |
Tierney at al. 2000. The GlucoWatch® biographer: A frequent, automatic and noninvasive glucose monitor. Ann. Med. 32:632-641. |
Torjman et al., Glucose monitoring in acute care: technologies on the horizon, Journal of Deabetes Science and Technology, 2(2):178-181, Mar. 2008. |
Trecroci, D. 2002. A Glimpse into the Future- Continuous Monitoring of Glucose with a Microfiber. Diabetes Interview 42-43. |
Tse and Gough. 1987. Time-Dependent Inactivation of Immobilized Glucose Oxidase and Catalase. Biotechnol. Bioeng. 29:705-713. |
Turner and Pickup, “Diabetes mellitus: biosensors for research and management,” Biosensors, 1:85-115 (1985). |
Unger et al. 2004. Glucose control in the hospitalized patient. Emerg Med 36(9):12-18. |
Updike et al. 1967. The enzyme electrode. Nature, 214:986-988. |
Updike et al. 1979. Continuous glucose monitor based on an immobilized enzyme electrode detector. J Lab Clin Med, 93(4):518-527. |
Updike et al. 1982. Implanting the glucose enzyme electrode: Problems, progress, and alternative solutions. Diabetes Care, 5(3):207-212. |
Updike et al. 1988. Laboratory Evaluation of New Reusable Blood Glucose Sensor. Diabetes Care, 11:801-807. |
Updike et al. 1994. Enzymatic glucose sensor: Improved long-term performance in vitro and in vivo. ASAIO Journal, 40(2):157-163. |
Updike et al. 1997. Principles of long-term fully implanted sensors with emphasis on radiotelemetric monitoring of blood glucose form inside a subcutaneous foreign body capsule (FBC). In Fraser, ed., Biosensors in the Body. New York. John Wiley & Sons, pp. 117-137. |
Updike et al. 2000. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 23(2):208-214. |
Utah Medical Products Inc., Blood Pressure Tranducers product specifications. 6 pp. 2003-2006, 2003. |
Vadgama, P. Nov. 1981. Enzyme electrodes as practical biosensors. Journal of Medical Engineering & Technology 5(6):293-298. |
Van den Berghe 2004. Tight blood glucose control with insulin in “real-life” intensive care. Mayo Clin Proc 79(8):977-978. |
Velho et al. 1989. In vitro and in vivo stability of electrode potentials in needle-type glucose sensors. Influence of needle material. Diabetes 38:164-171. |
Velho et al, 1989. Strategies for calibrating a subcutaneous glucose sensor. Biomed Biochim Acta 48(11/12):957-964. |
von Woedtke et al. 1989. In situ calibration of implanted electrochemical glucose sensors. Biomed Biochim. Acta 48(11/12):943-952. |
Wagner et al. 1998. Continuous amperometric monitoring of glucose in a brittle diabetic chimpanzee with a miniature subcutaneous electrode. Proc. Natl. Acad. Sci. A, 95:6379-6382. |
Wang et al. 1994. Highly Selective Membrane-Free, Mediator-Free Glucose Biosensor. Anal. Chem. 66:3600-3603. |
Wang et al. 1997. Improved ruggedness for membrane-based amperometric sensors using a pulsed amperometric method. Anal Chem 69:4482-4489. |
Ward et al. 1999. Assessment of chronically implanted subcutaneous glucose sensors in dogs: The effect of surrounding fluid masses. ASAIO Journal, 45:555-561. |
Ward et al. 2000. Understanding Spontaneous Output Fluctuations of an Amperometric Glucose Sensor: Effect of Inhalation Anesthesia and e of a Nonenzyme Containing Electrode. ASAIO Journal 540-546. |
Ward et al. 2000. Rise in background current over time in a subcutaneous glucose sensor in the rabbit: Relevance to calibration and accuracy. Biosensors & Bioelectronics, 15:53-61. |
Ward et al. 2002. A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosensors & Bioelectronics, 17:181-189. |
Wientjes, K. J. C. 2000. Development of a glucose sensor for diabetic patients (Ph.D. Thesis). |
Wikipedia 2006. “Intravenous therapy,” http://en.wikipedia.org/wiki/Intravenous—therapy, Aug. 15, 2006, 6 pp. |
Wilkins et al. 1988. The coated wire electrode glucose sensor, Horm Metab Res Suppi., 20:50-55. |
Wilkins et al. 1995. Glucose monitoring: state of the art and future possibilities. Med Eng Phys 18:273-288. |
Wilkins et al. 1995. Integrated implantable device for long-term glucose monitoring. Biosens. Bioelectron 10:485-494. |
Wilson et al. 1992. Progress toward the development of an implantable sensor for glucose. Clin. Chem. 38(9):1613-1617. |
Wilson et al. 2000. Enzyme-based biosensors for in vivo measurements. Chem. Rev., 100:2693-2704. |
Wood, W. et al. Mar. 1990. Hermetic Sealing with Epoxy. Mechanical Engineering 1-3. |
Woodward. 1982. How Fibroblasts and Giant Cells Encapsulate Implants: Considerations in Design of Glucose Sensor. Diabetes Care 5:278-281. |
Worsley et al., Measurement of glucose in blood with a phenyiboronic acid optical sensor, Journal of Diabetes Science and Technology, 2(2):213-220, Mar. 2008. |
Wright et al., Bioelectrochemical dehalogenations via direct electrochemistry of poly(ethylene oxide)-modified myoglobin, Electrochemistry Communications 1 (1999) 603-611. |
Wu et al. 1999. In situ electrochemical oxygen generation with an immunoisolation device. Annals New York Academy of Sciences, pp. 105-125. |
Yamasaki et al. 1989. Direct measurement of whole blood glucose by a needle-type sensor. Clinica Chimica Acta. 93:93-98. |
Yamasaki, Yoshimitsu. Sep. 1984. The development of a needle-type glucose sensor for wearable artificial endocrine pancreas. Medical Journal of Osaka University 35(1-2):25-34. |
Yang et al (1996). “A glucose biosensor based on an oxygen electrode: In-vitro performances in a model buffer solution and in blood plasma,” Biomedical Instrumentation & Technology, 30:55-61. |
Yang et al. 1998. Development of needle-type glucose sensor with high selectivity. Science and Actuators B 46:249-256. |
Yang, et al. 2004. A Comparison of Physical Properties and Fuel Cell Performance of Nation and Zirconium Phosphate/Nafion Composite Membranes. Journal of Membrane Science 237:145-161. |
Zamzow et al. Development and evaluation of a wearable blood glucose monitor. pp. M588-M591, 1990. |
Zethelius et al. 2008. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N. Engl. J. Med., 358: 2107-2116. |
Zhang et al (1993). Electrochemical oxidation of H2O2 on Pt and Pt + Ir electrodes in physiological buffer and its applicability to H2O2-based biosensors. J. Electroanal. Chem., 345:253-271. |
Zhang et al. 1994. Elimination of the acetaminophen interference in an implantable glucose sensor. Analytical Chemistry 66(7):1183-1188. |
Zhu et al. (1994). “Fabrication and characterization of glucose sensors based on a microarray H2O2 electrode.” Biosensors & Bioelectronics, 9: 295-300. |
Zhu et al. 2002. Planar amperometric glucose sensor based on glucose oxidase immobilized by chitosan film on prussian blue layer. Sensors, 2:127-136. |
Office Action dated Sep. 30, 2002 in U.S. Appl. No. 09/636,369. |
Office Action dated Jul. 15, 2008 in U.S. Appl. No. 10/633,367. |
Office Action dated Jun. 11, 2009 in U.S. Appl. No. 10/633,367. |
Office Action dated Jul. 7, 2009 in U.S. Appl. No. 12/102,729. |
Office Action dated Dec. 23, 2008 in U.S. Appl. No. 12/102,745. |
Office Action dated May 22, 2006 in U.S. Appl. No. 10/896,772. |
Office Action dated Dec. 14, 2005 in U.S. Appl. No. 10/896,772. |
Office Action dated Jul. 19, 2005 in U.S. Appl. No. 10/896,772. |
Office Action dated Jan. 11, 2005 in U.S. Appl. No. 10/896,772. |
Office Action dated Dec. 21, 2004 in U.S. Appl. No. 10/632,537. |
Office Action dated Oct. 20, 2004 in U.S. Appl. No. 10/632,537. |
Office Action dated May 29, 2008 in Reexam U.S. Appl. No. 95/001,039. |
Office Action dated Jun. 17, 2008 in U.S. Appl. No. 11/038,340. |
Office Action dated Jan. 5, 2009 in U.S. Appl. No. 11/038,340. |
Office Action dated May 19, 2009 in U.S. Appl. No. 11/038,340. |
Office Action dated Feb. 12, 2007 in U.S. Appl. No. 10/633,404. |
Office Action dated Jun. 17, 2008 in Reexam U.S. Appl. No. 95/001,038. |
Office Action dated Oct. 5, 2006 in U.S. Appl. No. 10/633,329. |
Office Action dated Mar. 26, 2007 in U.S. Appl. No. 10/633,329. |
Office Action dated Jul. 30, 2007 in U.S. Appl. No. 10/633,329. |
Office Action dated Feb. 4, 2008 in U.S. Appl. No. 10/633,329. |
Office Action dated Jun. 12, 2008 in U.S. Appl. No. 10/633,329. |
Office Action dated Dec. 18, 2008 in U.S. Appl. No. 10/633,329. |
Office Action dated Jun. 11, 2009 in U.S. Appl. No. 10/633,329. |
Office Action dated Jun. 23, 2009 in U.S. Appl. No. 10/648,849. |
Office Action dated Jun. 24, 2008 in U.S. Appl. No. 11/007,920. |
Office Action dated Jan. 27, 2006 in U.S. Appl. No. 11/007,635. |
Office Action dated Nov. 28, 2007 in U.S. Appl. No. 10/991,966. |
Office Action dated Jul. 22, 2008 in U.S. Appl. No. 10/991,966. |
Office Action dated Nov. 27, 2006 in U.S. Appl. No. 10/789,359. |
Office Action dated Mar. 20, 2008 in U.S. Appl. No. 10/789,359. |
Office Action dated Oct. 3, 2008 in U.S. Appl. No. 10/789,359. |
Office Action dated Jan. 15, 2008 in U.S. Appl. No. 11/034,344. |
Office Action mailed Jun. 5, 2008 in U.S. Appl. No. 10/838,909. |
Office Action mailed Mar. 16, 2009 in U.S. Appl. No. 10/838,909. |
Office Action dated Mar. 31, 2008 in U.S. Appl. No. 11/077,759. |
Office Action dated Jul. 10, 2008 in U.S. Appl. No. 11/077,759. |
Office Action dated May 26, 2009 in U.S. Appl. No. 11/077,759. |
Office Action dated Jul. 21, 2009 in U.S. Appl. No. 11/077,739. |
Office Action dated Jun. 1, 2007 in U.S. Appl. No. 11/077,740. |
Office Action dated Nov. 1, 2007 in U.S. Appl. No. 11/077,740. |
Office Action dated Feb. 7, 2008 in U.S. Appl. No. 11/077,740. |
Office Action dated Jul. 25, 2008 in U.S. Appl. No. 11/077,740. |
Office Action dated Apr. 28, 2009 in U.S. Appl. No. 11/077,740. |
Office Action dated Dec. 31, 2007 in U.S. Appl. No. 11/077,765. |
Office Action dated May 16, 2008 in U.S. Appl. No. 11/077,765. |
Office Action dated Sep. 19, 2008 in U.S. Appl. No. 11/077,765. |
Office Action dated Jan. 23, 2009 in U.S. Appl. No. 11/077,765. |
Office Action dated May 5, 2008 in U.S. Appl. No. 11/078,232. |
Office Action dated Nov. 12, 2008 in U.S. Appl. No. 11/078,232. |
Office Action dated Mar. 5, 2009 in U.S. Appl. No. 11/078,232. |
Office Action dated Jul. 21, 2009 in U.S. Appl. No. 11/078,232. |
Office Action dated Jul. 27, 2007 in U.S. Appl. No. 11/077,714. |
Office Action dated Apr. 10, 2007 in U.S. Appl. No. 11/077,714. |
Office Action dated Oct. 11, 2006 in U.S. Appl. No. 11/077,714. |
Office Action dated Jan. 10, 2008 in U.S. Appl. No. 11/077,714. |
Office Action dated Sep. 16, 2008 in U.S. Appl. No. 11/077,714. |
Office Action dated Apr. 16, 2009 in U.S. Appl. No. 11/077,714. |
Office Action dated Jun. 26, 2008 in U.S. Appl. No. 11/157,365. |
Office Action dated Jan. 7, 2009 in U.S. Appl. No. 11/157,365. |
Office Action dated Jul. 21, 2009 in U.S. Appl. No. 11/157,365. |
Office Action dated Oct. 4, 2006 in U.S. Appl. No. 11/334,876. |
Office Action dated Sep. 25, 2007 in U.S. Appl. No. 11/334,876. |
Office Action dated May 2, 2008 in U.S. Appl. No. 11/334,876. |
Office Action dated Aug. 26, 2008 in U.S. Appl. No. 11/334,876. |
Office Action dated Jun. 30, 2008 in U.S. Appl. No. 11/360,252. |
Office Action dated Jan. 29, 2009, in U.S. Appl. No. 11/360,252. |
Office Action dated Jul. 23, 2009, in U.S. Appl. No. 11/360,252. |
Office Action dated Aug. 11, 2008 in U.S. Appl. No. 11/360,819. |
Office Action dated Dec. 26, 2008 in U.S. Appl. No. 11/360,819. |
Office Action dated Nov. 28, 2008 in U.S. Appl. No. 11/333,837. |
Office Action dated Jun. 29, 2009 in U.S. Appl. No. 11/333,837. |
U.S. Appl. No. 09/447,227, filed Nov. 22, 1999. |
U.S. Appl. No. 11/654,135, filed Jan. 17, 2007. |
Ciba® Irgacure® 2959 Photoinitiator, Product Description. Apr. 2, 1998. Ciba Specialty Chemicals Inc., Basel, Switzerland. 3 pages. [corrected cite]. |
Direct 30/30® Blood Glucose Sensor, (Markwell Medical) Catalog, ©1990, ELCO Diagnostics Company. 1 page. [corrected cite]. |
DuPont' Dimension AR®. 1998. The chemistry analyzer that makes the most of your time, money and effort. Catalog. Dade International, Chemistry Systems. Newark, DE. 18 pages. . [corrected cite]. |
Huang et al., Sep. 1997, A 0.5mW Passive Telemetry IC for Biomedical Applications, Proceedings of the 23rd European Solid-State Circuits Conference (ESSCIRC '97), pp. 172-175, Southampton, UK [corrected cite]. |
Hunter et al. Mar. 31, 2000. Minimally Invasive Glucose Sensor and Insulin Delivery System. MIT Home Automation and Healthcare Consortium. Progress Report No. 2-5. 17 pages. . [corrected cite]. |
Nafion® 117 Solution Product Description, Product No. 70160, Sigma-Aldrich Corp., St. Louis, MO. Downloaded from https://www.signaaldrich.com/cgi-bin/hsrun/Suite7/Suite/HAHTpage/Suite.HsExternal Prod . . . on Apr. 7, 2005. [corrected cite]. |
Number | Date | Country | |
---|---|---|---|
20090240120 A1 | Sep 2009 | US |
Number | Date | Country | |
---|---|---|---|
61030499 | Feb 2008 | US |